Section 58

EurekaMag PDF full texts Chapter 57,529


Bhuvaneswari, S.; Manonmani, A.M.; Geetha, I. 2015: Cost-effective medium for the production of mosquito pupicidal lipopeptide from Bacillus subtilis subsp. subtilis (VCRC B471). Journal of Vector Borne Diseases 52(1): 58-62
Minardo, A.; Catalano, E.; Zeni, L. 2016: Cost-effective method for fast Brillouin optical time-domain analysis. Optics Express 24(22): 25424-25431
Fachmann, M.S.R.; Josefsen, M.H.; Hoorfar, J.; Nielsen, M.T.; Löfström, C. 2015: Cost-effective optimization of real-time PCR-based detection of Campylobacter and Salmonella with inhibitor tolerant DNA polymerases. Journal of Applied Microbiology 119(5): 1391-1402
Cervo, S.; De Paoli, P.; Perin, T.; Canzonieri, V.; Steffan, A. 2015: Cost-effective organization of an institutional human cancer biobank in a clinical setting: CRO-Biobank experience toward harmonization. International Journal of Biological Markers 30(2): E243-E251
Kung, A.W.C.; McGhee, S.M.; Tsang, S.W.Y.; So, J.; Chau, J. 2015: Cost-effective osteoporosis intervention thresholds for Hong Kong postmenopausal women. Hong Kong Medical Journal 21(Suppl 6): 13-16
Makras, P.; Athanasakis, K.; Boubouchairopoulou, N.; Rizou, S.; Anastasilakis, A.D.; Kyriopoulos, J.; Lyritis, G.P. 2015: Cost-effective osteoporosis treatment thresholds in Greece. Osteoporosis International: a Journal Established as Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the Usa 26(7): 1949-1957
Abali, A.E. 2015: Cost-effective outpatient burn-care for minor burns. Burns: Journal of the International Society for Burn Injuries 41(3): 639-640
Saravanakumar, A.; Vaideki, K.; Govindarajan, K.N.; Jayakumar, S.; Devanand, B. 2015: Cost-effective pediatric head and body phantoms for computed tomography dosimetry and its evaluation using pencil ion chamber and CT dose profiler. Journal of Medical Physics 40(3): 170-175
Edouard, S.; Prudent, E.; Gautret, P.; Memish, Z.A.; Raoult, D. 2015: Cost-effective pooling of DNA from nasopharyngeal swab samples for large-scale detection of bacteria by real-time PCR. Journal of Clinical Microbiology 53(3): 1002-1004
López, Y.; Manrique, V.; Niubo, E.; Valdés-Dapena, M.; Pérez Amarillo, J.án.; López, I.; Parra, B.; Escalona Venegas, G.; Riverón, A.M.ía.; López-Cánovas, L. 2015: Cost-effective procedure for Streptococcus pyogenes immobilized DNA preparation and miniPFGE subtyping. Journal of Infection in Developing Countries 9(7): 710-719
Bala, A.; Singh, B. 2016: Cost-effective production of biotechnologically important hydrolytic enzymes by Sporotrichum thermophile. Bioprocess and Biosystems Engineering 39(1): 181-191
Chakraborty, S.; Gupta, R.; Jain, K.K.; Kuhad, R.C. 2016: Cost-effective production of cellulose hydrolysing enzymes from Trichoderma sp. RCK65 under SSF and its evaluation in saccharification of cellulosic substrates. Bioprocess and Biosystems Engineering 39(11): 1659-1670
Mostafavi Tabatabaee, R.; Rasouli, M.R.; Maltenfort, M.G.; Parvizi, J. 2015: Cost-effective prophylaxis against venous thromboembolism after total joint arthroplasty: warfarin versus aspirin. Journal of Arthroplasty 30(2): 159-164
Aung, T.; Haynes, R.; Barton, J.; Cox, J.; Murawska, A.; Murphy, K.; Lay, M.; Armitage, J.; Bowman, L. 2016: Cost-effective recruitment methods for a large randomised trial in people with diabetes: A Study of Cardiovascular Events iN Diabetes (ASCEND). Trials 17(1): 286
Chappell, A.; Li, Y.; Yu, H.Q.; Zhang, Y.Z.; Li, X.Y. 2015: Cost-effective sampling of (137)Cs-derived net soil redistribution: part 2 - estimating the spatial mean change over time. Journal of Environmental Radioactivity 144: 168-174
Li, Y.; Chappell, A.; Nyamdavaa, B.; Yu, H.; Davaasuren, D.; Zoljargal, K. 2015: Cost-effective sampling of ¹³⁷Cs-derived net soil redistribution: part 1--estimating the spatial mean across scales of variation. Journal of Environmental Radioactivity 141: 97-105
Choi, S.; Kim, J.; Choi, N-Soon.; Kim, M.Gyu.; Park, S. 2015: Cost-effective scalable synthesis of mesoporous germanium particles via a redox-transmetalation reaction for high-performance energy storage devices. Acs Nano 9(2): 2203-2212
Zhou, J.; Ouyang, J.; Xu, Q.; Zheng, Z. 2016: Cost-effective simultaneous saccharification and fermentation of l-lactic acid from bagasse sulfite pulp by Bacillus coagulans CC17. Bioresource Technology 222: 431-438
Pellegrin, K.L.; Barbato, A.; Holuby, R.Scott.; Ciarleglio, A.E.; Taniguchi, R. 2014: Cost-effective strategies for rural community outreach, Hawaii, 2010-2011. Preventing chronic disease 11: E215
Rabotyagov, S.S.; Campbell, T.D.; White, M.; Arnold, J.G.; Atwood, J.; Norfleet, M.L.; Kling, C.L.; Gassman, P.W.; Valcu, A.; Richardson, J.; Turner, R.E.; Rabalais, N.N. 2014: Cost-effective targeting of conservation investments to reduce the northern Gulf of Mexico hypoxic zone. Proceedings of the National Academy of Sciences of the United States of America 111(52): 18530-18535
Ferguson, T.W.; Tangri, N.; Rigatto, C.; Komenda, P. 2015: Cost-effective treatment modalities for reducing morbidity associated with chronic kidney disease. Expert Review of Pharmacoeconomics and Outcomes Research 15(2): 243-252
Tai, C.J.; Pan, C.K.; Wu, C.H.; Chen, C.S. 2016: Cost-effective treatment with half year of trastuzumab and chemotherapy as adjuvant treatment for overexpression of Her2/neu breast cancer patients: Two institutional experiences in Taiwan. Journal of Clinical Oncology 24(18_Suppl): 10765-10765
Malaviya, A.N.; Kapoor, S. 2014: Cost-effective use of investigations in developing countries. Best Practice and Research. Clinical Rheumatology 28(6): 960-972
Morrow, D.S.; Broder, J. 2015: Cost-effective, Reusable, Leak-resistant Ultrasound-guided Vascular Access Trainer. Journal of Emergency Medicine 49(3): 313-317
Aggarwal, H.; Kumar, P.; Eachempati, P.; Krishanappa, S.K.K. 2015: Cost-effective, expedient, and time-saving surface texturing technique for facial prostheses. Journal of Prosthetic Dentistry 114(3): 456-457
Sharma, P.; Bajaj, B.K. 2015: Cost-effective-substrates for production of poly-β-hydroxybutyrate by a newly isolated Bacillus cereus PS-10. Journal of Environmental Biology 36(6): 1297-1304
DeLea, T.; Tappenden, P.; Sofrygin, O.; Karnon, J.; Amonkar, M.; Browning, D.; Rudge, H.J.; Walker, M.D. 2016: Cost-effectiveness (CE) of lapatinib plus capecitabine (L+C) in women with HER2+ metastatic breast cancer (MBC) who received prior therapy with trastuzumab (TZ) based on updated survival data from EGF100151. Journal of Clinical Oncology 26(15_Suppl): 6559-6559
Barón Esquivias, G.; Escolar Albaladejo, Gés.; Zamorano, Jé.Luis.; Betegón Nicolás, L.; Canal Fontcuberta, C.; de Salas-Cansado, M.; Rubio-Rodríguez, Dío.; Rubio-Terrés, C. 2015: Cost-effectiveness Analysis Comparing Apixaban and Acenocoumarol in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation in Spain. Revista Espanola de Cardiologia 68(8): 680-690
Chakravarty, A.; Naware, S.S. 2008: Cost-effectiveness Analysis for Technology Acquisition. Medical Journal Armed Forces India 64(1): 46-49
Kamae, I.; Hashimoto, Y.; Koretsune, Y.; Tanahashi, N.; Murata, T.; Phatak, H.; Liu, L.Z.; Tang, A.C.; Feng Wang, P.; Okumura, K. 2015: Cost-effectiveness Analysis of Apixaban against Warfarin for Stroke Prevention in Patients with Nonvalvular Atrial Fibrillation in Japan. Clinical Therapeutics 37(12): 2837-2851
Tempest, M.; Sapin, C.; Beillat, M.; Robinson, P.; Treur, M. 2015: Cost-effectiveness Analysis of Aripiprazole Once-Monthly for the Treatment of Schizophrenia in the UK. Journal of Mental Health Policy and Economics 18(4): 185-200
Davari, M.; Ashrafi, F.; Maracy, M.; Aslani, A.; Tabatabaei, M. 2015: Cost-effectiveness Analysis of Cetuximab in Treatment of Metastatic Colorectal Cancer in Iranian Pharmaceutical Market. International Journal of Preventive Medicine 6: 63
Lee, J.Kyu.; Jo, Y-Hoon.; Kang, C-Nam. 2016: Cost-effectiveness Analysis of Existing Pedicle Screws Reusing Technique in Extension Revision Operation for Adjacent Segmental Stenosis After Lumbar Posterolateral Fusion. Spine 41(13): E785-E790
Malhotra, A.; Wu, X.; Kalra, V.B.; Schindler, J.; Forman, H.P. 2016: Cost-effectiveness Analysis of Follow-up Strategies for Thunderclap Headache Patients with Negative Noncontrast CT. Academic Emergency Medicine: Official Journal of the Society for Academic Emergency Medicine 23(3): 243-250
Tuffaha, H.W.; Roberts, S.; Chaboyer, W.; Gordon, L.G.; Scuffham, P.A. 2016: Cost-effectiveness Analysis of Nutritional Support for the Prevention of Pressure Ulcers in High-Risk Hospitalized Patients. Advances in Skin and Wound Care 29(6): 261-267
Fínek, J.; Skoupá, J.; Jandová, P. 2015: Cost-effectiveness Analysis of Panitumumab Plus mFOLFOX6 Compared to Bevacizumab Plus mFOLFOX6 for First-line Treatment of Patients with Wild-type RAS Metastatic Colorectal Cancer--Czech Republic Model Adaptation. Klinicka Onkologie: Casopis Ceske a Slovenske Onkologicke Spolecnosti 28(4): 265-272
Begum, N.; Stephens, S.; Schoeman, O.; Fraschke, A.; Kirsch, B.; Briere, J-Baptiste.; Verheugt, F.W.A.; van Hout, B.A. 2015: Cost-effectiveness Analysis of Rivaroxaban in the Secondary Prevention of Acute Coronary Syndromes in Sweden. Cardiology and Therapy 4(2): 131-153
Gaziano, T.A.; Fonarow, G.C.; Claggett, B.; Chan, W.W.; Deschaseaux-Voinet, C.; Turner, S.J.; Rouleau, J.L.; Zile, M.R.; McMurray, J.J.V.; Solomon, S.D. 2016: Cost-effectiveness Analysis of Sacubitril/Valsartan vs Enalapril in Patients With Heart Failure and Reduced Ejection Fraction. JAMA Cardiology 1(6): 666-672
Park, S.-K.; Park, S.-H.; Lee, M.-Y.; Park, J.-H.; Jeong, J.-H.; Lee, E.-K. 2016: Cost-effectiveness Analysis of Treatment Sequence Initiating with Etanercept Compared with Leflunomide in Rheumatoid Arthritis: Impact of Reduced Etanercept Cost with Patent Expiration in South Korea. Clinical Therapeutics 38(11): 2430-2446.E3
Arias, M.; Díez, F.J. 2015: Cost-effectiveness Analysis with Influence Diagrams. Methods of Information in Medicine 54(4): 353-358
Campillo-Artero, C.; Ortún, V. 2016: Cost-effectiveness Analysis: Why and how. Revista Espanola de Cardiologia 69(4): 370-373
Eze-Nliam, C.M.; Zhang, Z.; Weiss, S.A.; Weintraub, W.S. 2014: Cost-effectiveness Assessment of Cardiac Interventions: Determining a Socially Acceptable Cost Threshold. Interventional Cardiology 6(1): 45-55
Laine, J. 2014: Cost-effectiveness alone is not sufficient as basis for prioritization. Duodecim; Laaketieteellinen Aikakauskirja 130(20): 2094-2098
Madsen, L.B.; Eddleston, M.; Hansen, K.S.; Pearson, M.; Agampodi, S.; Jayamanne, S.; Konradsen, F. 2015: Cost-effectiveness analyses of self-harm strategies aimed at reducing the mortality of pesticide self-poisonings in Sri Lanka: a study protocol. Bmj Open 5(2): E007333
Quitian, H.; Castaño, N.; Granados, C.; Gómez-Restrepo, C. 2014: Cost-effectiveness analysis (CEA) regarding vitamin a in children aged less than 5 years-old in Colombia. Revista de Salud Publica 16(3): 408-416
Heard, C.; Chaboyer, W.; Anderson, V.; Gillespie, B.M.; Whitty, J.A. 2017: Cost-effectiveness analysis alongside a pilot study of prophylactic negative pressure wound therapy. Journal of Tissue Viability 26(1): 79-84
Bielecka-Dabrowa, A.; Godoy, B.; Schefold, J.C.; Koziolek, M.; Banach, M.; von Haehling, S. 2018: Decompensated Heart Failure and Renal Failure: what Is the Current Evidence?. Current Heart Failure Reports 15(4): 224-238
Fukuda, H. 2016: Cost-effectiveness analysis for diabetes care. Nihon Rinsho. Japanese Journal of Clinical Medicine 74(Suppl 2): 707-712
Tromme, I.; Legrand, C.; Devleesschauwer, B.; Leiter, U.; Suciu, S.; Eggermont, A.; Sacré, L.; Baurain, J.-F.ço.; Thomas, L.; Beutels, P.; Speybroeck, N. 2016: Cost-effectiveness analysis in melanoma detection: a transition model applied to dermoscopy. European Journal of Cancer 67: 38-45
Catalá-López, F.; González-Bermejo, D. 2015: Cost-effectiveness analysis in the management of arterial hypertension. Hipertension y Riesgo Vascular 32(2): 45-47
Calaf, J.; Lete, I.; Canals, I.; Crespo, C.; Espinós, B.; Cristóbal, I. 2015: Cost-effectiveness analysis in the treatment of heavy menstrual bleeding in Spain. European Journal of Obstetrics Gynecology and Reproductive Biology 184: 24-31
Mezones-Holguin, E.; Canelo-Aybar, C.; Clark, A.D.; Janusz, C.B.; Jaúregui, B.ár.; Escobedo-Palza, S.; Hernandez, A.V.; Vega-Porras, D.; González, M.; Fiestas, F.án.; Toledo, W.; Michel, F.; Suárez, V.íc.J. 2015: Cost-effectiveness analysis of 10- and 13-valent pneumococcal conjugate vaccines in Peru. Vaccine 33(Suppl 1): A154-A166
Diaby, V.; Adunlin, G.; Ali, A.A.; Zeichner, S.B.; de Lima Lopes, G.; Kohn, C.G.; Montero, A.J. 2016: Cost-effectiveness analysis of 1st through 3rd line sequential targeted therapy in HER2-positive metastatic breast cancer in the United States. Breast Cancer Research and Treatment 160(1): 187-196
Kim, H.; Rajagopalan, M.S.; Beriwal, S.; Huq, M.S.; Smith, K.J. 2015: Cost-effectiveness analysis of 3D image-guided brachytherapy compared with 2D brachytherapy in the treatment of locally advanced cervical cancer. BrachyTherapy 14(1): 29-36
Nieves, D.; Puig-Peiró, R.; Ferrándiz, C.; Plazas, M.J.; Brosa, M. 2015: Cost-effectiveness analysis of 5-fluorouracil 0.5%/salicylic acid 10% in the treatment of actinic keratosis in Spain. Expert Review of Pharmacoeconomics and Outcomes Research 15(3): 539-543
Díaz-Cerezo, S.; García-Aparicio, Án.M.ía.; Parrondo, J.; Vallejo-Aparicio, L.A. 2015: Cost-effectiveness analysis of Belimumab in patients with systemic lupus erythematosus in Spain. Farmacia Hospitalaria: Organo Oficial de Expresion Cientifica de la Sociedad Espanola de Farmacia Hospitalaria 39(3): 161-170
Wu, X.; Kalra, V.B.; Forman, H.P.; Malhotra, A. 2016: Cost-effectiveness analysis of CTA and LP for evaluation of suspected SAH after negative non-contrast CT. Clinical Neurology and Neurosurgery 142: 104-111
Rours, G.I.J.G.; Smith-Norowitz, T.Anne.; Ditkowsky, J.; Hammerschlag, M.R.; Verkooyen, R.P.; de Groot, R.; Verbrugh, H.A.; Postma, M.J. 2016: Cost-effectiveness analysis of Chlamydia trachomatis screening in Dutch pregnant women. Pathogens and Global Health 110(7-8): 292-302
Narita, Y.; Matsushima, Y.; Shiroiwa, T.; Chiba, K.; Nakanishi, Y.; Kurokawa, T.; Urushihara, H. 2015: Cost-effectiveness analysis of EGFR mutation testing and gefitinib as first-line therapy for non-small cell lung cancer. Lung Cancer 90(1): 71-77
Arrieta, O.; Anaya, P.; Morales-Oyarvide, V.; Ramírez-Tirado, L.A.; Polanco, A.C. 2016: Cost-effectiveness analysis of EGFR mutation testing in patients with non-small cell lung cancer (NSCLC) with gefitinib or carboplatin-paclitaxel. European Journal of Health Economics: Hepac: Health Economics in Prevention and Care 17(7): 855-863
Byford, S.; Cary, M.; Barrett, B.; Aldred, C.R.; Charman, T.; Howlin, P.; Hudry, K.; Leadbitter, K.; Le Couteur, A.; McConachie, H.; Pickles, A.; Slonims, V.; Temple, K.J.; Green, J.; Bourne, K.; Blazey, L.; Holt, C.; Kapadia, D.; MacDonald, W.; White, L.; Houghton, T.; Taylor, C.; Cutress, A.; Leach, S.; Barron, S.; Colmer, R.; Randles, S.; Beggs, K.; Collino, J. 2015: Cost-effectiveness analysis of a communication-focused therapy for pre-school children with autism: results from a randomised controlled trial. Bmc Psychiatry 15: 316
McCollister, K.; Yang, X.; McKay, J.R. 2016: Cost-effectiveness analysis of a continuing care intervention for cocaine-dependent adults. Drug and Alcohol Dependence 158: 38-44
Jia, Y.; Li, L.; Cui, F.; Zhang, D.; Zhang, G.; Wang, F.; Gong, X.; Zheng, H.; Wu, Z.; Miao, N.; Sun, X.; Zhang, L.; Lv, J.; Yang, F. 2014: Cost-effectiveness analysis of a hepatitis B vaccination catch-up program among children in Shandong Province, China. Human Vaccines and Immunotherapeutics 10(10): 2983-2991
Westbrook, J.I.; Gospodarevskaya, E.; Li, L.; Richardson, K.L.; Roffe, D.; Heywood, M.; Day, R.O.; Graves, N. 2015: Cost-effectiveness analysis of a hospital electronic medication management system. Journal of the American Medical Informatics Association: Jamia 22(4): 784-793
Henry, N.; Hawes, C.; Lowin, J.; Lekander, I.; Filonenko, A.; Kallner, H.K. 2015: Cost-effectiveness analysis of a low-dose contraceptive levonorgestrel intrauterine system in Sweden. Acta Obstetricia et Gynecologica Scandinavica 94(8): 884-890
Izquierdo, G.; Torres, J.Pablo.; Santolaya, M.Elena.; Valenzuela, M.Teresa.; Vega, J.; Chomali, M. 2015: Cost-effectiveness analysis of a multicomponent meningococcal serogroup B vaccine in hypothetic epidemic situation in a middle-income country. Human Vaccines and Immunotherapeutics 11(4): 875-883
Forde, G.K.; Hornberger, J.; Michalopoulos, S.; Bristow, R.E. 2016: Cost-effectiveness analysis of a multivariate index assay compared to modified American College of Obstetricians and Gynecologists criteria and CA-125 in the triage of women with adnexal masses. Current Medical Research and Opinion 32(2): 321-329
Préaud, E.; Uhart, M.; Böhm, K.; Aidelsburger, P.; Anger, D.; Bianic, F.; Largeron, N. 2015: Cost-effectiveness analysis of a vaccination program for the prevention of herpes zoster and post-herpetic neuralgia in adults aged 50 and over in Germany. Human Vaccines and Immunotherapeutics 11(4): 884-896
Spackman, E.; Richmond, S.; Sculpher, M.; Bland, M.; Brealey, S.; Gabe, R.; Hopton, A.; Keding, A.; Lansdown, H.; Perren, S.; Torgerson, D.; Watt, I.; MacPherson, H. 2014: Cost-effectiveness analysis of acupuncture, counselling and usual care in treating patients with depression: the results of the ACUDep trial. Plos one 9(11): E113726
Petrovic, S.; Bogavac-Stanojevic, N.; Lakic, D.; Peco-Antic, A.; Vulicevic, I.; Ivanisevic, I.; Kotur-Stevuljevic, J.; Jelic-Ivanovic, Z. 2015: Cost-effectiveness analysis of acute kidney injury biomarkers in pediatric cardiac surgery. Biochemia Medica 25(2): 262-271
Simpson, S.H.; Lier, D.A.; Majumdar, S.R.; Tsuyuki, R.T.; Lewanczuk, R.Z.; Spooner, R.; Johnson, J.A. 2015: Cost-effectiveness analysis of adding pharmacists to primary care teams to reduce cardiovascular risk in patients with Type 2 diabetes: results from a randomized controlled trial. Diabetic Medicine: a Journal of the British Diabetic Association 32(7): 899-906
Zheng, H.R.; Wen, F.; Wu, Y.F.; Wheeler, J.R.C.; Li, Q. 2017: Cost-effectiveness analysis of additional docetaxel for metastatic hormone-sensitive prostate cancer treated with androgen-deprivation therapy from a Chinese perspective. European Journal of Cancer Care 26(6)
Wu, B.; Li, T.; Cai, J.; Xu, Y.; Zhao, G. 2014: Cost-effectiveness analysis of adjuvant chemotherapies in patients presenting with gastric cancer after D2 gastrectomy. Bmc Cancer 14: 984
Gandhi, P.K.; Gentry, W.M.; Ma, Q.; Bottorff, M.B. 2015: Cost-effectiveness analysis of allopurinol versus febuxostat in chronic gout patients: a U.S. payer perspective. Journal of Managed Care and Specialty Pharmacy 21(2): 165-175
Gajarski, R.J.; Smitko, K.; Despres, R.; Meden, J.; Hutton, D.W. 2015: Cost-effectiveness analysis of alternative cooling strategies following cardiac arrest. Springerplus 4: 427
Chen, C.X.; Hay, J.W. 2015: Cost-effectiveness analysis of alternative screening and treatment strategies for heterozygous familial hypercholesterolemia in the United States. International Journal of Cardiology 181: 417-424
Cromwell, I.; Gaudet, M.; Peacock, S.J.; Aquino-Parsons, C. 2016: Cost-effectiveness analysis of anal cancer screening in women with cervical neoplasia in British Columbia, Canada. Bmc Health Services Research 16: 206
Auzinger, G.; Playford, E.G.; Graham, C.N.; Knox, H.N.; Weinstein, D.; Kantecki, M.; Schlamm, H.; Charbonneau, C. 2015: Cost-effectiveness analysis of anidulafungin for the treatment of candidaemia and other forms of invasive candidiasis. Bmc Infectious Diseases 15: 463
Maggiolo, F.; Colombo, G.L.; Di Matteo, S.; Bruno, G.M.; Astuti, N.; Di Filippo, E.; Masini, G.; Bernardini, C. 2015: Cost-effectiveness analysis of antiretroviral therapy in a cohort of HIV-infected patients starting first-line highly active antiretroviral therapy during 6 years of observation. Patient related outcome measures 6: 53-60
Zhang, C.; Ke, W.; Gao, Y.; Zhou, S.; Liu, L.; Ye, X.; Yao, Z.; Yang, Y. 2015: Cost-effectiveness analysis of antiviral therapies for hepatitis B e antigen-positive chronic hepatitis B patients in China. Clinical Drug Investigation 35(3): 197-209
Zhang, P.; Yang, Y.; Wen, F.; Wheeler, J.; Fu, P.; Li, Q. 2016: Cost-effectiveness analysis of antiviral therapy in patients with advanced hepatitis B virus-related hepatocellular carcinoma treated with sorafenib. Journal of Gastroenterology and Hepatology 31(12): 1978-1985
Nshimyumukiza, L.éo.; Douville, X.; Fournier, D.; Duplantie, J.; Daher, R.K.; Charlebois, I.; Longtin, J.; Papenburg, J.; Guay, M.; Boissinot, M.; Bergeron, M.G.; Boudreau, D.; Gagné, C.; Rousseau, F.ço.; Reinharz, D. 2016: Cost-effectiveness analysis of antiviral treatment in the management of seasonal influenza A: point-of-care rapid test versus clinical judgment. Influenza and other Respiratory Viruses 10(2): 113-121
Chen, H.-D.; Zhou, J.; Wen, F.; Zhang, P.-F.; Zhou, K.-X.; Zheng, H.-R.; Yang, Y.; Li, Q. 2017: Cost-effectiveness analysis of apatinib treatment for chemotherapy-refractory advanced gastric cancer. Journal of Cancer Research and Clinical Oncology 143(2): 361-368
Elías, I.; Oyagüez, I.; Alvarez-Sala, L.Antonio.; García-Bragado, F.; Navarro, Aés.; González, P.; De Andrés-Nogales, F.; Soto, J. 2016: Cost-effectiveness analysis of apixaban compared to low-molecularweight heparins and vitamin k antagonists for treatment and secondary prevention of venous thromboembolism. Farmacia Hospitalaria: Organo Oficial de Expresion Cientifica de la Sociedad Espanola de Farmacia Hospitalaria 40(3): 187-208
Escolar-Albaladejo, Gés.; Barón-Esquivias, G.; Zamorano, Jé.Luis.; Betegón-Nicolás, L.; Canal-Fontcuberta, C.; de Salas-Cansado, M.; Rubio-Rodríguez, Dío.; Rubio-Terrés, C. 2016: Cost-effectiveness analysis of apixaban versus acetylsalicylic acid in the prevention of stroke in patients with non-valvular atrial fibrillation in Spain. Atencion Primaria 48(6): 394-405
Marsh, J.D.; Birmingham, T.B.; Giffin, J.R.; Isaranuwatchai, W.; Hoch, J.S.; Feagan, B.G.; Litchfield, R.; Willits, K.; Fowler, P. 2016: Cost-effectiveness analysis of arthroscopic surgery compared with non-operative management for osteoarthritis of the knee. Bmj Open 6(1): E009949
Petrou, P. 2015: Cost-effectiveness analysis of axitinib through a probabilistic decision model. Expert Opinion on PharmacoTherapy 16(8): 1233-1243
Van Keep, M.; Gairy, K.; Seshagiri, D.; Thilakarathne, P.; Lee, D. 2016: Cost-effectiveness analysis of bortezomib in combination with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone (VR-CAP) in patients with previously untreated mantle cell lymphoma. Bmc Cancer 16: 598
Song, D.L.; Altice, F.L.; Copenhaver, M.M.; Long, E.F. 2015: Cost-effectiveness analysis of brief and expanded evidence-based risk reduction interventions for HIV-infected people who inject drugs in the United States. Plos one 10(2): E0116694
Van Baaren, G.-J.; Hermes, W.; Franx, A.; van Pampus, M.G.; Bloemenkamp, K.W.M.; van der Post, J.A.; Porath, M.; Ponjee, G.A.E.; Tamsma, J.T.; Mol, B.W.J.; Opmeer, B.C.; de Groot, C.J.M. 2014: Cost-effectiveness analysis of cardiovascular risk factor screening in women who experienced hypertensive pregnancy disorders at term. Pregnancy Hypertension 4(4): 264-270
Hankin-Wei, A.; Rein, D.B.; Hernandez-Romieu, A.; Kennedy, M.J.; Bulkow, L.; Rosenberg, E.; Trigg, M.; Nelson, N.P. 2016: Cost-effectiveness analysis of catch-up hepatitis a vaccination among unvaccinated/partially-vaccinated children. Vaccine 34(35): 4243-4249
De Lossada, A.; Oteo-Álvaro, Á; Giménez, S.; Oyagüez, I.; Rejas, J. 2016: Cost-effectiveness analysis of celecoxib versus non-selective non-steroidal anti-inflammatory drug therapy for the treatment of osteoarthritis in Spain: a current perspective. Semergen 42(4): 235-243
Ko, M.J.; Kim, J.; Kim, Y.; Lee, Y.J.; Hong, S.R.; Lee, J.K. 2015: Cost-effectiveness analysis of cervical cancer screening strategies based on the Papanicolaou smear test in Korea. Asian Pacific Journal of Cancer Prevention: Apjcp 16(6): 2317-2322
Romeo, M.; Soler, G.; Villacampa, M.Martínez.; Laquente, B.; Doriga, A.López.; Pisa, A.; Rey, M.; Santos, C.; Salazar, R.; Lluch, J.R.Germà. 2016: Cost-effectiveness analysis of cetuximab as third-line treatment in metastatic colorectal cancer. Journal of Clinical Oncology 26(15_Suppl): 15090-15090
Burnett, H.F.; Lambley, R.; West, S.K.; Ungar, W.J.; Mireskandari, K. 2015: Cost-effectiveness analysis of clinic-based chloral hydrate sedation versus general anaesthesia for paediatric ophthalmological procedures. British Journal of Ophthalmology 99(11): 1565-1570
Tosanguan, J.; Chaiyakunapruk, N. 2016: Cost-effectiveness analysis of clinical smoking cessation interventions in Thailand. Addiction 111(2): 340-350
Wen, F.; Yao, K.; Du, Z.-D.; He, X.-F.; Zhang, P.-F.; Tang, R.-L.; Li, Q. 2014: Cost-effectiveness analysis of colon cancer treatments from MOSIAC and No. 16968 trials. World Journal of Gastroenterology 20(47): 17976-17984
Sekandi, J.N.; Dobbin, K.; Oloya, J.; Okwera, A.; Whalen, C.C.; Corso, P.S. 2015: Cost-effectiveness analysis of community active case finding and household contact investigation for tuberculosis case detection in urban Africa. Plos one 10(2): E0117009
Mokhtari-Payam, M.; Moradi-Lakeh, M.; Yaghoubi, M.; Moradijou, M. 2015: Cost-effectiveness analysis of confocal scan laser ophthalmoscope (HRT II) versus GDX for diagnosing glaucoma. Journal of Current Ophthalmology 27(1-2): 16-20
Carles, M.òr.; Brosa, M.; Souto, J.C.; Garcia-Alamino, J.M.; Guyatt, G.; Alonso-Coello, P. 2015: Cost-effectiveness analysis of dabigatran and anticoagulation monitoring strategies of vitamin K antagonist. Bmc Health Services Research 15: 289
Abad Paniagua, E.J.é; Casado Escribano, P.; Fernández Rodriguez, J.é M.ía.; Morales Escobar, F.J.; Betegón Nicolás, L.; Sánchez-Covisa, J.ín.; Brosa, M. 2015: Cost-effectiveness analysis of dapagliflozin compared to DPP4 inhibitors and other oral antidiabetic drugs in the treatment of type-2 diabetes mellitus in Spain. Atencion Primaria 47(8): 505-513
Shao, H.; Zhai, S.; Zou, D.; Mir, M.Umer.; Zawadzki, N.K.; Shi, Q.; Liu, S.; Shi, L. 2017: Cost-effectiveness analysis of dapagliflozin versus glimepiride as monotherapy in a Chinese population with type 2 diabetes mellitus. Current Medical Research and Opinion 33(2): 359-369
Machado de Assis, T.ál.S.; Azeredo-da-Silva, A.é L.F.; Werneck, G.L.; Rabello, A. 2016: Cost-effectiveness analysis of diagnostic tests for human visceral leishmaniasis in Brazil. Transactions of the Royal Society of Tropical Medicine and Hygiene 110(8): 464-471
YaghoubiFard, S.; Goudarzi, R.; Etminan, A.; Baneshi, M.; Barouni, M.; Jafari Sirizi, M. 2016: Cost-effectiveness analysis of dialysis and kidney transplant in patients with renal impairment using disability adjusted life years in Iran. Medical Journal of the Islamic Republic of Iran 30: 390
Penaloza-Ramos, M.Cristina.; Jowett, S.; Barton, P.; Roalfe, A.; Fletcher, K.; Taylor, C.J.; Hobbs, F.Richard.; McManus, R.J.; Mant, J. 2016: Cost-effectiveness analysis of different systolic blood pressure targets for people with a history of stroke or transient ischaemic attack: Economic analysis of the PAST-BP study. European Journal of Preventive Cardiology 23(15): 1590-1598
Lakić, D.; Petrović, B.; Petrova, G. 2014: Cost-effectiveness analysis of different types of labor for singleton pregnancy: real life data. Srpski Arhiv Za Celokupno Lekarstvo 142(11-12): 688-694
Ward, M.J.; Self, W.H.; Singer, A.; Lazar, D.; Pines, J.M. 2016: Cost-effectiveness analysis of early point-of-care lactate testing in the emergency department. Journal of Critical Care 36: 69-75
Pearson-Stuttard, J.; Hooton, W.; Critchley, J.; Capewell, S.; Collins, M.; Mason, H.; Guzman-Castillo, M.; O'Flaherty, M. 2017: Cost-effectiveness analysis of eliminating industrial and all trans fats in England and Wales: modelling study. Journal of Public Health 39(3): 574-582
Morris, S.; Gurusamy, K.S.; Sheringham, J.; Davidson, B.R. 2015: Cost-effectiveness analysis of endoscopic ultrasound versus magnetic resonance cholangiopancreatography in patients with suspected common bile duct stones. Plos one 10(3): E0121699
Picot, M.-C.; Jaussent, A.; Neveu, D.; Kahane, P.; Crespel, A.; Gelisse, P.; Hirsch, E.; Derambure, P.; Dupont, S.; Landré, E.; Chassoux, F.; Valton, L.; Vignal, J.-P.; Marchal, C.éc.; Lamy, C.; Semah, F.; Biraben, A.; Arzimanoglou, A.; Petit, J.ér.ôm.; Thomas, P.; Macioce, V.ér.; Dujols, P.; Ryvlin, P. 2016: Cost-effectiveness analysis of epilepsy surgery in a controlled cohort of adult patients with intractable partial epilepsy: a 5-year follow-up study. Epilepsia 57(10): 1669-1679
Feng, H.; Song, G.; Yang, J.; Hao, C.; Wang, M.; Li, B.; Zhao, D.; Liu, Z.; Wei, W.; Qiao, Y. 2015: Cost-effectiveness analysis of esophageal cancer once-in-a-lifetime endoscopic screening in high-risk areas of rural China. Zhonghua Zhong Liu Za Zhi 37(6): 476-480
Chuang, L.H.; Verheggen, B.G.; Charokopou, M.; Gibson, D.; Grandy, S.; Kartman, B. 2016: Cost-effectiveness analysis of exenatide once-weekly versus dulaglutide, liraglutide, and lixisenatide for the treatment of type 2 diabetes mellitus: an analysis from the UK NHS perspective. Journal of Medical Economics 19(12): 1127-1134
Deng, J.; Gu, S.; Shao, H.; Dong, H.; Zou, D.; Shi, L. 2015: Cost-effectiveness analysis of exenatide twice daily (BID) vs insulin glargine once daily (QD) as add-on therapy in Chinese patients with Type 2 diabetes mellitus inadequately controlled by oral therapies. Journal of Medical Economics 18(11): 974-989
Launio, C.C.; Asis, C.A.; Manalili, R.G.; Javier, E.F. 2016: Cost-effectiveness analysis of farmers' rice straw management practices considering CH4 and N2O emissions. Journal of Environmental Management 183: 245-252
Perez-Ruiz, F.; Díaz-Torné, C.; Carcedo, D. 2016: Cost-effectiveness analysis of febuxostat in patients with gout in Spain. Journal of Medical Economics 19(6): 604-610
Varier, R.U.; Biltaji, E.; Smith, K.J.; Roberts, M.S.; Kyle Jensen, M.; LaFleur, J.; Nelson, R.E. 2015: Cost-effectiveness analysis of fecal microbiota transplantation for recurrent Clostridium difficile infection. Infection Control and Hospital Epidemiology 36(4): 438-444
Hofmarcher, T.; Borg, S. 2015: Cost-effectiveness analysis of ferric carboxymaltose in iron-deficient patients with chronic heart failure in Sweden. Journal of Medical Economics 18(7): 492-501
Peral, C.; Sánchez-Ballester, F.; García-Mediero, J.é M.; Ramos, J.; Rejas, J. 2016: Cost-effectiveness analysis of fesoterodine flexible dose in newly diagnosed patients with overactive bladder in routine clinical practice in Spain. Clinicoeconomics and Outcomes Research: Ceor 8: 541-550
Zhou, J.; Zhao, R.; Wen, F.; Zhang, P.; Tang, R.; Du, Z.; He, X.; Zhang, J.; Li, Q. 2015: Cost-effectiveness analysis of gemcitabine, S-1 and gemcitabine plus S-1 for treatment of advanced pancreatic cancer based on GEST study. Medical Oncology 32(4): 121
Dong, D.; Tan-Koi, W-Chuen.; Teng, G.Gee.; Finkelstein, E.; Sung, C. 2015: Cost-effectiveness analysis of genotyping for HLA-B*5801 and an enhanced safety program in gout patients starting allopurinol in Singapore. Pharmacogenomics 16(16): 1781-1793
Rashidian, A.; Alinia, C.; Majdzadeh, R. 2015: Cost-effectiveness analysis of health care waste treatment facilities in iran hospitals; a provider perspective. Iranian Journal of Public Health 44(3): 352-360
Gounder, P.P.; Bulkow, L.R.; Meltzer, M.I.; Bruce, M.G.; Hennessy, T.W.; Snowball, M.; Spradling, P.R.; Adhikari, B.B.; McMahon, B.J. 2016: Cost-effectiveness analysis of hepatocellular carcinoma screening by combinations of ultrasound and alpha-fetoprotein among Alaska Native people, 1983-2012. International journal of circumpolar health 75: 31115
Li, X.; Stander, M.P.; Van Kriekinge, G.; Demarteau, N. 2015: Cost-effectiveness analysis of human papillomavirus vaccination in South Africa accounting for human immunodeficiency virus prevalence. Bmc Infectious Diseases 15: 566
Matros, E.; Albornoz, C.R.; Razdan, S.N.; Mehrara, B.J.; Macadam, S.A.; Ro, T.; McCarthy, C.M.; Disa, J.J.; Cordeiro, P.G.; Pusic, A.L. 2015: Cost-effectiveness analysis of implants versus autologous perforator flaps using the BREAST-Q. Plastic and Reconstructive Surgery 135(4): 937-946
Maredza, M.; Bertram, M.Y.; Saloojee, H.; Chersich, M.F.; Tollman, S.M.; Hofman, K.J. 2013: Cost-effectiveness analysis of infant feeding strategies to prevent mother-to-child transmission of HIV in South Africa. African Journal of Aids Research: Ajar 12(3): 151-160
Wu, D.Bin-Chia.; Roberts, C.; Lee, V.Wing.Yan.; Hong, L-Wen.; Tan, K.Kee.; Mak, V.; Lee, K.Kwing.Chin. 2016: Cost-effectiveness analysis of infant universal routine pneumococcal vaccination in Malaysia and Hong Kong. Human Vaccines and Immunotherapeutics 12(2): 403-416
Vaidya, V.; Gangan, N.; Comerota, A.; Lurie, F. 2017: Cost-Effectiveness Analysis of Initial Treatment Strategies for Nonembolic Acute Limb Ischemia Using Real-Word Data. Annals of Vascular Surgery 39: 276-283
Zemplényi, A.T.; Kaló, Z.; Kovács, G.; Farkas, R.; Beöthe, T.; Bányai, D.; Sebestyén, Z.; Endrei, D.; Boncz, I.; Mangel, L. 2018: Cost-effectiveness analysis of intensity-modulated radiation therapy with normal and hypofractionated schemes for the treatment of localised prostate cancer. European Journal of Cancer Care 27(1)
Piñol, C. 2016: Cost-effectiveness analysis of interferon beta-1b as treatment for patients with clinically isolated syndrome suggestive of multiple sclerosis in Spain. Neurologia 31(4): 247-254
Linde, M.; Steiner, T.J.; Chisholm, D. 2015: Cost-effectiveness analysis of interventions for migraine in four low- and middle-income countries. Journal of Headache and Pain 16: 15
Novaes, H.Maria.Dutilh.; de Soárez, Pícia.Coelho.; Silva, G.Azevedo.; Ayres, A.; Itria, A.; Rama, C.Helena.; Sartori, A.Marli.Christovam.; Clark, A.D.; Resch, S. 2015: Cost-effectiveness analysis of introducing universal human papillomavirus vaccination of girls aged 11 years into the National Immunization Program in Brazil. Vaccine 33 Suppl. 1: A135-A142
Wang, G.; Liu, Y.; Qiu, P.; Zhou, S.-F.; Xu, L.; Wen, P.; Wen, J.; Xiao, X. 2015: Cost-effectiveness analysis of lamivudine, telbivudine, and entecavir in treatment of chronic hepatitis B with adefovir dipivoxil resistance. Drug Design Development and Therapy 9: 2839-2846
Lee, V.Wing-Yan.; Tsai, R.Bing-Ching.; Chow, I.Hang-Iao.; Yan, B.Ping-Yen.; Kaya, M.Gungor.; Park, J-Wun.; Lam, Y-Yin. 2016: Cost-effectiveness analysis of left atrial appendage occlusion compared with pharmacological strategies for stroke prevention in atrial fibrillation. Bmc Cardiovascular Disorders 16(1): 167
Ferreira Laso, L.; López Picado, A.; Antoñanzas Villar, F.; Lamata de la Orden, L.; Ceballos Garcia, M.; Ibañez López, C.; Pipaon Ruilope, L.; Lamata Hernandez, F.; Valero Martinez, C.; Aizpuru, F.; Hernandez Chaves, R. 2015: Cost-effectiveness analysis of levobupivacaine 0.5 %, a local anesthetic, infusion in the surgical wound after modified radical mastectomy. Clinical Drug Investigation 35(9): 575-582
Park, J.-H.; Lee, Y.-H.; Ko, S.-K.; Cha, B.-S. 2015: Cost-effectiveness analysis of low density lipoprotein cholesterol-lowering therapy in hypertensive patients with type 2 diabetes in Korea: single-pill regimen (amlodipine/atorvastatin) versus double-pill regimen (amlodipine+atorvastatin). Epidemiology and Health 37: E2015010
Chalayer, E.; Bourmaud, A.él.; Tinquaut, F.; Chauvin, F.; Tardy, B. 2016: Cost-effectiveness analysis of low-molecular-weight heparin versus aspirin thromboprophylaxis in patients newly diagnosed with multiple myeloma. Thrombosis Research 145: 119-125
Kanarkiewicz, M.łg.; Szczęsny, T.J.; Krysiński, J.; Buciński, A.; Kowalewski, J.; Pawłowicz, Z. 2015: Cost-effectiveness analysis of lung cancer screening with low-dose computerised tomography of the chest in Poland. Contemporary Oncology 19(6): 480-486
Chen, I.T.; Aung, T.; Thant, H.N.N.; Sudhinaraset, M.; Kahn, J.G. 2015: Cost-effectiveness analysis of malaria rapid diagnostic test incentive schemes for informal private healthcare providers in Myanmar. Malaria Journal 14: 55
Walusimbi, S.; Kwesiga, B.; Rodrigues, R.; Haile, M.; de Costa, A.; Bogg, L.; Katamba, A. 2016: Cost-effectiveness analysis of microscopic observation drug susceptibility test versus Xpert MTB/Rif test for diagnosis of pulmonary tuberculosis in HIV patients in Uganda. Bmc Health Services Research 16(1): 563
Rodríguez-Martínez, C.E.; Sossa-Briceño, M.P.; Vladimir Lemos, E. 2015: Cost-effectiveness analysis of mometasone furoate versus beclomethasone dipropionate for the treatment of pediatric allergic rhinitis in Colombia. Advances in Therapy 32(3): 254-269
Gordon, L.G.; James, R.; Tuffaha, H.W.; Lowe, A.; Yaxley, J. 2017: Cost-effectiveness analysis of multiparametric MRi with increased active surveillance for low-risk prostate cancer in Australia. Journal of Magnetic Resonance Imaging: Jmri 45(5): 1304-1315
Savitz, S.T.; Chen, R.C.; Sher, D.J. 2015: Cost-effectiveness analysis of neurocognitive-sparing treatments for brain metastases. Cancer 121(23): 4231-4239
Burgers, L.T.; Redekop, W.K.; Al, M.J.; Lhachimi, S.K.; Armstrong, N.; Walker, S.; Rothery, C.; Westwood, M.; Severens, J.L. 2017: Cost-effectiveness analysis of new generation coronary CT scanners for difficult-to-image patients. European Journal of Health Economics: Hepac: Health Economics in Prevention and Care 18(6): 731-742
Morris, J.; Straube, A.; Diener, H.-C.; Ahmed, F.; Silver, N.; Walker, S.; Liebler, E.; Gaul, C. 2016: Cost-effectiveness analysis of non-invasive vagus nerve stimulation for the treatment of chronic cluster headache. Journal of Headache and Pain 17: 43
Verhoef, T.I.; Trend, V.; Kelly, B.; Robinson, N.; Fox, P.; Morris, S. 2016: Cost-effectiveness analysis of offering free leisure centre memberships to physically inactive members of the public receiving state benefits: a case study. BMC public health 16: 616
Hamid, R.; Loveman, C.; Millen, J.; Globe, D.; Corbell, C.; Colayco, D.; Stanisic, S.; Gultyaev, D. 2015: Cost-effectiveness analysis of onabotulinumtoxinA (BOTOX(®)) for the management of urinary incontinence in adults with neurogenic detrusor overactivity: a UK perspective. Pharmacoeconomics 33(4): 381-393
Ramponi, F.; Ronco, C.; Mason, G.; Rettore, E.; Marcelli, D.; Martino, F.; Neri, M.; Martin-Malo, A.; Canaud, B.; Locatelli, F. 2016: Cost-effectiveness analysis of online hemodiafiltration versus high-flux hemodialysis. Clinicoeconomics and Outcomes Research: Ceor 8: 531-540
Kockaya, G.; Kose, A.; Yenilmez, F.B.; Ozdemir, O.; Kucuksayrac, E. 2015: Cost-effectiveness analysis of oral anti-viral drugs used for treatment of chronic hepatitis B in Turkey. Cost Effectiveness and Resource Allocation: C/E 13: 21
Aballea, S.; Chancellor, J.; Raikou, M.; Drummond, M.; Weinstein, M.; Jourdan, S.; Carita, P.; Bridgewater, J. 2016: Cost-effectiveness analysis of oxaliplatin/5-FU/LV in adjuvant treatment of stage III colon cancer in the U.S. Journal of Clinical Oncology 23(16_Suppl): 3532-3532
Goeree, R.; Goeree, J. 2016: Cost-effectiveness analysis of oxycodone with naloxone versus oxycodone alone for the management of moderate-to-severe pain in patients with opioid-induced constipation in Canada. Journal of Medical Economics 19(3): 277-291
Wang, L.Y.; Roman, B.R.; Migliacci, J.C.; Palmer, F.L.; Tuttle, R.M.; Shaha, A.R.; Shah, J.P.; Patel, S.G.; Ganly, I. 2015: Cost-effectiveness analysis of papillary thyroid cancer surveillance. Cancer 121(23): 4132-4140
Hantrakun, V.; Chierakul, W.; Chetchotisakd, P.; Anunnatsiri, S.; Currie, B.J.; Peacock, S.J.; Day, N.P.J.; Cheah, P.Y.; Cheah, P.; Limmathurotsakul, D.; Lubell, Y. 2015: Cost-effectiveness analysis of parenteral antimicrobials for acute melioidosis in Thailand. Transactions of the Royal Society of Tropical Medicine and Hygiene 109(6): 416-418
Menezes, F.G.d.; Abreu, R.M.; Itria, A. 2016: Cost-effectiveness analysis of paricalcitol versus calcitriol for the treatment of SHPT in dialytic patients from the SUS perspective. Jornal Brasileiro de Nefrologia: 'orgao Oficial de Sociedades Brasileira e Latino-Americana de Nefrologia 38(3): 313-319
Hernandez, L.; Guo, S.; Kinter, E.; Fay, M. 2016: Cost-effectiveness analysis of peginterferon beta-1a compared with interferon beta-1a and glatiramer acetate in the treatment of relapsing-remitting multiple sclerosis in the United States. Journal of Medical Economics 19(7): 684-695
Yalçin Balçik, P.ın.; Şahin, B. 2016: Cost-effectiveness analysis of pemetrexed and gemcitabine treatment for advanced nonsmall cell lung cancer in Turkey. Turkish Journal of Medical Sciences 46(1): 152-158
Jiang, M.; You, J.H. 2016: Cost-effectiveness analysis of personalized antiplatelet therapy in patients with acute coronary syndrome. Pharmacogenomics 17(7): 701-713
Chong, H.Y.; Saokaew, S.; Dumrongprat, K.; Permsuwan, U.; Wu, D.B.-C.; Sritara, P.; Chaiyakunapruk, N. 2014: Cost-effectiveness analysis of pharmacogenetic-guided warfarin dosing in Thailand. Thrombosis Research 134(6): 1278-1284
Iannazzo, S.; Cortesi, P.A.; Crea, R.; Steinitz, K.; Mantovani, L.G.; Gringeri, A. 2017: Cost-effectiveness analysis of pharmacokinetic-driven prophylaxis vs. standard prophylaxis in patients with severe haemophilia a. Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 28(6): 425-430
Kieninger, M.P.ña.; Caballero, E.G.én.; Sosa, A.A.; Amarilla, C.T.; Jáuregui, B.ár.; Janusz, C.B.; Clark, A.D.; Castellanos, R.úl.M. 2015: Cost-effectiveness analysis of pneumococcal conjugate vaccine introduction in Paraguay. Vaccine 33(Suppl 1): A143-A153
Mezones-Holguín, E.; Bolaños-Díaz, R.; Fiestas, Víctor.; Sanabria, César.; Gutiérrez-Aguado, A.; Fiestas, Fán.; Suárez, Víctor.J.; Rodriguez-Morales, A.J.; Hernández, Aán.V. 2014: Cost-effectiveness analysis of pneumococcal conjugate vaccines in preventing pneumonia in Peruvian children. Journal of Infection in Developing Countries 8(12): 1552-1562
Maurer, K.A.; Chen, H.-F.; Wagner, A.L.; Hegde, S.T.; Patel, T.; Boulton, M.L.; Hutton, D.W. 2016: Cost-effectiveness analysis of pneumococcal vaccination for infants in China. Vaccine 34(50): 6343-6349
Kuo, M.-J.; Chen, H.-H.; Chen, C.-L.; Fann, J.C.-Y.; Chen, S.L.-S.; Chiu, S.Y.-H.; Lin, Y.-M.; Liao, C.-S.; Chang, H.-C.; Lin, Y.-S.; Yen, A.M.-F. 2016: Cost-effectiveness analysis of population-based screening of hepatocellular carcinoma: Comparing ultrasonography with two-stage screening. World Journal of Gastroenterology 22(12): 3460-3470
Nichols, B.E.; Boucher, C.A.B.; van der Valk, M.; Rijnders, B.J.A.; van de Vijver, D.A.M.C. 2016: Cost-effectiveness analysis of pre-exposure prophylaxis for HIV-1 prevention in the Netherlands: a mathematical modelling study. Lancet. Infectious Diseases 16(12): 1423-1429
Igarashi, A.; Akazawa, M.; Murata, T.; Taguchi, T.; Sadosky, A.; Ebata, N.; Willke, R.; Fujii, K.; Doherty, J.; Kobayashi, M. 2015: Cost-effectiveness analysis of pregabalin for treatment of chronic low back pain in patients with accompanying lower limb pain (neuropathic component) in Japan. Clinicoeconomics and Outcomes Research: Ceor 7: 505-520
Murugappan, G.; Ohno, M.S.; Lathi, R.B. 2015: Cost-effectiveness analysis of preimplantation genetic screening and in vitro fertilization versus expectant management in patients with unexplained recurrent pregnancy loss. Fertility and Sterility 103(5): 1215-1220
Margusino-Framiñán, L.; Pertega-Diaz, S.; Pena-Bello, L.; Sangiao-Alvarellos, S.; Outeiriño-Blanco, E.; Pita-Gutierrez, F.; Pita-Fernandez, S.; Cordido, F. 2015: Cost-effectiveness analysis of preoperative treatment of acromegaly with somatostatin analogue on surgical outcome. European Journal of Internal Medicine 26(9): 736-741
Meier, G.; Gregg, M.; Poulsen Nautrup, B. 2015: Cost-effectiveness analysis of quadrivalent influenza vaccination in at-risk adults and the elderly: an updated analysis in the U.K. Journal of Medical Economics 18(9): 746-761
García, A.; Ortiz de Lejarazu, Rúl.; Reina, J.; Callejo, D.; Cuervo, Jús.; Morano Larragueta, Rúl. 2016: Cost-effectiveness analysis of quadrivalent influenza vaccine in Spain. Human Vaccines and Immunotherapeutics 12(9): 2269-2277
Yang, M-Chin.; Tan, E.Chia-Hui.; Su, J-Jhih. 2017: Cost-effectiveness analysis of quadrivalent versus trivalent influenza vaccine in Taiwan: A lifetime multi-cohort model. Human Vaccines and Immunotherapeutics 13(1): 81-89
Peixoto, H.M.; Brito, M.A.M.; Romero, G.A.S.; Monteiro, W.M.; de Lacerda, M.V.G.; de Oliveira, M.R.F. 2016: Cost-effectiveness analysis of rapid diagnostic tests for G6PD deficiency in patients with Plasmodium vivax malaria in the Brazilian Amazon. Malaria Journal 15: 82
Kabeshova, A.; Ben Hariz, S.; Tsakeu, E.; Benamouzig, R.; Launois, R. 2016: Cost-effectiveness analysis of rifaximin-α administration for the reduction of episodes of overt hepatic encephalopathy in recurrence compared with standard treatment in France. Therapeutic Advances in Gastroenterology 9(4): 473-482
Alkoshi, S.; Maimaiti, N.; Dahlui, M. 2014: Cost-effectiveness analysis of rotavirus vaccination among Libyan children using a simple economic model. Libyan Journal of Medicine 9(1): 26236
Urueña, A.ía.; Pippo, T.ás.; Betelu, M.ía.S.; Virgilio, F.; Hernández, L.; Giglio, N.; Gentile, Án.; Diosque, M.áx.; Vizzotti, C. 2015: Cost-effectiveness analysis of rotavirus vaccination in Argentina. Vaccine 33(Suppl 1): A126-A134
Cui, S.; Tobe, R.G.; Mo, X.; Liu, X.; Xu, L.; Li, S. 2016: Cost-effectiveness analysis of rotavirus vaccination in China: Projected possibility of scale-up from the current domestic option. Bmc Infectious Diseases 16(1): 677
Kaucley, L.; Levy, P. 2015: Cost-effectiveness analysis of routine immunization and supplementary immunization activity for measles in a health district of Benin. Cost Effectiveness and Resource Allocation: C/E 13: 14
Delgleize, E.; Leeuwenkamp, O.; Theodorou, E.; Van de Velde, N. 2016: Cost-effectiveness analysis of routine pneumococcal vaccination in the UK: a comparison of the PHiD-CV vaccine and the PCV-13 vaccine using a Markov model. Bmj Open 6(11): E010776
Huntington, S.F.; Svoboda, J.; Doshi, J.A. 2015: Cost-effectiveness analysis of routine surveillance imaging of patients with diffuse large B-cell lymphoma in first remission. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 33(13): 1467-1474
Tipsmark, L.S.; Fassov, J.; Lundby, L.; Laurberg, S.; Ehlers, L.; Krogh, K. 2016: Cost-effectiveness analysis of sacral nerve stimulation as treatment for severe irritable bowel syndrome. Colorectal Disease: the Official Journal of the Association of Coloproctology of Great Britain and Ireland 18(1): O30-O36
Whalen, J.; Stillman, I.; Ambavane, A.; Felber, E.; Makenbaeva, D.; Bolinder, B. 2016: Cost-effectiveness analysis of second-line tyrosine kinase inhibitor treatment for chronic myelogenous leukemia. Journal of Medical Economics 19(5): 445-461
Kuwabara, H.; Westerhout, K.; Treur, M.; Cerri, K.; Mahlich, J.; Yatsuhashi, H. 2015: Cost-effectiveness analysis of simeprevir in combination with peginterferon and ribavirin for treatment-naïve chronic hepatitis C genotype 1 patients in Japan. Journal of Medical Economics 18(7): 502-511
Gimeno-Ballester, V.; Mar, J.; San Miguel, R.ón. 2016: Cost-effectiveness analysis of simeprevir with daclatasvir for non-cirrhotic genotype-1b-naïve patients plus chronic hepatitis C. Expert Review of Pharmacoeconomics and Outcomes Research 16(2): 285-294
Kim, H.; Rajagopalan, M.S.; Beriwal, S.; Huq, M.S.; Smith, K.J. 2015: Cost-effectiveness analysis of single fraction of stereotactic body radiation therapy compared with single fraction of external beam radiation therapy for palliation of vertebral bone metastases. International Journal of Radiation Oncology Biology Physics 91(3): 556-563
Cantor, S.B.; Deshmukh, A.A.; Luca, N.S.; Nogueras-González, G.M.; Rajan, T.; Prokhorov, A.V. 2015: Cost-effectiveness analysis of smoking-cessation counseling training for physicians and pharmacists. Addictive Behaviors 45: 79-86
Pfeil, A.M.; Reich, O.; Guerra, I.M.; Cure, S.; Negro, F.; Müllhaupt, B.; Lavanchy, D.; Schwenkglenks, M. 2015: Cost-effectiveness analysis of sofosbuvir compared to current standard treatment in Swiss patients with chronic hepatitis C. Plos one 10(5): E0126984
Buti, M.ía.; Domínguez-Hernández, R.; Oyagüez, I.; Casado, M.Án. 2016: Cost-effectiveness analysis of sofosbuvir, peginterferon and ribavirin in patients with chronic hepatitis C: Early treatment in the initial stage of fibrosis vs. delayed treatment in advanced fibrosis. Gastroenterologia y Hepatologia 39(7): 449-457
Mar, J.; Mar-Barrutia, L.; Gimeno-Ballester, V.; San Miguel, R.ón. 2016: Cost-effectiveness analysis of sofosbuvir-simeprevir regimens for chronic hepatitis C genotype 1 patients with advanced fibrosis. Medicina Clinica 146(2): 61-64
Han, Y.; Xiao, H.; Zhou, Z.; Yuan, M.; Zeng, Y.; Wu, H.; Fang, Y. 2015: Cost-effectiveness analysis of strategies introducing integrated ¹⁸F-FDG PET/CT into the mediastinal lymph node staging of non-small-cell lung cancer. Nuclear Medicine Communications 36(3): 234-241
Ke, W.; Zhang, C.; Liu, L.; Gao, Y.; Yao, Z.; Ye, X.; Zhou, S.; Yang, Y. 2016: Cost-effectiveness analysis of tenofovir disoproxil fumarate for treatment of chronic hepatitis B in China. Hepatology International 10(6): 924-936
Wilkins, E.; Fisher, M.; Brogan, A.J.; Talbird, S.E.; La, E.M. 2016: Cost-effectiveness analysis of tenofovir/emtricitabine and abacavir/lamivudine in combination with efavirenz or atazanavir/ritonavir for treatment-naïve adults with HIV-1 infection in the UK, based on the AIDS Clinical Trials Group 5202 clinical trial. HIV Medicine 17(7): 505-515
You, J.H.S.; Lui, G.; Kam, K.M.; Lee, N.L.S. 2015: Cost-effectiveness analysis of the Xpert MTB/RIF assay for rapid diagnosis of suspected tuberculosis in an intermediate burden area. Journal of Infection 70(4): 409-414
Tonmukayakul, U.; Arrow, P. 2017: Cost-effectiveness analysis of the atraumatic restorative treatment-based approach to managing early childhood caries. Community Dentistry and Oral Epidemiology 45(1): 92-100
Ordóñez, J.E.; Orozco, J.J. 2015: Cost-effectiveness analysis of the available pneumococcal conjugated vaccines for children under five years in Colombia. Cost Effectiveness and Resource Allocation: C/E 13: 6
Ruiz-Sánchez, D.; Peinado, I.Iglesias.; Alaguero-Calero, M.; Sastre-Heres, A.José.; Diez, B.García.; Peña-Díaz, J. 2016: Cost-effectiveness analysis of the bevacizumab-irinotecan regimen in the treatment of primary glioblastoma multiforme recurrences. Oncology Letters 12(3): 1935-1940
Mather, R.C.; Garrett, W.E.; Cole, B.J.; Hussey, K.; Bolognesi, M.P.; Lassiter, T.; Orlando, L.A. 2015: Cost-effectiveness analysis of the diagnosis of meniscus tears. American Journal of Sports Medicine 43(1): 128-137
Gibson, E.; Begum, N.; Martinón-Torres, F.; Safadi, M.A.él.; Sackeyfio, A.; Hackett, J.; Rajaram, S. 2016: Cost-effectiveness analysis of the direct and indirect impact of intranasal live attenuated influenza vaccination strategies in children: alternative country profiles. Journal of Market Access and Health Policy 4
Javanbakht, M.; Moradi-Lakeh, M.; Yaghoubi, M.; Esteghamati, A.; Mansour Ghanaie, R.; Mahmoudi, S.; Shamshiri, A.-R.; Zahraei, S.M.; Baxter, L.; Shakerian, S.; Chaudhri, I.; Fleming, J.A.; Munier, A.; Baradaran, H.R. 2015: Cost-effectiveness analysis of the introduction of rotavirus vaccine in Iran. Vaccine 33(Suppl 1): A192-A200
Aguilar, I.B.M.; Mendoza, L.O.; García, O.; Díaz, I.; Figueroa, J.; Duarte, R.M.ía.; Perdomo, G.; Garcia, A.G.F.; Janusz, C.B. 2015: Cost-effectiveness analysis of the introduction of the human papillomavirus vaccine in Honduras. Vaccine 33(Suppl 1): A167-A173
Sibak, M.; Moussa, I.; El-Tantawy, N.; Badr, S.; Chaudhri, I.; Allam, E.; Baxter, L.; Abo Freikha, S.; Hoestlandt, Céline.; Lara, C.; Hajjeh, R.; Munier, A. 2015: Cost-effectiveness analysis of the introduction of the pneumococcal conjugate vaccine (PCV-13) in the Egyptian national immunization program, 2013. Vaccine 33 Suppl. 1: A182-A191
Nogueira, Túlio.Eduardo.; Esfandiari, S.; Leles, Cáudio.Rodrigues. 2016: Cost-effectiveness analysis of the single-implant mandibular overdenture versus conventional complete denture: study protocol for a randomized controlled trial. Trials 17(1): 533
Bugiantella, W.; Rondelli, F.; Mariani, L.; Polistena, A.; Sanguinetti, A.; Avenia, N.; Mariani, E. 2017: Cost-effectiveness analysis of the temporary percutaneous ileostomy for faecal diversion after colorectal resection in elderly. Aging Clinical and Experimental Research 29(Suppl. 1): 47-53
Ceballos, M.; Orozco, L.E.; Valderrama, C.O.; Londoño, D.I.; Lugo, L.H. 2017: Cost-Effectiveness Analysis of the use of a Prophylactic Antibiotic for Patients Undergoing Lower Limb Amputation due to Diabetes or Vascular Illness in Colombia. Annals of Vascular Surgery 40: 327-334
Gimeno-Ballester, V.; Mar, J.; O'Leary, A.; Adams, Róisín.; San Miguel, Rón. 2017: Cost-effectiveness analysis of therapeutic options for chronic hepatitis C genotype 3 infected patients. Expert Review of Gastroenterology and Hepatology 11(1): 85-93
Altaf, M.; Zubedi, A.M.; Nazneen, F.; Kareemulla, S.; Ali, S.A.; Aleemuddin, N.M.; Hannan Hazari, M.A. 2015: Cost-effectiveness analysis of three different combinations of inhalers for severe and very severe chronic obstructive pulmonary disease patients at a tertiary care teaching hospital of South India. Perspectives in Clinical Research 6(3): 150-158
Mejía, A.; Senior, J.M.; Ceballos, M.; Atehortúa, S.; Toro, J.M.; Saldarriaga, C.; Mejía, M.ía.E.; Ramírez, C. 2015: Cost-effectiveness analysis of ticagrelor compared to clopidogrel for the treatment of patients with acute coronary syndrome in Colombia. Biomedica: Revista del Instituto Nacional de Salud 35(4): 531-540
Le, Q.A.; Bae, Y.H.; Kang, J.H. 2016: Cost-effectiveness analysis of trastuzumab emtansine (T-DM1) in human epidermal growth factor receptor 2 (HER2): positive advanced breast cancer. Breast Cancer Research and Treatment 159(3): 565-573
Garrison, L.P.; Perez, E.A.; Dueck, A.; Lalla, D.; Paton, V.; Lubeck, D. 2016: Cost-effectiveness analysis of trastuzumab in the adjuvant setting for treatment of HER2+ breast cancer. Journal of Clinical Oncology 24(18_Suppl): 6023-6023
Aboutorabi, A.; Hadian, M.; Ghaderi, H.; Salehi, M.; Ghiasipour, M. 2014: Cost-effectiveness analysis of trastuzumab in the adjuvant treatment for early breast cancer. Global Journal of Health Science 7(1): 98-106
Amarowicz, J.ła.; Bolisęga, D.; Rutkowski, J.; Kumorek, A.; Czerwiński, E. 2015: Cost-effectiveness analysis of treatment of osteoporotic fractures in relation to FRAX algorithm in a sample of Polish population. Ortopedia Traumatologia Rehabilitacja 17(1): 59-69
Bamber, L.; Muston, D.; McLeod, E.; Guillermin, A.; Lowin, J.; Patel, R. 2015: Cost-effectiveness analysis of treatment of venous thromboembolism with rivaroxaban compared with combined low molecular weight heparin/vitamin K antagonist. Thrombosis Journal 13: 20
Zhou, J.; Zhao, R.; Wen, F.; Zhang, P.; Wu, Y.; Tang, R.; Chen, H.; Zhang, J.; Li, Q. 2016: Cost-effectiveness analysis of treatments for metastatic pancreatic cancer based on PRODIGE and MPACT trials. Tumori 3: 294-300
Mo, M.; Zheng, Y.; Liu, G.; Fang, H.; Zhang, X.; Zhai, L.; Chen, Y.; Lyu, L.; Zhu, J.; Luo, J.; Zhang, L.; Cao, Z.; Xu, W.; Shao, Z. 2015: Cost-effectiveness analysis of two breast cancer screening modalities in Shanghai, China. Zhonghua Zhong Liu Za Zhi 37(12): 944-951
Quartuccio, L.; di Bidino, R.; Ruggeri, M.; Schiavon, F.; Biasi, D.; Adami, S.; Punzi, L.; Cicchetti, A.; de Vita, S. 2015: Cost-effectiveness analysis of two rituximab retreatment regimens for longstanding rheumatoid arthritis. Arthritis Care and Research 67(7): 947-955
Duan, L.; Huang, M.; Yan, H.; Zhang, Y.; Gu, F. 2015: Cost-effectiveness analysis of two therapeutic schemes in the treatment of acromegaly: a retrospective study of 168 cases. Journal of Endocrinological Investigation 38(7): 717-723
Sartori, A.M.C.; de Soárez, P.íc.C.; Fernandes, E.G.; Gryninger, L.C.F.; Viscondi, J.Y.K.; Novaes, H.M.D. 2016: Cost-effectiveness analysis of universal maternal immunization with tetanus-diphtheria-acellular pertussis (Tdap) vaccine in Brazil. Vaccine 34(13): 1531-1539
Boklage, S.H.; Mangel, A.W.; Ramamohan, V.; Mladsi, D.; Wang, T. 2016: Cost-effectiveness analysis of universal noninvasive testing for post-treatment confirmation of Helicobacter pylori eradication and the impact of patient adherence. Patient Preference and Adherence 10: 1025-1035
Donnay Candil, S.; Balsa Barro, J.é A.; Álvarez Hernández, J.; Crespo Palomo, C.; Pérez-Alcántara, F.án.; Polanco Sánchez, C. 2015: Cost-effectiveness analysis of universal screening for thyroid disease in pregnant women in Spain. Endocrinologia y Nutricion: Organo de la Sociedad Espanola de Endocrinologia y Nutricion 62(7): 322-330
Bongiovanni, I.; Couillerot-Peyrondet, A.-L.; Sambuc, C.éa.; Dantony, E.; Elsensohn, M.-H.él.én.; Sainsaulieu, Y.ël.; Ecochard, R.é; Couchoud, C.éc. 2016: Cost-effectiveness analysis of various strategies of end-stage renal disease patients' care in France. Nephrologie and Therapeutique 12(2): 104-115
Hong, N.J.L.; Clarke, G.M.; Yaffe, M.J.; Holloway, C.M.B. 2016: Cost-effectiveness analysis of whole-mount pathology processing for patients with early breast cancer undergoing breast conservation. Current Oncology 23(Suppl 1): S23-S31
Huang, J.; Wang, X. 2015: Cost-effectiveness analysis parallel to a randomized controlled trial comparing vertical scar reduction and inverted T-shaped reduction mammaplasty. Plastic and Reconstructive Surgery 135(6): 1060e-1061e
Khan, A.; Amitava, A.K.; Rizvi, S.A.R.; Siddiqui, Z.; Kumari, N.; Grover, S. 2015: Cost-effectiveness analysis should continually assess competing health care options especially in high volume environments like cataract surgery. Indian Journal of Ophthalmology 63(6): 496-500
Babo Martins, S.; Rushton, J. 2014: Cost-effectiveness analysis: adding value to assessment of animal health welfare and production. Revue Scientifique et Technique 33(3): 681-689
Sabatelli, L.; Seppälä, U.; Sastre, J.; Crater, G. 2017: Cost-effectiveness and Budget Impact of Routine use of Fractional Exhaled Nitric Oxide Monitoring for the Management of Adult Asthma Patients in Spain. Journal of Investigational Allergology and Clinical Immunology 27(2): 89-97
Mo, X.; Gai Tobe, R.; Liu, X.; Mori, R. 2016: Cost-effectiveness and Health Benefits of Pediatric 23-valent Pneumococcal Polysaccharide Vaccine, 7-valent Pneumococcal Conjugate Vaccine and Forecasting 13-valent Pneumococcal Conjugate Vaccine in China. Pediatric Infectious Disease Journal 35(11): E353-E361
Colbourn, T.; Pulkki-Brännström, A.-M.; Nambiar, B.; Kim, S.; Bondo, A.; Banda, L.; Makwenda, C.; Batura, N.; Haghparast-Bidgoli, H.; Hunter, R.; Costello, A.; Baio, G.; Skordis-Worrall, J. 2015: Cost-effectiveness and affordability of community mobilisation through women's groups and quality improvement in health facilities (MaiKhanda trial) in Malawi. Cost Effectiveness and Resource Allocation: C/E 13(1): 1
Pil, L.; Fobelets, M.; Putman, K.; Trybou, J.; Annemans, L. 2016: Cost-effectiveness and budget impact analysis of a population-based screening program for colorectal cancer. European Journal of Internal Medicine 32: 72-78
Poole, C.D.; Smith, J.; Davies, J.S. 2015: Cost-effectiveness and budget impact of Empirical vitamin D therapy on unintentional falls in older adults in the UK. Bmj Open 5(9): E007910
Chhatwal, J.; Kanwal, F.; Roberts, M.S.; Dunn, M.A. 2015: Cost-effectiveness and budget impact of hepatitis C virus treatment with sofosbuvir and ledipasvir in the United States. Annals of Internal Medicine 162(6): 397-406
Deuffic-Burban, S.; Obach, D.; Canva, V.; Pol, S.; Roudot-Thoraval, F.; Dhumeaux, D.; Mathurin, P.; Yazdanpanah, Y. 2016: Cost-effectiveness and budget impact of interferon-free direct-acting antiviral-based regimens for hepatitis C treatment: the French case. Journal of Viral Hepatitis 23(10): 767-779
Van Boven, J.F.; Kocks, J.W.; Postma, M.J. 2016: Cost-effectiveness and budget impact of the fixed-dose dual bronchodilator combination tiotropium-olodaterol for patients with COPD in the Netherlands. International Journal of Chronic Obstructive Pulmonary Disease 11: 2191-2201
Gardner, T.B.; Spangler, C.C.; Byanova, K.L.; Ripple, G.H.; Rockacy, M.J.; Levenick, J.M.; Smith, K.D.; Colacchio, T.A.; Barth, R.J.; Zaki, B.I.; Tsapakos, M.J.; Gordon, S.R. 2016: Cost-effectiveness and clinical efficacy of biliary stents in patients undergoing neoadjuvant therapy for pancreatic adenocarcinoma in a randomized controlled trial. Gastrointestinal Endoscopy 84(3): 460-466
Cai, Y.L.; Zhang, S.X.; Yang, P.C.; Lin, Y. 2016: Cost-effectiveness and cost-benefit analysis on strategy for preventing mother-to-child transmission of hepatitis B virus. Zhonghua Liu Xing Bing Xue Za Zhi 37(6): 846-851
Tiberg, I.én.; Lindgren, B.ör.; Carlsson, A.; Hallström, I. 2016: Cost-effectiveness and cost-utility analyses of hospital-based home care compared to hospital-based care for children diagnosed with type 1 diabetes; a randomised controlled trial; results after two years' follow-up. Bmc Pediatrics 16: 94
Amirsadri, M.; Hassani, A. 2015: Cost-effectiveness and cost-utility analysis of OTC use of simvastatin 10 mg for the primary prevention of myocardial infarction in Iranian men. Daru: Journal of Faculty of Pharmacy Tehran University of Medical Sciences 23: 56
Chaufan, C.; Harris, G. 2015: Cost-effectiveness and health care costs. Health Affairs 34(1): 188
Odden, M.C.; Pletcher, M.J.; Coxson, P.G.; Thekkethala, D.; Guzman, D.; Heller, D.; Goldman, L.; Bibbins-Domingo, K. 2015: Cost-effectiveness and population impact of statins for primary prevention in adults aged 75 years or older in the United States. Annals of Internal Medicine 162(8): 533-541
Verhoef, T.I.; Morris, S. 2015: Cost-effectiveness and pricing of antibacterial drugs. Chemical Biology and Drug Design 85(1): 4-13
van Hoek, A.Jan.; Campbell, H.; Amirthalingam, G.; Andrews, N.; Miller, E. 2016: Cost-effectiveness and programmatic benefits of maternal vaccination against pertussis in England. Journal of Infection 73(1): 28-37
Becerra, V.; Gracia, A.; Desai, K.; Abogunrin, S.; Brand, S.; Chapman, R.; García Alonso, F.; Fuster, Vín.; Sanz, Gés. 2015: Cost-effectiveness and public health benefit of secondary cardiovascular disease prevention from improved adherence using a polypill in the UK. Bmj Open 5(5): E007111
Menzies, N.A.; Gomez, G.B.; Bozzani, F.; Chatterjee, S.; Foster, N.; Baena, I.G.; Laurence, Y.V.; Qiang, S.; Siroka, A.; Sweeney, S.; Verguet, S.ép.; Arinaminpathy, N.; Azman, A.S.; Bendavid, E.; Chang, S.T.; Cohen, T.; Denholm, J.T.; Dowdy, D.W.; Eckhoff, P.A.; Goldhaber-Fiebert, J.D.; Handel, A.; Huynh, G.H.; Lalli, M.; Lin, H.-H.; Mandal, S.; McBryde, E.S.; Pandey, S.; Salomon, J.A.; Suen, S.-C.; Sumner, T.; Trauer, J.M.; Wagner, B.G.; Whalen, C.C.; Wu, C.-Y.; Boccia, D.; Chadha, V.K.; Charalambous, S.; Chin, D.P.; Churchyard, G.; Daniels, C.; Dewan, P.; Ditiu, L.; Eaton, J.W.; Grant, A.D.; Hippner, P.; Hosseini, M.; Mametja, D.; Pretorius, C.; Pillay, Y.; Rade, K.; Sahu, S.; Wang, L.; Houben, R.M.G.J.; Kimerling, M.E.; White, R.G.; Vas 2016: Cost-effectiveness and resource implications of aggressive action on tuberculosis in China, India, and South Africa: a combined analysis of nine models. LANCET. Global Health 4(11): E816-E826
Miquel-Cases, A.; Steuten, L.M.G.; Rigter, L.S.; van Harten, W.H. 2016: Cost-effectiveness and resource use of implementing MRI-guided NACT in ER-positive/HER2-negative breast cancers in the Netherlands. Bmc Cancer 16: 712
Giménez-Manzorro, Ál.; García-González, X.; Rodríguez-González, C.G.; Ochoa-Palominos, A.; Sanjurjo-Sáez, M.ía.; Clemente-Ricote, G. 2015: Cost-effectiveness and safety of telaprevir and boceprevir for chronic hepatitis C in real-world clinical practice. Gastroenterologia y Hepatologia 38(10): 575-582
Tuffaha, H.W.; Roberts, S.; Chaboyer, W.; Gordon, L.G.; Scuffham, P.A. 2015: Cost-effectiveness and value of information analysis of nutritional support for preventing pressure ulcers in high-risk patients: implement now, research later. Applied Health Economics and Health Policy 13(2): 167-179
Lester-Coll, N.H.; Rutter, C.E.; Evans, S.B. 2016: Cost-effectiveness assessment of lumpectomy cavity boost in elderly women with early stage estrogen receptor positive breast cancer receiving adjuvant radiotherapy. RadioTherapy and Oncology: Journal of the European Society for Therapeutic Radiology and Oncology 119(1): 52-56
Gisbert, J.P.; Gomollón, F.; Méndez, I. 2016: Cost-effectiveness assessment through theoretical cost-minimization analysis of the use of two gastro-resistant modified-release mesalazine formulations in the management of ulcerative colitis in Spain. Gastroenterologia y Hepatologia 39(3): 199-212
Zhang, C.; Ke, W.; Liu, L.; Gao, Y.; Yao, Z.; Ye, X.; Zhou, S.; Yang, Y. 2016: Cost-effectiveness comparison of lamivudine plus adefovir combination treatment and nucleos(t)ide analog monotherapies in Chinese chronic hepatitis B patients. Drug Design Development and Therapy 10: 897-910
Welsch, T.; Müssle, B.; Distler, M.; Knoth, H.; Weitz, Jürgen.; Häckl, D. 2016: Cost-effectiveness comparison of prophylactic octreotide and pasireotide for prevention of fistula after pancreatic surgery. Langenbeck's Archives of Surgery 401(7): 1027-1035
Cone, E.B.; Pareek, G.; Ursiny, M.; Eisner, B. 2017: Cost-effectiveness comparison of ureteral calculi treated with ureteroscopic laser lithotripsy versus shockwave lithotripsy. World Journal of Urology 35(1): 161-166
Moriwaki, K. 2015: Cost-effectiveness considerations in the treatment of osteoporosis. Nihon Rinsho. Japanese Journal of Clinical Medicine 73(10): 1754-1759
Brunstein, J. 2016: Cost-effectiveness considerations with molecular diagnostics in oncology. Mlo: Medical Laboratory Observer 48(5): 30-31
Gyrd-Hansen, D.; Olsen, K.R.; Bollweg, K.; Kronborg, C.; Ebinger, M.; Audebert, H.J. 2015: Cost-effectiveness estimate of prehospital thrombolysis: results of the PHANTOM-S study. Neurology 84(11): 1090-1097
Thommes, E.W.; Ismaila, A.; Chit, A.; Meier, G.; Bauch, C.T. 2015: Cost-effectiveness evaluation of quadrivalent influenza vaccines for seasonal influenza prevention: a dynamic modeling study of Canada and the United Kingdom. Bmc Infectious Diseases 15: 465
Hu, H.-h.; Yu, Q.; Zhang, X.; Cao, C.-l.; Li, S.-z.; Zhu, H. 2015: Cost-effectiveness evaluation on comprehensive control measures carrying out in schistosomiasis endemic areas with regard to different layers of administrative villages stratified by infection situation of human and domestic animals. Ii Correlation analysis of costs and inputs with changes of schistosomiasis endemic situation in inner embankment of marshland and lake regions from 2006 to 2013. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi 27(1): 17-21
Nuijten, M.J.; Keller, J.J.; Visser, C.E.; Redekop, K.; Claassen, E.; Speelman, P.; Pronk, M.H. 2015: Cost-effectiveness in Clostridium difficile treatment decision-making. World Journal of Clinical Cases 3(11): 935-941
Van Agthoven, M.; van der Kolk, A.; Knegtering, H.; Delespaul, P.A.E.G.; Arends, J.; Jeurissen, P.P.T.; Krabbe, P.F.M.; Huijsman, R.; Luijk, R.; De Beurs, E.; Hakkaart-Van Roijen, L.; Bruggeman, R. 2015: Cost-effectiveness in Dutch mental health care: future because of ROM?. Tijdschrift Voor Psychiatrie 57(9): 672-679
Ebm, C.C.; Sutton, L.; Rhodes, A.; Cecconi, M. 2014: Cost-effectiveness in goal-directed therapy: are the dollars spent worth the value?. Journal of Cardiothoracic and Vascular Anesthesia 28(6): 1660-1666
Moraz, G.; Garcez, A.d.S.; de Assis, E.M.; dos Santos, J.P.; Barcellos, N.êm.T.; Kroeff, L.R. 2015: Cost-effectiveness in health in Brazil: a systematic review. Ciencia and Saude Coletiva 20(10): 3211-3229
Epinette, J.-A.; Lafuma, A.; Robert, J.; Doz, M. 2016: Cost-effectiveness model comparing dual-mobility to fixed-bearing designs for total hip replacement in France. Orthopaedics and Traumatology Surgery and Research: Otsr 102(2): 143-148
Kim, D.D.; Hutton, D.W.; Raouf, A.A.; Salama, M.; Hablas, A.; Seifeldin, I.A.; Soliman, A.S. 2015: Cost-effectiveness model for hepatitis C screening and treatment: Implications for Egypt and other countries with high prevalence. Global Public Health 10(3): 296-317
Sailer, A.M.; van Zwam, W.H.; Wildberger, J.E.; Grutters, J.P.C. 2015: Cost-effectiveness modelling in diagnostic imaging: a stepwise approach. European Radiology 25(12): 3629-3637
Zhao, Y.J.; Lin, L.; Zhou, H.J.; Tan, K.T.; Chew, A.P.; Foo, C.G.; Oh, C.T.D.; Lim, B.P.; Lim, W.S. 2016: Cost-effectiveness modelling of novel oral anticoagulants incorporating real-world elderly patients with atrial fibrillation. International Journal of Cardiology 220: 794-801
Beresniak, A.; Caruba, T.; Sabatier, B.; Juillière, Y.; Dubourg, O.; Danchin, N. 2015: Cost-effectiveness modelling of percutaneous coronary interventions in stable coronary artery disease. World Journal of Cardiology 7(10): 594-602
Dixon, P.; Hollinghurst, S.; Ara, R.; Edwards, L.; Foster, A.; Salisbury, C. 2016: Cost-effectiveness modelling of telehealth for patients with raised cardiovascular disease risk: evidence from a cohort simulation conducted alongside the Healthlines randomised controlled trial. Bmj Open 6(9): E012355
Wong, E.Mi.Ling.; Lo, S.Man.; Ng, Y.Chu.; Lee, L.Lap.Yip.; Yuen, T.M.Y.; Chan, J.Tak.Shing.; Chair, S.Ying. 2016: Cost-effectiveness of 'Program We Care' for patients with chronic obstructive pulmonary disease: A case-control study. International Emergency Nursing 27: 37-41
Pandya, A.; Sy, S.; Cho, S.; Weinstein, M.C.; Gaziano, T.A. 2015: Cost-effectiveness of 10-Year Risk Thresholds for Initiation of Statin Therapy for Primary Prevention of Cardiovascular Disease. JAMA 314(2): 142-150
Beemster, T.T.; van Velzen, J.M.; van Bennekom, C.A.M.; Frings-Dresen, M.H.W.; Reneman, M.F. 2015: Cost-effectiveness of 40-hour versus 100-hour vocational rehabilitation on work participation for workers on sick leave due to subacute or chronic musculoskeletal pain: study protocol for a randomized controlled trial. Trials 16: 317
Bairdain, S.; Samnaliev, M. 2015: Cost-effectiveness of Adolescent Bariatric Surgery. Cureus 7(2): E248
Ross, E.L.; Hutton, D.W.; Stein, J.D.; Bressler, N.M.; Jampol, L.M.; Glassman, A.R. 2016: Cost-effectiveness of Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema Treatment: Analysis from the Diabetic Retinopathy Clinical Research Network Comparative Effectiveness Trial. JAMA Ophthalmology 134(8): 888-896
Quitian Reyes, H.; Arciniegas Barrera, J.A.; Bohórquez Peñaranda, A.; Gómez Restrepo, C. 2016: Cost-effectiveness of Antipsychotics in the Maintenance Treatment of Schizophrenia in Colombia. Revista Colombiana de Psiquiatria 45(2): 67-74
Lip, G.Y.H.; Lanitis, T.; Kongnakorn, T.; Phatak, H.; Chalkiadaki, C.; Liu, X.; Kuznik, A.; Lawrence, J.; Dorian, P. 2015: Cost-effectiveness of Apixaban Compared With Edoxaban for Stroke Prevention in Nonvalvular Atrial Fibrillation. Clinical therapeutics 37(11): 2476-2488.e27
Lanitis, T.; Leipold, R.; Hamilton, M.; Rublee, D.; Quon, P.; Browne, C.; Cohen, A.T. 2016: Cost-effectiveness of Apixaban Versus Other Oral Anticoagulants for the Initial Treatment of Venous Thromboembolism and Prevention of Recurrence. Clinical Therapeutics 38(3): 478-93.E1-16
Bish, E.K.; Moritz, E.D.; El-Amine, H.; Bish, D.R.; Stramer, S.L. 2015: Cost-effectiveness of Babesia microti antibody and nucleic acid blood donation screening using results from prospective investigational studies. Transfusion 55(9): 2256-2271
Klebanoff, M.J.; Chhatwal, J.; Nudel, J.D.; Corey, K.E.; Kaplan, L.M.; Hur, C. 2017: Cost-effectiveness of Bariatric Surgery in Adolescents with Obesity. JAMA Surgery 152(2): 136-141
Warren, J.A.; Ewing, J.A.; Hale, A.L.; Blackhurst, D.W.; Bour, E.S.; Scott, J.D. 2015: Cost-effectiveness of Bariatric Surgery: Increasing the Economic Viability of the Most Effective Treatment for Type Ii Diabetes Mellitus. American Surgeon 81(8): 807-811
Park, H.-Y.; Ku, H.-m.; Sohn, H.-S.; Seo, H.-S.; Yung Lee, H.; Hwa Lim, K.; Kwon, J.-W. 2016: Cost-effectiveness of Bedaquiline for the Treatment of Multidrug-resistant Tuberculosis in the Republic of Korea. Clinical Therapeutics 38(3): 655-67.E1-2
Black, W.C.; Keeler, E.B.; Soneji, S.S. 2015: Cost-effectiveness of CT screening in the National Lung Screening Trial. New England Journal of Medicine 372(4): 388
Pinsky, P.F. 2015: Cost-effectiveness of CT screening in the National Lung Screening Trial. New England Journal of Medicine 372(4): 387
Schackman, B.R.; Haas, D.W.; Park, S.S.; Li, X.C.; Freedberg, K.A. 2015: Cost-effectiveness of CYP2B6 genotyping to optimize efavirenz dosing in HIV clinical practice. Pharmacogenomics 16(18): 2007-2018
Sabapathy, S.; Neslusan, C.; Yoong, K.; Teschemaker, A.; Johansen, P.; Willis, M. 2016: Cost-effectiveness of Canagliflozin versus Sitagliptin when Added to Metformin and Sulfonylurea in Type 2 Diabetes in Canada. Journal of Population Therapeutics and Clinical Pharmacology 23(2): E151-E168
Owusu-Edusei, K.; Chesson, H.W.; Gift, T.L.; Brunham, R.C.; Bolan, G. 2015: Cost-effectiveness of Chlamydia vaccination programs for young women. Emerging Infectious Diseases 21(6): 960-968
Moore, J.B.; Heboyan, Vé.; Oniffrey, T.M.; Brinkley, J.; Andrews, S.M.; Kolbe, M.Bea. 2017: Cost-effectiveness of Community-Based Minigrants to Increase Physical Activity in Youth. Journal of public health management and practice: JPHMP 23(4): 364-369
Mikailov, A.; Cohen, J.; Joyce, C.; Mostaghimi, A. 2016: Cost-effectiveness of Confirmatory Testing Before Treatment of Onychomycosis. JAMA Dermatology 152(3): 276-281
Català, R.; Villoro, R.; Merino, Mía.; Sangenís, S.; Colomés, Lís.; Hernández Flix, S.; Pérez de Llano, L.A. 2016: Cost-effectiveness of Continuous Positive Airway Pressure Treatment in Moderate-Severe Obstructive Sleep Apnea Syndrome. Archivos de Bronconeumologia 52(9): 461-469
Teti, V.P.; Akdagli, S.; Most, S.P. 2016: Cost-effectiveness of Corticosteroid Nasal Spray vs Surgical Therapy in Patients with Severe to Extreme Anatomical Nasal Obstruction. JAMA Facial Plastic Surgery 18(3): 165-170
Wright, E.K.; Kamm, M.A.; Dr Cruz, P.; Hamilton, A.L.; Ritchie, K.J.; Bell, S.J.; Brown, S.J.; Connell, W.R.; Desmond, P.V.; Liew, D. 2016: Cost-effectiveness of Crohn's disease post-operative care. World Journal of Gastroenterology 22(14): 3860-3868
Peng, S.; Tafazzoli, A.; Dorman, E.; Rosenblatt, L.; Villasis-Keever, A.; Sorensen, S. 2015: Cost-effectiveness of DTG + ABC/3TC versus EFV/TDF/FTC for first-line treatment of HIV-1 in the United States. Journal of Medical Economics 18(10): 763-776
Debes, A.K.; Gilman, R.H.; Onyango-Makumbi, C.; Ruff, A.; Oberhelman, R.; Dowdy, D.W. 2017: Cost-effectiveness of Diagnostic Algorithms for Tuberculosis in Children Less Than 5 Years of Age. Pediatric infectious disease journal 36(1): 36-43
Pasquel, F.J.; Hendrick, A.M.; Ryan, M.; Cason, E.; Ali, M.K.; Narayan, K.M.V. 2015: Cost-effectiveness of Different Diabetic Retinopathy Screening Modalities. Journal of Diabetes Science and Technology 10(2): 301-307
Chahal, H.S.; Marseille, E.A.; Tice, J.A.; Pearson, S.D.; Ollendorf, D.A.; Fox, R.K.; Kahn, J.G. 2016: Cost-effectiveness of Early Treatment of Hepatitis C Virus Genotype 1 by Stage of Liver Fibrosis in a US Treatment-Naive Population. JAMA Internal Medicine 176(1): 65-73
Burgers, L.T.; Vahl, A.C.; Severens, J.L.; Wiersema, A.M.; Cuypers, P.W.M.; Verhagen, H.J.M.; Redekop, W.K. 2016: Cost-effectiveness of Elective Endovascular Aneurysm Repair Versus Open Surgical Repair of Abdominal Aortic Aneurysms. European Journal of Vascular and Endovascular Surgery: the Official Journal of the European Society for Vascular Surgery 52(1): 29-40
Beerthuizen, T.; Voorend-van Bergen, S.; van den Hout, W.B.; Vaessen-Verberne, A.A.; Brackel, H.J.; Landstra, A.M.; van den Berg, N.J.; de Jongste, J.C.; Merkus, P.J.; Pijnenburg, M.ël.W.; Sont, J.K. 2016: Cost-effectiveness of FENO-based and web-based monitoring in paediatric asthma management: a randomised controlled trial. Thorax 71(7): 607-613
Soini, E.; Hautala, A.; Poikonen, E.; Becker, U.; Kyttälä, M.; Martikainen, J. 2016: Cost-effectiveness of First-line Chronic Lymphocytic Leukemia Treatments when Full-dose Fludarabine Is Unsuitable. Clinical Therapeutics 38(4): 889-904.E14
Lilly, C.M.; Touray, S. 2016: Cost-effectiveness of Fluid Resuscitation of Critically Ill Adults: New Insights From Uncharted Territory. Chest 150(6): 1179-1180
Leung, H.W.C.; Chan, A.L.F.; Muo, C.-H. 2016: Cost-effectiveness of Gemcitabine Plus Modern Radiotherapy in Locally Advanced Pancreatic Cancer. Clinical Therapeutics 38(5): 1174-1183
Bristow, C.C.; Larson, E.; Anderson, L.J.; Klausner, J.D. 2016: Cost-effectiveness of HIV and syphilis antenatal screening: a modelling study. Sexually Transmitted Infections 92(5): 340-346
Walwyn, L.; Janusz, C.B.; Clark, A.D.; Prieto, E.; Waight, E.; Largaespada, N. 2015: Cost-effectiveness of HPV vaccination in Belize. Vaccine 33(Suppl 1): A174-A181
Aljunid, S.; Maimaiti, N.; Nur, A.M.; Noor, M.R.M.; Wan Puteh, S.E. 2016: Cost-effectiveness of HPV vaccination regime: comparing twice versus thrice vaccinations dose regime among adolescent girls in Malaysia. Bmc Public Health 16: 71
Le, P.; Griffiths, U.K.; Anh, D.D.; Franzini, L.; Chan, W.; Swint, J.M. 2015: Cost-effectiveness of Haemophilus influenzae type b vaccine in Vietnam. Vaccine 33(36): 4639-4646
Wong, I.O.L.; Schooling, C.M.; Cowling, B.J. 2014: Cost-effectiveness of Helicobacter pylori screening and treatment for gastric cancer in Hong Kong: a decision analytic approach. Hong Kong Medical Journal 20(Suppl 7): 13-15
Ammerman, R.T.; Mallow, P.J.; Rizzo, J.A.; Putnam, F.W.; Van Ginkel, J.B. 2017: Cost-effectiveness of In-Home Cognitive Behavioral Therapy for low-income depressed mothers participating in early childhood prevention programs. Journal of Affective Disorders 208: 475-482
Li, R.; Simmons, K.B.; Bertolli, J.; Rivera-Garcia, B.; Cox, S.; Romero, L.; Koonin, L.M.; Valencia-Prado, M.; Bracero, N.; Jamieson, D.J.; Barfield, W.; Moore, C.A.; Mai, C.T.; Korhonen, L.C.; Frey, M.T.; Perez-Padilla, J.; Torres-Muñoz, R.; Grosse, S.D. 2017: Cost-effectiveness of Increasing Access to Contraception during the Zika Virus Outbreak, Puerto Rico, 2016. Emerging Infectious Diseases 23(1): 74-82
Glaubius, R.L.; Hood, G.; Penrose, K.J.; Parikh, U.M.; Mellors, J.W.; Bendavid, E.; Abbas, U.L. 2016: Cost-effectiveness of Injectable Preexposure Prophylaxis for HIV Prevention in South Africa. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 63(4): 539-547
Richman, I.B.; Fairley, M.; Jørgensen, M.Emil.; Schuler, A.; Owens, D.K.; Goldhaber-Fiebert, J.D. 2016: Cost-effectiveness of Intensive Blood Pressure Management. JAMA Cardiology 1(8): 872-879
Gissel, C.; Götz, G.; Mahlich, J.ör.; Repp, H. 2015: Cost-effectiveness of Interferon-free therapy for Hepatitis C in Germany--an application of the efficiency frontier approach. Bmc Infectious Diseases 15: 297
Vidal, J.; Slof, J.; Serrano, D.; Marqués, T.; Kumru, H.; Benito-Penalva, Jús. 2017: Cost-effectiveness of Intrathecal Baclofen Therapy in severe refractory non-focal disabling spasticity: a Spanish hospital perspective. Expert Review of Pharmacoeconomics and Outcomes Research 17(1): 67-76
Wang, G.-L.; Liu, Y.; Qiu, P.; Zhou, S.-F.; Xu, L.-F.; Wen, P.; Wen, J.-B.; Xiao, X.-Z. 2016: Cost-effectiveness of Lamivudine, Telbivudine, Adefovir Dipivoxil and Entecavir on decompensated hepatitis B virus-related cirrhosis. European Review for Medical and Pharmacological Sciences 20(5): 866-872
Mladsi, D.; Ronquest, N.; Odom, D.; Miles, L.; Saag, K. 2016: Cost-effectiveness of Low-dose Submicron Diclofenac Compared with Generic Diclofenac. Clinical Therapeutics 38(11): 2418-2429
Carreon, L.Y.; Bratcher, K.R.; Ammous, F.; Glassman, S.D. 2018: Cost-effectiveness of Lumbar Epidural Steroid Injections. Spine 43(1): 35-40
Goffin, J.R.; Flanagan, W.M.; Miller, A.B.; Fitzgerald, N.R.; Memon, S.; Wolfson, M.C.; Evans, W.K. 2015: Cost-effectiveness of Lung Cancer Screening in Canada. JAMA Oncology 1(6): 807-813
Moore, S.G.; Tumeh, J.; Flowers, C.R. 2016: Cost-effectiveness of MRI compared to mammography for breast cancer screening in a high risk population. Journal of Clinical Oncology 24(18_Suppl): 6060-6060
Wu, X.; Kalra, V.B.; Forman, H.P.; Malhotra, A. 2015: Cost-effectiveness of MRi to Assess for Posttraumatic Ligamentous Cervical Spine Injury. Orthopedics 38(9): 529
Norrlid, H.; Hjalte, F.; Lundqvist, A.; Svensson, Åk.; Tennvall, G.R. 2016: Cost-effectiveness of Maintenance Treatment with a Barrier-strengthening Moisturizing Cream in Patients with Atopic Dermatitis in Finland, Norway and Sweden. Acta Dermato-Venereologica 96(2): 173-176
Wang, Y.; Chen, Y.-W.; Leow, J.J.; Levy, A.C.; Chang, S.L.; Gelpi, F.-H. 2016: Cost-effectiveness of Management Options for Small Renal Mass: a Systematic Review. American Journal of Clinical Oncology 39(5): 484-490
Lehur, P.A.; Didnée, A.S.; Faucheron, J.-L.; Meurette, G.; Zerbib, P.; Siproudhis, L.; Vinson-Bonnet, B.éa.; Dubois, A.; Casa, C.; Hardouin, J.-B.; Durand-Zaleski, I. 2016: Cost-effectiveness of new Surgical Treatments for Hemorrhoidal Disease: a Multicentre Randomized Controlled Trial Comparing Transanal Doppler-guided Hemorrhoidal Artery Ligation with Mucopexy and Circular Stapled Hemorrhoidopexy. Annals of Surgery 264(5): 710-716
Nagayama, H.; Tomori, K.; Ohno, K.; Takahashi, K.; Yamauchi, K. 2016: Cost-effectiveness of Occupational Therapy in Older People: Systematic Review of Randomized Controlled Trials. Occupational Therapy International 23(2): 103-120
Saab, S.; Gonzalez, Y.S.; Huber, C.; Wang, A.; Juday, T. 2016: Cost-effectiveness of Ombitasvir/Paritaprevir/Ritonavir, Dasabuvir+Ribavirin for US Post-Liver Transplant Recurrent Genotype 1 HCV. Liver International: Official Journal of the International Association for the Study of the Liver 36(4): 515-521
Thokala, P.; Goodacre, S.; Ward, M.; Penn-Ashman, J.; Perkins, G.D. 2015: Cost-effectiveness of Out-of-Hospital Continuous Positive Airway Pressure for Acute Respiratory Failure. Annals of Emergency Medicine 65(5): 556-563.E6
Mastey, V.; Johnstone, B.M. 2016: Cost-effectiveness of PCSK9 Inhibitor Therapy. JAMA 316(20): 2151-2152
Kazi, D.S.; Moran, A.E.; Coxson, P.G.; Penko, J.; Ollendorf, D.A.; Pearson, S.D.; Tice, J.A.; Guzman, D.; Bibbins-Domingo, K. 2016: Cost-effectiveness of PCSK9 Inhibitor Therapy in Patients with Heterozygous Familial Hypercholesterolemia or Atherosclerotic Cardiovascular Disease. JAMA 316(7): 743-753
Gerke, O.; Hermansson, R.; Hess, S.ør.; Schifter, S.ør.; Vach, W.; Høilund-Carlsen, P.F. 2015: Cost-effectiveness of PET and PET/computed tomography: a systematic review. Pet Clinics 10(1): 105-124
Kwon, J-Won.; Park, H-Young.; Kim, Y.Jee.; Moon, S-Hwan.; Kang, H-Young. 2016: Cost-effectiveness of Pharmaceutical Interventions to Prevent Osteoporotic Fractures in Postmenopausal Women with Osteopenia. Journal of Bone Metabolism 23(2): 63-77
Xu, S.; Immaneni, S.; Hazen, G.B.; Silverberg, J.I.; Paller, A.S.; Lio, P.A. 2017: Cost-effectiveness of Prophylactic Moisturization for Atopic Dermatitis. JAMA Pediatrics 171(2): E163909
Okafor, P.N.; Farraye, F.A.; Okafor, A.T.; Erim, D.O. 2015: Cost-effectiveness of Prophylaxis Against Pneumocystis jiroveci Pneumonia in Patients with Crohn's Disease. Digestive Diseases and Sciences 60(12): 3743-3755
Wen, F.; Yang, Y.; Zhang, P.; Zhang, J.; Zhou, J.; Tang, R.; Chen, H.; Zheng, H.; Fu, P.; Li, Q. 2015: Cost-effectiveness of RAS screening before monoclonal antibodies therapy in metastatic colorectal cancer based on FIRE3 Study. Cancer Biology and Therapy 16(11): 1577-1584
Cavusoglu Sezen, S.; Dokuyucu, O.; Saylan, M.; Burke, C.; Mahon, R.; Keskinaslan, A. 2015: Cost-effectiveness of Ranibizumab Vs. Dexamethasone Implant In Diabetic Macular Edema. Value in Health 18(7): A422
Hollenbeak, C.S.; Weinstock, R.S.; Cibula, D.; Delahanty, L.M.; Trief, P.M. 2016: Cost-effectiveness of SHINE: A Telephone Translation of the Diabetes Prevention Program. Health Services Insights 9: 21-28
Slof, J.; Ruiz, L.; Vila, C. 2015: Cost-effectiveness of Sativex in multiple sclerosis spasticity: new data and application to Italy. Expert Review of Pharmacoeconomics and Outcomes Research 15(3): 379-391
Lowry, E.A.; de Alba Campomanes, A.G. 2016: Cost-effectiveness of School-Based Eye Examinations in Preschoolers Referred for Follow-up from Visual Screening. JAMA Ophthalmology 134(6): 658-664
Zarrouk, M.; Lundqvist, A.; Holst, J.; Troëng, T.; Gottsäter, A. 2016: Cost-effectiveness of Screening for Abdominal Aortic Aneurysm in Combination with Medical Intervention in Patients with Small Aneurysms. European Journal of Vascular and Endovascular Surgery: the Official Journal of the European Society for Vascular Surgery 51(6): 766-773
Mihaylova, B.; Schlackow, I.; Herrington, W.; Lozano-Kühne, J.; Kent, S.; Emberson, J.; Reith, C.; Haynes, R.; Cass, A.; Craig, J.; Gray, A.; Collins, R.; Landray, M.J.; Baigent, C.; Collins, R.; Baigent, C.; Landray, M.J.; Bray, C.; Chen, Y.; Baxter, A.; Young, A.; Hill, M.; Knott, C.; Cass, A.; Feldt-Rasmussen, B.; Fellström, B.; Grobbee, D.E.; Grönhagen-Riska, C.; Haas, M.; Holdaas, H.; Hooi, L.S.; Jiang, L.; Kasiske, B.; Krairittichai, U.; Levin, A.; Massy, Z.A.; Tesar, V.; Walker, R.; Wanner, C.; Wheeler, D.C.; Wiecek, A.; Dasgupta, T.; Herrington, W.; Lewis, D.; Mafham, M.; Majoni, W.; Reith, C.; Emberson, J.; Parish, S.; Simpson, D.; Strony, J.; Musliner 2016: Cost-effectiveness of Simvastatin plus Ezetimibe for Cardiovascular Prevention in CKD: Results of the Study of Heart and Renal Protection (SHARP). American Journal of Kidney Diseases: the Official Journal of the National Kidney Foundation 67(4): 576-584
Schwendicke, F.; Göstemeyer, G. 2016: Cost-effectiveness of Single- Versus Multistep Root Canal Treatment. Journal of Endodontics 42(10): 1446-1452
Luo, J.; Kesselheim, A.S. 2015: Cost-effectiveness of Statin Therapy for ASCVD. JAMA 314(20): 2191
Snoswell, C.; Finnane, A.; Janda, M.; Soyer, H.P.; Whitty, J.A. 2016: Cost-effectiveness of Store-and-Forward Teledermatology: a Systematic Review. JAMA Dermatology 152(6): 702-708
Kvamme, M.K.; Lie, E.; Uhlig, T.; Moger, T.A.; Kvien, T.K.; Kristiansen, I.S. 2015: Cost-effectiveness of TNF inhibitors vs synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: a Markov model study based on two longitudinal observational studies. Rheumatology 54(7): 1226-1235
Lee, M.-Y.; Park, S.-K.; Park, S.-Y.; Byun, J.-H.; Lee, S.-M.; Ko, S.-K.; Lee, E.-K. 2015: Cost-effectiveness of Tofacitinib in the Treatment of Moderate to Severe Rheumatoid Arthritis in South Korea. Clinical Therapeutics 37(8): 1662-76.E2
Padula, W.V.; Larson, R.A.; Dusetzina, S.B.; Apperley, J.F.; Hehlmann, R.; Baccarani, M.; Eigendorff, E.; Guilhot, J.; Guilhot, F.; Hehlmann, R.; Mahon, F.-X.; Martinelli, G.; Mayer, J.; Müller, M.C.; Niederwieser, D.; Saussele, S.; Schiffer, C.A.; Silver, R.T.; Simonsson, B.; Conti, R.M. 2016: Cost-effectiveness of Tyrosine Kinase Inhibitor Treatment Strategies for Chronic Myeloid Leukemia in Chronic Phase After Generic Entry of Imatinib in the United States. Journal of the National Cancer Institute 108(7)
Long, E.F.; Ganz, P.A. 2015: Cost-effectiveness of Universal BRCA1/2 Screening: Evidence-Based Decision Making. JAMA Oncology 1(9): 1217-1218
Gantt, S.; Dionne, F.; Kozak, F.K.; Goshen, O.; Goldfarb, D.M.; Park, A.H.; Boppana, S.B.; Fowler, K. 2016: Cost-effectiveness of Universal and Targeted Newborn Screening for Congenital Cytomegalovirus Infection. JAMA Pediatrics 170(12): 1173-1180
Piccininni, C.; Bisnaire, L.; Penner, M. 2017: Cost-effectiveness of Wait time Reduction for Intensive Behavioral Intervention Services in Ontario, Canada. JAMA Pediatrics 171(1): 23-30
Sadique, Z.; Lopman, B.; Cooper, B.S.; Edmunds, W.John. 2016: Cost-effectiveness of Ward Closure to Control Outbreaks of Norovirus Infection in United Kingdom National Health Service Hospitals. Journal of Infectious Diseases 213 Suppl. 1: S19-S26
Shireman, T.I.; Svarstad, B.L. 2016: Cost-effectiveness of Wisconsin TEAM model for improving adherence and hypertension control in black patients. Journal of the American Pharmacists Association: Japha 56(4): 389-396
Langley, I.; Lin, H.-H.; Squire, S.B. 2015: Cost-effectiveness of Xpert MTB/RIF and investing in health care in Africa. LANCET. Global Health 3(2): E83-E84
Zhao, D.; Gai Tobe, R.; Cui, M.; He, J.; Wu, B. 2016: Cost-effectiveness of a 23-valent pneumococcal polysaccharide vaccine immunization programme for the elderly in Shanghai, China. Vaccine 34(50): 6158-6165
Bish, E.K.; Moritz, E.D.; El-Amine, H.; Bish, D.R.; Stramer, S.L. 2016: Cost-effectiveness of a Babesia microti blood donation intervention based on real-time prospective screening in endemic areas of the United States. Transfusion 56(3): 775-777
Vilà, A.; Villegas, Eàlia.; Cruanyes, J.; Delgado, R.; Sabaté, R-Ana.; Ortega, J.; Araguás, C.; Humet, C.; Abad, G.; Álvarez, J.Miguel.; Ballber, M.Dolores.; Bertrán, S.; Boada, J.Ma.; Boada, A.; Domenech, A.; Escudé, M.Ma.; Genestar, R.Ma.; Guerrero, Aés.; López, F.; Gutiérrez, N.; Martín, A.; Miralles, Vçs.; Pou, A.; Puget, Mía.; Sanz, M.Ángeles.; Serradell, E.; Torres, M.; Villacé, P.; Ximenis, A.; Zaragoza, C.; Andreu, C.; Arana, M.; Creixell, Gòria.; Cot, R.; Farret, M.; Figueras, M.Josep.; Isart, O.; Neciosup, C.; Meneses, Mónica.; Moreno, S.; Ruíz, A.; Pr 2015: Cost-effectiveness of a Barcelona home care program for individuals with multimorbidity. Journal of the American Geriatrics Society 63(5): 1017-1024
Regueiro, A.; Bosch, J.; Martín-Yuste, V.; Rosas, A.; Faixedas, M.T.; Gómez-Hospital, J.A.; Figueras, J.; Curós, A.; Cequier, A.; Goicolea, J.; Fernández-Ortiz, A.; Macaya, C.; Tresserras, R.; Pellisé, L.; Sabaté, M. 2015: Cost-effectiveness of a European ST-segment elevation myocardial infarction network: results from the Catalan Codi Infart network. Bmj Open 5(12): E009148
Farag, I.; Howard, K.; Hayes, A.J.; Ferreira, M.L.; Lord, S.R.; Close, J.T.; Vogler, C.; Dean, C.M.; Cumming, R.G.; Sherrington, C. 2015: Cost-effectiveness of a Home-Exercise Program Among Older People After Hospitalization. Journal of the American Medical Directors Association 16(6): 490-496
Nguyen, H.V.; Tan, G.Siew.Wei.; Tapp, R.Jennifer.; Mital, S.; Ting, D.Shu.Wei.; Wong, H.Tym.; Tan, C.S.; Laude, A.; Tai, E.Shyong.; Tan, N.Chuan.; Finkelstein, E.A.; Wong, T.Yin.; Lamoureux, E.L. 2016: Cost-effectiveness of a National Telemedicine Diabetic Retinopathy Screening Program in Singapore. Ophthalmology 123(12): 2571-2580
Graziose, M.M.; Koch, P.A.; Wang, Y.C.; Lee Gray, H.; Contento, I.R. 2017: Cost-effectiveness of a Nutrition Education Curriculum Intervention in Elementary Schools. Journal of Nutrition Education and Behavior 49(8): 684-691.E1
Cheng, Q.; Church, J.; Haas, M.; Goodall, S.; Sangster, J.; Furber, S. 2016: Cost-effectiveness of a Population-based Lifestyle Intervention to Promote Healthy Weight and Physical Activity in Non-attenders of Cardiac Rehabilitation. Heart Lung and Circulation 25(3): 265-274
Zhang, A.Y.; Fu, A.Z. 2016: Cost-effectiveness of a behavioral intervention for persistent urinary incontinence in prostate cancer patients. Psycho-Oncology 25(4): 421-427
Connelly, L.B.; Le, H.N.D. 2015: Cost-effectiveness of a bivalent human papillomavirus vaccination program in Japan. Sexual Health 12(6): 520-531
Rey, G.N.; Aguilar, P.S.M.; Pérez, F.C.; Orford, J.; Escudero, G.S.; Sainz, M.T. 2016: Cost-effectiveness of a brief intervention to support indigenous women in Hidalgo (Mexico) who live with alcohol abusers. Revista Panamericana de Salud Publica 39(2): 69-75
Verberne, C.J.; Wiggers, T.; Grossmann, I.; de Bock, G.H.; Vermeulen, K.M. 2016: Cost-effectiveness of a carcinoembryonic antigen (CEA) based follow-up programme for colorectal cancer (the CEA Watch trial). Colorectal Disease: the Official Journal of the Association of Coloproctology of Great Britain and Ireland 18(3): O91-O96
Sadique, Z.; Harrison, D.A.; Grieve, R.; Rowan, K.M.; Pearse, R.M. 2015: Cost-effectiveness of a cardiac output-guided haemodynamic therapy algorithm in high-risk patients undergoing major gastrointestinal surgery. Perioperative Medicine 4: 13
Braam, K.I.; van Dijk-Lokkart, E.M.; van Dongen, J.M.; van Litsenburg, R.R.L.; Takken, T.; Huisman, J.; Merks, J.H.M.; Bosmans, J.E.; Hakkenbrak, N.A.G.; Bierings, M.B.; van den Heuvel-Eibrink, M.M.; Veening, M.A.; van Dulmen-den Broeder, E.; Kaspers, G.J.L. 2017: Cost-effectiveness of a combined physical exercise and psychosocial training intervention for children with cancer: Results from the quality of life in motion study. European Journal of Cancer Care 26(6)
Pizzi, L.T.; Jutkowitz, E.; Frick, K.D.; Suh, D-Churl.; Prioli, K.M.; Gitlin, L.N. 2014: Cost-effectiveness of a community-integrated home-based depression intervention in older African Americans. Journal of the American Geriatrics Society 62(12): 2288-2295
Fitzpatrick, C.; Hui, Z.; Lixia, W.; Renzhong, L.; Yunzhou, R.; Mingting, C.; Yanlin, Z.; Jin, Z.; Wei, S.; Caihong, X.; Cheng, C.; Alston, T.; Yan, Q.; Chengfei, L.; Yunting, F.; Shitong, H.; Qiang, S.; Scano, F.; Chin, D.P.; Floyd, K. 2015: Cost-effectiveness of a comprehensive programme for drug-resistant tuberculosis in China. Bulletin of the World Health Organization 93(11): 775-784
Mash, R.; Kroukamp, R.; Gaziano, T.; Levitt, N. 2015: Cost-effectiveness of a diabetes group education program delivered by health promoters with a guiding style in underserved communities in Cape Town, South Africa. Patient Education and Counseling 98(5): 622-626
Cereda, E.; Klersy, C.; Andreola, M.; Pisati, R.; Schols, J.M.G.A.; Caccialanza, R.; D'Andrea, F. 2017: Cost-effectiveness of a disease-specific oral nutritional support for pressure ulcer healing. Clinical Nutrition 36(1): 246-252
Nazir, J.; Heemstra, L.; van Engen, A.; Hakimi, Z.; Ivanescu, C. 2015: Cost-effectiveness of a fixed-dose combination of solifenacin and oral controlled adsorption system formulation of tamsulosin in men with lower urinary tract symptoms associated with benign prostatic hyperplasia. Bmc Urology 15: 41
Yong, J.H.E.; Masucci, L.; Hoch, J.S.; Sujic, R.; Beaton, D. 2016: Cost-effectiveness of a fracture liaison service--a real-world evaluation after 6 years of service provision. Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 27(1): 231-240
Thi Anh Thu, L.; Thi Hong Thoa, V.; Thi Van Trang, D.; Phuc Tien, N.; Thuy Van, D.; Thi Kim Anh, L.; Wertheim, H.F.L.; Truong Son, N. 2015: Cost-effectiveness of a hand hygiene program on health care-associated infections in intensive care patients at a tertiary care hospital in Vietnam. American Journal of Infection Control 43(12): E93-E99
Belchior, E.; Lévy-Bruhl, D.; Le Strat, Y.; Herida, M. 2016: Cost-effectiveness of a herpes zoster vaccination program among the French elderly people. Human Vaccines and Immunotherapeutics 12(9): 2378-2382
Suman, A.; Schaafsma, F.G.; Elders, P.J.M.; van Tulder, M.W.; Anema, J.R. 2015: Cost-effectiveness of a multifaceted implementation strategy for the Dutch multidisciplinary guideline for nonspecific low back pain: design of a stepped-wedge cluster randomised controlled trial. Bmc Public Health 15: 522
Toscano, C.M.; Zhuo, X.; Imai, K.; Duncan, B.B.; Polanczyk, Císi.A.; Zhang, P.; Engelgau, M.; Schmidt, M.Inês. 2015: Cost-effectiveness of a national population-based screening program for type 2 diabetes: the Brazil experience. Diabetology and Metabolic Syndrome 7: 95
Moran, P.S.; Teljeur, C.; Masterson, Sán.; O'Neill, M.; Harrington, P.; Ryan, Máirín. 2015: Cost-effectiveness of a national public access defibrillation programme. Resuscitation 91: 48-55
Lamberts, M.P.; Özdemir, C.; Drenth, J.P.H.; van Laarhoven, C.J.H.M.; Westert, G.P.; Kievit, W. 2017: Cost-effectiveness of a new strategy to identify uncomplicated gallstone disease patients that will benefit from a cholecystectomy. Surgical Endoscopy 31(6): 2534-2540
Lacny, S.; Zarrabi, M.; Martin-Misener, R.; Donald, F.; Sketris, I.; Murphy, A.L.; DiCenso, A.; Marshall, D.A. 2016: Cost-effectiveness of a nurse practitioner-family physician model of care in a nursing home: controlled before and after study. Journal of Advanced Nursing 72(9): 2138-2152
Greving, J.P.; Kaasjager, H.A.H.; Vernooij, J.W.P.; Hovens, M.M.C.; Wierdsma, J.; Grandjean, H.M.H.; van der Graaf, Y.; de Wit, G.A.; Visseren, F.L.J. 2015: Cost-effectiveness of a nurse-led internet-based vascular risk factor management programme: economic evaluation alongside a randomised controlled clinical trial. Bmj Open 5(5): E007128
Verhoef, T.I.; Doshi, P.; Lehner, D.; Morris, S. 2016: Cost-effectiveness of a physical exercise programme for residents of care homes: a pilot study. BMC geriatrics 16: 83
Cheng, I.; Castren, M.; Kiss, A.; Zwarenstein, M.; Brommels, M.; Mittmann, N. 2016: Cost-effectiveness of a physician-nurse supplementary triage assessment team at an academic tertiary care emergency department. Cjem 18(3): 191-204
Gordon, L.G.; DiSipio, T.; Battistutta, D.; Yates, P.; Bashford, J.; Pyke, C.; Eakin, E.; Hayes, S.C. 2017: Cost-effectiveness of a pragmatic exercise intervention for women with breast cancer: results from a randomized controlled trial. Psycho-Oncology 26(5): 649-655
Vermeulen, K.M.; Visser, E.; Messelink, E.J.; Schram, A.J.; Berger, M.Y.; de Bock, G.H.; Dekker, J.H. 2016: Cost-effectiveness of a pro-active approach of urinary incontinence in women. Bjog: An International Journal of Obstetrics and Gynaecology 123(7): 1213-1220
Joshi, S.; Kulkarni, V.; Gangakhedkar, R.; Mahajan, U.; Sharma, S.; Shirole, D.; Chandhiok, N. 2015: Cost-effectiveness of a repeat HIV test in pregnancy in India. Bmj Open 5(6): E006718
Nagy, Bázs.; Zsólyom, Aána.; Nagyjánosi, László.; Merész, Gő.; Steiner, Tás.; Papp, E.; Dessewffy, Zán.; Jermendy, Görgy.; Winkler, Gábor.; Kaló, Zán.; Vokó, Zán. 2016: Cost-effectiveness of a risk-based secondary screening programme of type 2 diabetes. Diabetes/Metabolism Research and Reviews 32(7): 710-729
López-Núñez, C.; Alonso-Pérez, F.; Pedrosa, I.; Secades-Villa, R. 2016: Cost-effectiveness of a voucher-based intervention for smoking cessation. American Journal of Drug and Alcohol Abuse 42(3): 296-305
Manders, S.H.M.; Kievit, W.; Adang, E.; Brus, H.L.; Moens, H.J.B.; Hartkamp, A.; Hendriks, L.; Brouwer, E.; Visser, H.; Vonkeman, H.E.; Hendrikx, J.; Jansen, T.L.; Westhovens, R.; van de Laar, M.A.F.J.; van Riel, P.L.C.M. 2015: Cost-effectiveness of abatacept, rituximab, and TNFi treatment after previous failure with TNFi treatment in rheumatoid arthritis: a pragmatic multi-centre randomised trial. Arthritis Research and Therapy 17: 134
Rubio-Valera, M.; Beneitez, I.; Peñarrubia-María, M.ía.T.; Luciano, J.V.; Mendive, J.M.; McCrone, P.; Knapp, M.; Sabés-Figuera, R.; Kocyan, K.; García-Campayo, J.; Serrano-Blanco, A. 2015: Cost-effectiveness of active monitoring versus antidepressants for major depression in primary health care: a 12-month non-randomized controlled trial (INFAP study). Bmc Psychiatry 15: 63
Venkatesh, S.; Pasternak, J.D.; Beninato, T.; Drake, F.T.; Kluijfhout, W.P.; Liu, C.; Gosnell, J.E.; Shen, W.T.; Clark, O.H.; Duh, Q.-Y.; Suh, I. 2017: Cost-effectiveness of active surveillance versus hemithyroidectomy for micropapillary thyroid cancer. Surgery 161(1): 116-126
Fan, L.; Owusu-Edusei, K.; Schillie, S.F.; Murphy, T.V. 2016: Cost-effectiveness of active-passive prophylaxis and antiviral prophylaxis during pregnancy to prevent perinatal hepatitis B virus infection. Hepatology 63(5): 1471-1480
Gissel, C.; Götz, G.; Repp, H. 2016: Cost-effectiveness of adalimumab for rheumatoid arthritis in Germany. Zeitschrift für Rheumatologie 75(10): 1006-1015
Yokomizo, L.; Limketkai, B.; Park, K.T. 2016: Cost-effectiveness of adalimumab, infliximab or vedolizumab as first-line biological therapy in moderate-to-severe ulcerative colitis. Bmj Open Gastroenterology 3(1): E000093
Suijkerbuijk, A.W.M.; van Gils, P.F.; Greeven, P.G.J.; de Wit, G.A. 2015: Cost-effectiveness of addiction care. Tijdschrift Voor Psychiatrie 57(7): 498-507
Wolfson, L.J.; Walker, A.; Hettle, R.; Lu, X.; Kambili, C.; Murungi, A.; Knerer, G. 2015: Cost-effectiveness of adding bedaquiline to drug regimens for the treatment of multidrug-resistant tuberculosis in the UK. Plos one 10(3): E0120763
Jakubowiak, A.J.; Campioni, M.; Benedict, Ágnes.; Houisse, I.; Tichy, E.; Giannopoulou, A.; Aggarwal, S.K.; Barber, B.L.; Panjabi, S. 2016: Cost-effectiveness of adding carfilzomib to lenalidomide and dexamethasone in relapsed multiple myeloma from a US perspective. Journal of Medical Economics 19(11): 1061-1074
Laires, P.A.; Ejzykowicz, F.; Hsu, T.-Y.; Ambegaonkar, B.; Davies, G. 2015: Cost-effectiveness of adding ezetimibe to atorvastatin vs switching to rosuvastatin therapy in Portugal. Journal of Medical Economics 18(8): 565-572
Mandrik, O.; Corro Ramos, I.; Knies, S.; Al, M.; Severens, J.L. 2015: Cost-effectiveness of adding rituximab to fludarabine and cyclophosphamide for treatment of chronic lymphocytic leukemia in Ukraine. Cancer Management and Research 7: 279-289
Kikuchi, K.; Miyakawa, Y.; Ikeda, S.; Sato, Y.; Takebayashi, T. 2015: Cost-effectiveness of adding rituximab to splenectomy and romiplostim for treating steroid-resistant idiopathic thrombocytopenic purpura in adults. Bmc Health Services Research 15: 2
Simon-Tuval, T.; Neumann, P.J.; Greenberg, D. 2016: Cost-effectiveness of adherence-enhancing interventions: a systematic review. Expert Review of Pharmacoeconomics and Outcomes Research 16(1): 67-84
Dufour, P.R.; Douillard, J.; Ychou, M.; Seitz, J.; Perrocheau, G.; Tilleul, P.; Maes, P.; Husseini, F. 2016: Cost-effectiveness of adjuvant capecitabine, Mayo Clinic and de Gramont regimens for stage III colon cancer in the French setting. Journal of Clinical Oncology 24(18_Suppl): 13506-13506
Hisashige, A.; Sasako, M.; Nakajima, T. 2016: Cost-effectiveness of adjuvant chemotherapy with S-1, an oral fluoropyrimidine, for curatively resected gastric cancer. Journal of Clinical Oncology 26(15_Suppl): 4578-4578
Mangen, M.-J.ée.J.; Rozenbaum, M.H.; Huijts, S.M.; van Werkhoven, C.H.; Postma, D.F.; Atwood, M.; van Deursen, A.M.M.; van der Ende, A.; Grobbee, D.E.; Sanders, E.A.M.; Sato, R.; Verheij, T.J.M.; Vissink, C.E.; Bonten, M.J.M.; de Wit, G.A. 2015: Cost-effectiveness of adult pneumococcal conjugate vaccination in the Netherlands. European Respiratory Journal 46(5): 1407-1416
Younossi, Z.M.; Park, H.; Saab, S.; Ahmed, A.; Dieterich, D.; Gordon, S.C. 2015: Cost-effectiveness of all-oral ledipasvir/sofosbuvir regimens in patients with chronic hepatitis C virus genotype 1 infection. Alimentary Pharmacology and Therapeutics 41(6): 544-563
Erenay, F.S.; Alagoz, O.; Banerjee, R.; Said, A.; Cima, R.R. 2016: Cost-effectiveness of alternative colonoscopy surveillance strategies to mitigate metachronous colorectal cancer incidence. Cancer 122(16): 2560-2570
Ang, M.; Nguyen, H.V.; Kiew, S.Y.; Chen, S.; Chee, S.-P.; Finkelstein, E. 2015: Cost-effectiveness of alternative strategies for interferon-γ release assays and tuberculin skin test in tuberculous uveitis. British Journal of Ophthalmology 99(7): 984-989
Chan, L.; Chen, C-Huan.; Hwang, J-Jen.; Yeh, S-Jou.; Shyu, K-Gi.; Lin, R-Tay.; Li, Y-Heng.; Liu, L.Z.; Li, J.Z.; Shau, W-Yi.; Weng, T-Chang. 2016: Cost-effectiveness of amlodipine compared with valsartan in preventing stroke and myocardial infarction among hypertensive patients in Taiwan. International Journal of General Medicine 9: 175-182
Steinke, S.; Gutknecht, M.; Zeidler, C.; Dieckhöfer, A.M.; Herrlein, O.; Lüling, H.; Ständer, S.; Augustin, M. 2017: Cost-effectiveness of an 8% Capsaicin Patch in the Treatment of Brachioradial Pruritus and Notalgia Paraesthetica, two Forms of Neuropathic Pruritus. Acta Dermato-Venereologica 97(1): 71-76
Carbonell-Baeza, A.; Soriano-Maldonado, A.; Gallo, F.Javier.; López del Amo, Mía.Puerto.; Ruiz-Cabello, P.; Andrade, A.; Borges-Cosic, M.; Peces-Rama, A.Rubén.; Spacírová, Z.; Álvarez-Gallardo, I.C.; García-Mochón, L.; Segura-Jiménez, Víctor.; Estévez-López, F.; Camiletti-Moirón, D.; Martín-Martín, J.Jesús.; Aranda, P.; Delgado-Fernández, M.; Aparicio, V.A. 2015: Cost-effectiveness of an exercise intervention program in perimenopausal women: the Fitness League Against MENopause COst (FLAMENCO) randomized controlled trial. Bmc Public Health 15: 555
Leung, M-Kit.; You, J.H.S. 2016: Cost-effectiveness of an influenza vaccination program offering intramuscular and intradermal vaccines versus intramuscular vaccine alone for elderly. Vaccine 34(22): 2469-2476
Diamantopoulos, A.; Sawyer, L.M.; Lip, G.Y.H.; Witte, K.K.; Reynolds, M.R.; Fauchier, L.; Thijs, V.; Brown, B.; Quiroz Angulo, M.E.; Diener, H.-C. 2016: Cost-effectiveness of an insertable cardiac monitor to detect atrial fibrillation in patients with cryptogenic stroke. International Journal of Stroke: Official Journal of the International Stroke Society 11(3): 302-312
Murphy, S.M.; Campbell, A.N.C.; Ghitza, U.E.; Kyle, T.L.; Bailey, G.L.; Nunes, E.V.; Polsky, D. 2016: Cost-effectiveness of an internet-delivered treatment for substance abuse: Data from a multisite randomized controlled trial. Drug and Alcohol Dependence 161: 119-126
Pohjolainen, V.; Räsänen, P.; Roine, R.P.; Sintonen, H.; Koponen, S.; Karlsson, H. 2017: Cost-effectiveness of anorexia nervosa in QALYs. Nordic Journal of Psychiatry 71(1): 67-71
Saxena, N.; George, P.Paul.; Heng, B.Hoon.; Lim, T.Han.; Yong, S.Onn. 2015: Cost-effectiveness of anti-oxidant vitamins plus zinc treatment to prevent the progression of intermediate age-related macular degeneration. A Singapore perspective. Indian Journal of Ophthalmology 63(6): 516-523
Friedlander, A.H.; Chang, T.I.; Aghazadehsanai, N.; Graves, L.L. 2016: Cost-effectiveness of antibiotic prophylaxis. Journal of the American Dental Association 147(4): 229-230
Skaar, D.D.; Park, T.; Swiontkowski, M.F.; Kuntz, K.M. 2015: Cost-effectiveness of antibiotic prophylaxis for dental patients with prosthetic joints: Comparisons of antibiotic regimens for patients with total hip arthroplasty. Journal of the American Dental Association 146(11): 830-839
Aljabri, A.; Huckleberry, Y.; Karnes, J.H.; Gharaibeh, M.; Kutbi, H.I.; Raz, Y.; Yun, S.; Abraham, I.; Erstad, B. 2016: Cost-effectiveness of anticoagulants for suspected heparin-induced thrombocytopenia in the United States. Blood 128(26): 3043-3051
Krejczy, M.; Harenberg, J.; Wehling, M.; Obermann, K.; Lip, G.Y.H. 2015: Cost-effectiveness of anticoagulation in patients with nonvalvular atrial fibrillation with edoxaban compared to warfarin in Germany. BioMed research international 2015: 876923
Habib, A.G.; Lamorde, M.; Dalhat, M.M.; Habib, Z.G.; Kuznik, A. 2015: Cost-effectiveness of antivenoms for snakebite envenoming in Nigeria. Plos Neglected Tropical Diseases 9(1): E3381
Wang, W.; Wang, J.; Dang, S.; Zhuang, G. 2016: Cost-effectiveness of antiviral therapy during late pregnancy to prevent perinatal transmission of hepatitis B virus. Peerj 4: E1709
Hallinen, T.; Soini, E.J.; Linna, M.; Saarni, S.I. 2016: Cost-effectiveness of apixaban and warfarin in the prevention of thromboembolic complications among atrial fibrillation patients. Springerplus 5(1): 1354
Athanasakis, K.; Karampli, E.; Tsounis, D.; Bilitou, A.; Kyriopoulos, J. 2015: Cost-effectiveness of apixaban vs. other new oral anticoagulants for the prevention of stroke: an analysis on patients with non-valvular atrial fibrillation in the Greek healthcare setting. Clinical Drug Investigation 35(11): 693-705
Moolenaar, L.M.; Cissen, M.; de Bruin, J.P.; Hompes, P.G.A.; Repping, S.; van der Veen, F.; Mol, B.W.J. 2015: Cost-effectiveness of assisted conception for male subfertility. Reproductive Biomedicine Online 30(6): 659-666
Domínguez-Ortega, J.; Phillips-Anglés, E.; Barranco, P.; Quirce, S. 2015: Cost-effectiveness of asthma therapy: a comprehensive review. Journal of Asthma: Official Journal of the Association for the Care of Asthma 52(6): 529-537
Qin, G.; Zhuang, X. 2017: Cost-effectiveness of augmenting current perinatal hepatitis B prevention program with maternal antiviral therapy. Hepatology 65(3): 1074-1075
Gilligan, A.M.; Waycaster, C.R.; Motley, T.A. 2015: Cost-effectiveness of becaplermin gel on wound healing of diabetic foot ulcers. Wound Repair and Regeneration: Official Publication of the Wound Healing Society and the European Tissue Repair Society 23(3): 353-360
Joensuu, J.T.; Aaltonen, K.J.; Aronen, P.; Sokka, T.; Puolakka, K.; Tuompo, R.; Korpela, M.; Vasala, M.; Ilva, K.; Nordström, D.; Blom, M. 2016: Cost-effectiveness of biologic compared with conventional synthetic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis: a Register study. Rheumatology 55(10): 1803-1811
Romijn, G.; Riper, H.; Kok, R.; Donker, T.; Goorden, M.; van Roijen, L.H.; Kooistra, L.; van Balkom, A.; Koning, J. 2015: Cost-effectiveness of blended vs. face-to-face cognitive behavioural therapy for severe anxiety disorders: study protocol of a randomized controlled trial. Bmc Psychiatry 15: 311
Chen, W.; Yang, Y.; Chen, Y.; Du, F.; Zhan, H. 2016: Cost-effectiveness of bortezomib for multiple myeloma: a systematic review. Clinicoeconomics and Outcomes Research: Ceor 8: 137-151
Gocgun, Y.; Banjevic, D.; Taghipour, S.; Montgomery, N.; Harvey, B.J.; Jardine, A.K.S.; Miller, A.B. 2015: Cost-effectiveness of breast cancer screening policies using simulation. Breast 24(4): 440-448
Sussman, M.; Yu, J.; Kamat, S.A.; Hartry, A.; Legacy, S.; Duffy, R.; Aigbogun, M.S. 2017: Cost-effectiveness of brexpiprazole adjunctive treatment for major depressive disorder. Journal of Affective Disorders 207: 54-62
Akazawa, M. 2015: Cost-effectiveness of cancer drug treatments. Nihon Rinsho. Japanese Journal of Clinical Medicine 73(Suppl 2): 706-712
Schwendicke, F.; Paris, S.; Stolpe, M. 2014: Cost-effectiveness of caries excavations in different risk groups - a micro-simulation study. Bmc Oral Health 14: 153
Groot-Jensen, S.; Kiessling, A.; Zethraeus, N.; Björnstedt-Bennermo, M.; Henriksson, P. 2016: Cost-effectiveness of case-based training for primary care physicians in evidence-based medicine of patients with coronary heart disease. European Journal of Preventive Cardiology 23(4): 420-427
Mistro, Sóstenes.; Rosa, L.; Gomes, Bárbara.; Miranda, Lígia.; Badaró, R. 2016: Cost-effectiveness of caspofungin versus liposomal amphotericin B in the treatment of systemic fungal infections: a systematic review of economic analyses. Expert Review of Pharmacoeconomics and Outcomes Research 16(4): 465-473
Kelly, P.D.; Parker, S.L.; Mendenhall, S.K.; Bible, J.E.; Sivasubramaniam, P.; Shau, D.N.; McGirt, M.J.; Devin, C.J. 2015: Cost-effectiveness of cell saver in short-segment lumbar laminectomy and fusion (≤3 levels). Spine 40(17): E978-E985
Vuong, T.; Shanahan, M.; Nguyen, N.; Le, G.; Ali, R.; Pham, K.; Vuong, T.T.A.; Dinh, T.; Ritter, A. 2016: Cost-effectiveness of center-based compulsory rehabilitation compared to community-based voluntary methadone maintenance treatment in Hai Phong City, Vietnam. Drug and Alcohol Dependence 168: 147-155
Hurry, M.; Zhou, Z-Yi.; Zhang, J.; Zhang, C.; Fan, L.; Rebeira, M.; Xie, J. 2016: Cost-effectiveness of ceritinib in patients previously treated with crizotinib in anaplastic lymphoma kinase positive (ALK+) non-small cell lung cancer in Canada. Journal of Medical Economics 19(10): 936-944
Ertel, A.E.; Robinson, B.R.H.; Eckman, M.H. 2016: Cost-effectiveness of cervical spine clearance interventions with litigation and long-term-care implications in obtunded adult patients following blunt injury. Journal of Trauma and Acute Care Surgery 81(5): 897-904
Park, T.; Choi, C-Ju.; Choi, Y.; Suh, D-Churl. 2016: Cost-effectiveness of cetuximab for colorectal cancer. Expert Review of Pharmacoeconomics and Outcomes Research 16(6): 667-677
Chien, C.-R.; Hsia, T.-C.; Chen, C.-Y. 2014: Cost-effectiveness of chemotherapy combined with thoracic radiotherapy versus chemotherapy alone for limited stage small cell lung cancer: a population-based propensity-score matched analysis. Thoracic Cancer 5(6): 530-536
Stochkendahl, M.J.; Sørensen, J.; Vach, W.; Christensen, H.W.; Høilund-Carlsen, P.F.; Hartvigsen, J. 2016: Cost-effectiveness of chiropractic care versus self-management in patients with musculoskeletal chest pain. Open Heart 3(1): E000334
Dalaba, M.A.; Akweongo, P.; Aborigo, R.A.; Saronga, H.P.; Williams, J.; Blank, A.; Kaltschmidt, J.; Sauerborn, R.; Loukanova, S. 2015: Cost-effectiveness of clinical decision support system in improving maternal health care in Ghana. Plos one 10(5): E0125920
Cárdenas, M.; de la Fuente, S.; Castro-Villegas, M.C.; Romero-Gómez, M.; Ruiz-Vílchez, D.; Calvo-Gutiérrez, J.; Escudero-Contreras, A.; Del Prado, J.R.; Collantes-Estévez, E.; Font, P. 2016: Cost-effectiveness of clinical remission by treat to target strategy in established rheumatoid arthritis: results of the CREATE registry. Rheumatology International 36(12): 1627-1632
Abdel-Qadir, H.; Roifman, I.; Wijeysundera, H.C. 2015: Cost-effectiveness of clopidogrel, prasugrel and ticagrelor for dual antiplatelet therapy after acute coronary syndrome: a decision-analytic model. Cmaj Open 3(4): E438-E446
Motley, T.A.; Gilligan, A.M.; Lange, D.L.; Waycaster, C.R.; Dickerson, J.E. 2015: Cost-effectiveness of clostridial collagenase ointment on wound closure in patients with diabetic foot ulcers: economic analysis of results from a multicenter, randomized, open-label trial. Journal of Foot and Ankle Research 8: 7
Yamaguchi, S.; Sato, S.; Horio, N.; Yoshida, K.; Shimodaira, M.; Taneda, A.; Ikebuchi, E.; Nishio, M.; Ito, J. 2017: Cost-effectiveness of cognitive remediation and supported employment for people with mental illness: a randomized controlled trial. Psychological Medicine 47(1): 53-65
Grochtdreis, T.; Brettschneider, C.; Wegener, A.; Watzke, B.; Riedel-Heller, S.; Härter, M.; König, H.-H. 2015: Cost-effectiveness of collaborative care for the treatment of depressive disorders in primary care: a systematic review. Plos one 10(5): E0123078
Miravitlles, M.; Gáldiz, J.B.; Huerta, A.; Villacampa, A.; Carcedo, D.; Garcia-Rio, F. 2016: Cost-effectiveness of combination therapy umeclidinium/vilanterol versus tiotropium in symptomatic COPD Spanish patients. International Journal of Chronic Obstructive Pulmonary Disease 11: 123-132
Hornberger, J.; Li, Q.; Quinn, B. 2015: Cost-effectiveness of combinatorial pharmacogenomic testing for treatment-resistant major depressive disorder patients. American Journal of Managed Care 21(6): E357-E365
Mori, T.; Crandall, C.J.; Ganz, D.A. 2017: Cost-effectiveness of combined oral bisphosphonate therapy and falls prevention exercise for fracture prevention in the USA. Osteoporosis International: a Journal Established as Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the Usa 28(2): 585-595
Violato, M.; Dakin, H.; Chakravarthy, U.; Reeves, B.C.; Peto, T.; Hogg, R.E.; Harding, S.P.; Scott, L.J.; Taylor, J.; Cappel-Porter, H.; Mills, N.; O'Reilly, D.; Rogers, C.A.; Wordsworth, S. 2016: Cost-effectiveness of community versus hospital eye service follow-up for patients with quiescent treated age-related macular degeneration alongside the ECHoES randomised trial. Bmj Open 6(10): E011121
McPake, B.; Edoka, I.; Witter, S.; Kielmann, K.; Taegtmeyer, M.; Dieleman, M.; Vaughan, K.; Gama, E.; Kok, M.; Datiko, D.; Otiso, L.; Ahmed, R.; Squires, N.; Suraratdecha, C.; Cometto, G. 2015: Cost-effectiveness of community-based practitioner programmes in Ethiopia, Indonesia and Kenya. Bulletin of the World Health Organization 93(9): 631-639a
Nayagam, S.; Conteh, L.; Sicuri, E.; Shimakawa, Y.; Suso, P.; Tamba, S.; Njie, R.; Njai, H.; Lemoine, M.; Hallett, T.B.; Thursz, M. 2016: Cost-effectiveness of community-based screening and treatment for chronic hepatitis B in the Gambia: an economic modelling analysis. LANCET. Global Health 4(8): E568-E578
Abu-Raddad, L.J. 2015: Cost-effectiveness of community-based strategies for HIV. LANCET. HIV 2(4): E122-E123
Smith, J.A.; Sharma, M.; Levin, C.; Baeten, J.M.; van Rooyen, H.; Celum, C.; Hallett, T.B.; Barnabas, R.V. 2015: Cost-effectiveness of community-based strategies to strengthen the continuum of HIV care in rural South Africa: a health economic modelling analysis. LANCET. HIV 2(4): E159-E168
Turner, H.C.; Truscott, J.E.; Anderson, R.M. 2016: Cost-effectiveness of community-wide treatment for helminthiasis. Lancet. Global Health 4(3): E156
Chinthammit, C.; Armstrong, E.P.; Boesen, K.; Martin, R.; Taylor, A.M.; Warholak, T. 2015: Cost-effectiveness of comprehensive medication reviews versus noncomprehensive medication review interventions and subsequent successful medication changes in a Medicare Part D population. Journal of Managed Care and Specialty Pharmacy 21(5): 381-389
Drechsler, M.; Smith, H.G.; Sturm, A.; Wätzold, F. 2016: Cost-effectiveness of conservation payment schemes for species with different range sizes. Conservation Biology: the Journal of the Society for Conservation Biology 30(4): 894-899
García, M.; Chicaíza, L.A.; Quitián, H.; Linares, A.; Ramírez, Ós. 2015: Cost-effectiveness of consolidation treatments for acute myeloid leukemia in high-risk pediatric patients within the Colombian healthcare system. Biomedica: Revista del Instituto Nacional de Salud 35(4): 549-556
Roze, S.; Duteil, E.; Smith-Palmer, J.; de Portu, S.; Valentine, W.; de Brouwer, B.F.E.; Reznik, Y.; de Valk, H.W. 2016: Cost-effectiveness of continuous subcutaneous insulin infusion in people with type 2 diabetes in the Netherlands. Journal of Medical Economics 19(8): 742-749
Roze, S.; Smith-Palmer, J.; Valentine, W.; de Portu, S.; Nørgaard, K.; Pickup, J.C. 2015: Cost-effectiveness of continuous subcutaneous insulin infusion versus multiple daily injections of insulin in Type 1 diabetes: a systematic review. Diabetic Medicine: a Journal of the British Diabetic Association 32(11): 1415-1424
Lee, S.-P.; Jang, E.J.; Kim, Y.-J.; Cha, M.-J.; Park, S.-Y.; Song, H.J.; Choi, J.E.; Shim, J.-I.; Ahn, J.; Lee, H.J. 2015: Cost-effectiveness of coronary CT angiography in patients with chest pain: Comparison with myocardial single photon emission tomography. Journal of Cardiovascular Computed Tomography 9(5): 428-437
Roberts, E.T.; Horne, A.; Martin, S.S.; Blaha, M.J.; Blankstein, R.; Budoff, M.J.; Sibley, C.; Polak, J.F.; Frick, K.D.; Blumenthal, R.S.; Nasir, K. 2015: Cost-effectiveness of coronary artery calcium testing for coronary heart and cardiovascular disease risk prediction to guide statin allocation: the Multi-Ethnic Study of Atherosclerosis (MESA). Plos one 10(3): E0116377
Li, C-Kong.; Tong, B.C.Y.; You, J.H.S. 2016: Cost-effectiveness of culture-guided antimicrobial prophylaxis for the prevention of infections after prostate biopsy. International Journal of Infectious Diseases: Ijid: Official Publication of the International Society for Infectious Diseases 43: 7-12
Saab, S.; Parisé, Hélène.; Virabhak, S.; Wang, A.; Marx, S.E.; Sanchez Gonzalez, Y.; Misurski, D.; Johnson, S. 2016: Cost-effectiveness of currently recommended direct-acting antiviral treatments in patients infected with genotypes 1 or 4 hepatitis C virus in the US. Journal of Medical Economics 19(8): 795-805
Moshyk, A.; Martel, M.-J.; Tahami Monfared, A.A.; Goeree, R. 2016: Cost-effectiveness of daclatasvir plus sofosbuvir-based regimen for treatment of hepatitis C virus genotype 3 infection in Canada. Journal of Medical Economics 19(2): 181-192
Charokopou, M.; McEwan, P.; Lister, S.; Callan, L.; Bergenheim, K.; Tolley, K.; Postema, R.; Townsend, R.; Roudaut, M. 2015: Cost-effectiveness of dapagliflozin versus DPP-4 inhibitors as an add-on to Metformin in the Treatment of Type 2 Diabetes Mellitus from a UK Healthcare System Perspective. Bmc Health Services Research 15: 496
Mauskopf, J.; Fay, M.; Iyer, R.; Sarda, S.; Livingston, T. 2016: Cost-effectiveness of delayed-release dimethyl fumarate for the treatment of relapsing forms of multiple sclerosis in the United States. Journal of Medical Economics 19(4): 432-442
Dellis, A.; Papatsoris, A. 2016: Cost-effectiveness of denosumab as a bone protective agent for patients with castration resistant prostate cancer. Expert Review of Pharmacoeconomics and Outcomes Research 16(1): 5-10
Pershad, J.; Waters, T.M.; Langham, M.R.; Li, T.; Huang, E.Y. 2015: Cost-effectiveness of diagnostic approaches to suspected appendicitis in children. Journal of the American College of Surgeons 220(4): 738-746
Morris, S.; Gurusamy, K.S.; Sheringham, J.; Davidson, B.R. 2015: Cost-effectiveness of diagnostic laparoscopy for assessing resectability in pancreatic and periampullary cancer. Bmc Gastroenterology 15: 44
Buendía, J.A.; Sánchez-Villamil, J.P.; Urman, G. 2016: Cost-effectiveness of diagnostic strategies of severe bacterial infection in infants with fever without a source. Biomedica: Revista del Instituto Nacional de Salud 36(3): 406-414
Shen, L.; Luo, Y.; Lu, Z.; Hu, X.; Ding, W.; Yu, B. 2014: Cost-effectiveness of different regimens of anesthesia for day surgery in China. International Journal of Clinical and Experimental Medicine 7(12): 5744-5750
Sankatsing, V.ér.D.V.; Heijnsdijk, E.A.M.; van Luijt, P.A.; van Ravesteyn, N.T.; Fracheboud, J.; de Koning, H.J. 2015: Cost-effectiveness of digital mammography screening before the age of 50 in the Netherlands. International Journal of Cancer 137(8): 1990-1999
Permsuwan, U.; Dilokthornsakul, P.; Saokaew, S.; Thavorn, K.; Chaiyakunapruk, N. 2016: Cost-effectiveness of dipeptidyl peptidase-4 inhibitor monotherapy in elderly type 2 diabetes patients in Thailand. Clinicoeconomics and Outcomes Research: Ceor 8: 521-529
Permsuwan, U.; Dilokthornsakul, P.; Thavorn, K.; Saokaew, S.; Chaiyakunapruk, N. 2017: Cost-effectiveness of dipeptidyl peptidase-4 inhibitor monotherapy versus sulfonylurea monotherapy for people with type 2 diabetes and chronic kidney disease in Thailand. Journal of Medical Economics 20(2): 171-181
Virabhak, S.; Yasui, K.; Yamazaki, K.; Johnson, S.; Mitchell, D.; Yuen, C.; Samp, J.C.; Igarashi, A. 2016: Cost-effectiveness of direct-acting antiviral regimen ombitasvir/paritaprevir/ritonavir in treatment-naïve and treatment-experienced patients infected with chronic hepatitis C virus genotype 1b in Japan. Journal of Medical Economics 19(12): 1144-1156
Knapp, M.; King, D.; Romeo, R.ée.; Adams, J.; Baldwin, A.; Ballard, C.; Banerjee, S.; Barber, R.; Bentham, P.; Brown, R.G.; Burns, A.; Dening, T.; Findlay, D.; Holmes, C.; Johnson, T.; Jones, R.; Katona, C.; Lindesay, J.; Macharouthu, A.; McKeith, I.; McShane, R.; O'Brien, J.T.; Phillips, P.P.J.; Sheehan, B.; Howard, R. 2017: Cost-effectiveness of donepezil and memantine in moderate to severe Alzheimer's disease (the DOMINO-AD trial). International Journal of Geriatric Psychiatry 32(12): 1205-1216
Cucchetti, A.; Trevisani, F.; Cappelli, A.; Mosconi, C.; Renzulli, M.; Pinna, A.Daniele.; Golfieri, R. 2016: Cost-effectiveness of doxorubicin-eluting beads versus conventional trans-arterial chemo-embolization for hepatocellular carcinoma. Digestive and liver disease: official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 48(7): 798-805
François, C.ém.; Hauser, R.A.; Aballéa, S.; Dorey, J.; Kharitonova, E.; Hewitt, L.A. 2016: Cost-effectiveness of droxidopa in patients with neurogenic orthostatic hypotension: post-hoc economic analysis of Phase 3 clinical trial data. Journal of Medical Economics 19(5): 515-525
Martelli, L.; Olivera, P.; Roblin, X.; Attar, A.; Peyrin-Biroulet, L. 2017: Cost-effectiveness of drug monitoring of anti-TNF therapy in inflammatory bowel disease and rheumatoid arthritis: a systematic review. Journal of Gastroenterology 52(1): 19-25
Baschet, L.; Bourguignon, S.; Marque, S.éb.; Durand-Zaleski, I.; Teiger, E.; Wilquin, F.; Levesque, K. 2016: Cost-effectiveness of drug-eluting stents versus bare-metal stents in patients undergoing percutaneous coronary intervention. Open Heart 3(2): E000445
Sowa, P.M.; Downes, M.J.; Gordon, L.G. 2017: Cost-effectiveness of dual-energy X-ray absorptiometry plus antiresorptive treatment in Australian women with breast cancer who receive aromatase inhibitors. Journal of Bone and Mineral Metabolism 35(2): 199-208
Preblick, R.; Kwong, W.Jacqueline.; White, R.H.; Goldhaber, S.Z. 2015: Cost-effectiveness of edoxaban for the treatment of venous thromboembolism based on the Hokusai-VTE study. Hospital Practice 43(5): 249-257
Miller, J.D.; Ye, X.; Lenhart, G.M.; Farr, A.M.; Tran, O.V.; Kwong, W.Jackie.; Magnuson, E.A.; Weintraub, W.S. 2016: Cost-effectiveness of edoxaban versus rivaroxaban for stroke prevention in patients with nonvalvular atrial fibrillation (NVAF) in the US. Clinicoeconomics and Outcomes Research: Ceor 8: 215-226
Magnuson, E.A.; Vilain, K.; Wang, K.; Li, H.; Kwong, W.J.; Antman, E.M.; Ruff, C.T.; Giugliano, R.P.; Cohen, D.J. 2015: Cost-effectiveness of edoxaban vs warfarin in patients with atrial fibrillation based on results of the ENGAGE AF-TIMi 48 trial. American Heart Journal 170(6): 1140-1150
Van Heesch, M.M.J.; van Asselt, A.D.I.; Evers, J.L.H.; van der Hoeven, M.A.H.B.M.; Dumoulin, J.C.M.; van Beijsterveldt, C.E.M.; Bonsel, G.J.; Dykgraaf, R.H.M.; van Goudoever, J.B.; Koopman-Esseboom, C.; Nelen, W.L.D.M.; Steiner, K.; Tamminga, P.; Tonch, N.; Torrance, H.L.; Dirksen, C.D. 2016: Cost-effectiveness of embryo transfer strategies: a decision analytic model using long-term costs and consequences of singletons and multiples born as a consequence of IVF. Human Reproduction 31(11): 2527-2540
Sutton, A.J.; Vohra, R.S.; Hollyman, M.; Marriott, P.J.; Buja, A.; Alderson, D.; Pasquali, S.; Griffiths, E.A.; Vohra, R.S.; Spreadborough, P.; Hollyman, M.; Marriott, P.J.; Kirkham, A.; Pasquali, S.; Alderson, D.; Griffiths, E.A.; Fenwick, S.; Elmasry, M.; Nunes, Q.M.; Kennedy, D.; Khan, R.B.; Khan, M.A.S.; Magee, C.J.; Jones, S.M.; Mason, D.; Parappally, C.P.; Mathur, P.; Saunders, M.; Jamel, S.; Ul Haque, S.; Zafar, S.; Shiwani, M.H.; Samuel, N.; Dar, F.; Jackson, A.; Lovett, B.; Dindyal, S.; Winter, H.; Fletcher, T.; Rahman, S.; Wheatley, K.; Nieto, T.; Ayaani, S.; Youssef, H.; Nijjar, R.S.; Watkin, H.; Naumann, D.; Emesih, S.; Sarmah, P.B.; Lee, K.; Joji, N.; Heath, J.; Teasdale, R.L.; Weerasinghe, C.; Needham, P.J.; Welbourn, H.; Fors 2017: Cost-effectiveness of emergency versus delayed laparoscopic cholecystectomy for acute gallbladder pathology. British Journal of Surgery 104(1): 98-107
Hogendoorn, W.; Lavida, A.; Hunink, M.G.M.; Moll, F.L.; Geroulakos, G.; Muhs, B.E.; Sumpio, B.E. 2015: Cost-effectiveness of endovascular repair, open repair, and conservative management of splenic artery aneurysms. Journal of Vascular Surgery 61(6): 1432-1440
Aronsson, M.; Persson, J.; Blomstrand, C.; Wester, P.; Levin, L.-Åk. 2016: Cost-effectiveness of endovascular thrombectomy in patients with acute ischemic stroke. Neurology 86(11): 1053-1059
Luebke, T.; Brunkwall, J. 2015: Cost-effectiveness of endovenous laser ablation of the great saphenous vein in patients with uncomplicated primary varicosis. Bmc Cardiovascular Disorders 15: 138
Athanasakis, K.; Bilitou, A.; Lee, D.; Karampli, E.; Karavidas, A.; Parissis, J.; Sykara, G.; Kyriopoulos, J. 2016: Cost-effectiveness of eplerenone in NYHA class Ii chronic heart failure patients with reduced LVEF: an analysis for Greece. Clinicoeconomics and Outcomes Research: Ceor 8: 583-590
Van Genugten, M.L.L.; Weintraub, W.S.; Zhang, Z.; Voors, A.A. 2005: Cost-effectiveness of eplerenone plus standard treatment compared with standard treatment in patients with myocardial infarction complicated by left ventricular systolic dysfunction and heart failure in the Netherlands. Netherlands Heart Journal: Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation 13(11): 393-400
Bianic, F.; Campbell, R.; Damera, V.; De Simone, P.; Roccia, A.; Gregson, J.; Ricci, J-Francois. 2016: Cost-effectiveness of everolimus plus reduced tacrolimus in de novo liver-recipients in the Italian setting. Journal of Medical Economics 19(9): 866-873
D'Amico, F.; Rehill, A.; Knapp, M.; Lowery, D.; Cerga-Pashoja, A.; Griffin, M.; Iliffe, S.; Warner, J. 2016: Cost-effectiveness of exercise as a therapy for behavioural and psychological symptoms of dementia within the EVIDEM-E randomised controlled trial. International Journal of Geriatric Psychiatry 31(6): 656-665
Shah, S.J.; Rehman, A.; Shaukat, M.H.S.; Awais, M. 2017: Cost-effectiveness of exercise stress testing performed as part of executive health examinations. Irish Journal of Medical Science 186(2): 281-284
Van der Schans, J.; Kotsopoulos, N.; Hoekstra, P.J.; Hak, E.; Postma, M.J. 2015: Cost-effectiveness of extended-release methylphenidate in children and adolescents with attention-deficit/hyperactivity disorder sub-optimally treated with immediate release methylphenidate. Plos one 10(5): E0127237
Eze, K.C.; Irekpita, E.; Salami, T.A. 2016: Cost-effectiveness of extracorporeal shock wave lithotripsy in a poor resource setting: the Okada, Nigeria experience. Nigerian Medical Journal: Journal of the Nigeria Medical Association 57(1): 44-48
Younis, T.; Rayson, D.; Jovanovic, S.; Skedgel, C. 2016: Cost-effectiveness of febrile neutropenia prevention with primary versus secondary G-CSF prophylaxis for adjuvant chemotherapy in breast cancer: a systematic review. Breast Cancer Research and Treatment 159(3): 425-432
Boyd, K.A.; Tappin, D.M.; Bauld, L. 2016: Cost-effectiveness of financial incentives for smoking cessation in pregnancy. Addiction 111(6): 115-117
Neovius, M.; Tiblad, E.; Westgren, M.; Kublickas, M.; Neovius, K.; Wikman, A. 2016: Cost-effectiveness of first trimester non-invasive fetal RHD screening for targeted antenatal anti-D prophylaxis in RhD-negative pregnant women: a model-based analysis. Bjog: An International Journal of Obstetrics and Gynaecology 123(8): 1337-1346
Ciaranello, A.L.; Doherty, K.; Penazzato, M.; Lindsey, J.C.; Harrison, L.; Kelly, K.; Walensky, R.P.; Essajee, S.; Losina, E.; Muhe, L.; Wools-Kaloustian, K.; Ayaya, S.; Weinstein, M.C.; Palumbo, P.; Freedberg, K.A. 2015: Cost-effectiveness of first-line antiretroviral therapy for HIV-infected African children less than 3 years of age. Aids 29(10): 1247-1259
Khan, I.; Morris, S.; Hackshaw, A.; Lee, S.-M. 2015: Cost-effectiveness of first-line erlotinib in patients with advanced non-small-cell lung cancer unsuitable for chemotherapy. Bmj Open 5(7): E006733
Kumar, G.; Woods, B.; Hess, L.M.; Treat, J.; Boye, M.E.; Bryden, P.; Winfree, K.B. 2015: Cost-effectiveness of first-line induction and maintenance treatment sequences in non-squamous non-small cell lung cancer (NSCLC) in the U.S. Lung Cancer 89(3): 294-300
Egger, N.; Wild, B.; Zipfel, S.; Junne, F.; Konnopka, A.; Schmidt, U.; de Zwaan, M.; Herpertz, S.; Zeeck, A.; Löwe, B.; von Wietersheim, J.; Tagay, S.; Burgmer, M.; Dinkel, A.; Herzog, W.; König, H.-H. 2016: Cost-effectiveness of focal psychodynamic therapy and enhanced cognitive-behavioural therapy in out-patients with anorexia nervosa. Psychological Medicine 46(16): 3291-3301
Ross Terres, J.A.; Lozano-Ortega, G.; Kendall, R.; Sculpher, M.J. 2015: Cost-effectiveness of fondaparinux versus enoxaparin in non-ST-elevation acute coronary syndrome in Canada (OASIS-5). Bmc Cardiovascular Disorders 15: 180
Ito, K.; Leslie, W.D. 2015: Cost-effectiveness of fracture prevention in rural women with limited access to dual-energy X-ray absorptiometry. Osteoporosis International: a Journal Established as Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the Usa 26(8): 2111-2119
Barzi, A.; Lenz, H.-J. 2015: Cost-effectiveness of genomic testing for colorectal cancer: are we there yet?. Oncology 29(3): 183-184; 186
Wen, T-Jen.; Wen, Y-Wen.; Chien, C-Ru.; Chiang, S-Chin.; Hsu, W.Wei-Yuan.; Shen, L-Jiuan.; Hsiao, F-Yuan. 2017: Cost-effectiveness of granulocyte colony-stimulating factor prophylaxis in chemotherapy-induced febrile neutropenia among breast cancer and Non-Hodgkin's lymphoma patients under Taiwan's national health insurance system. Journal of Evaluation in Clinical Practice 23(2): 288-293
Yang, F.; Lau, T.; Luo, N. 2016: Cost-effectiveness of haemodialysis and peritoneal dialysis for patients with end-stage renal disease in Singapore. Nephrology 21(8): 669-677
Retèl, V.P.; van den Boer, C.; Steuten, L.M.G.; Okła, S.ła.; Hilgers, F.J.; van den Brekel, M.W. 2015: Cost-effectiveness of heat and moisture exchangers compared to usual care for pulmonary rehabilitation after total laryngectomy in Poland. European Archives of Oto-Rhino-Laryngology: Official Journal of the European Federation of Oto-Rhino-Laryngological Societies: Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 272(9): 2381-2388
Takura, T. 2015: Cost-effectiveness of hemodialysis in Japan. Contributions to Nephrology 185: 124-131
Leidner, A.J.; Chesson, H.W.; Xu, F.; Ward, J.W.; Spradling, P.R.; Holmberg, S.D. 2015: Cost-effectiveness of hepatitis C treatment for patients in early stages of liver disease. Hepatology 61(6): 1860-1869
Chit, A.; Becker, D.L.; DiazGranados, C.A.; Maschio, M.; Yau, E.; Drummond, M. 2015: Cost-effectiveness of high-dose versus standard-dose inactivated influenza vaccine in adults aged 65 years and older: an economic evaluation of data from a randomised controlled trial. LANCET. Infectious Diseases 15(12): 1459-1466
Stollenwerk, B.; Bartmus, T.; Klug, F.; Stock, S.; Müller, D. 2015: Cost-effectiveness of hip protector use on a geriatric ward in Germany: a Markov model. Osteoporosis International: a Journal Established as Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the Usa 26(4): 1367-1379
Maru, S.; Byrnes, J.; Carrington, M.J.; Chan, Y.-K.; Thompson, D.R.; Stewart, S.; Scuffham, P.A. 2015: Cost-effectiveness of home versus clinic-based management of chronic heart failure: Extended follow-up of a pragmatic, multicentre randomized trial cohort - the WHICH? study (Which Heart Failure Intervention Is Most Cost-Effective and Consumer Friendly in Reducing Hospital Care). International Journal of Cardiology 201: 368-375
Van der Zweerde, T.; Lancee, J.; Slottje, P.; Bosmans, J.; Van Someren, E.; Reynolds, C.; Cuijpers, P.; van Straten, A. 2016: Cost-effectiveness of i-Sleep, a guided online CBT intervention, for patients with insomnia in general practice: protocol of a pragmatic randomized controlled trial. Bmc Psychiatry 16: 85
Jensen, C.; Ross, J.; Feenstra, T.L.; Raghoebar, G.M.; Speksnijder, C.; Meijer, H.J.A.; Cune, M.S. 2017: Cost-effectiveness of implant-supported mandibular removable partial dentures. Clinical Oral Implants Research 28(5): 594-601
Mealing, S.; Woods, B.; Hawkins, N.; Cowie, M.R.; Plummer, C.J.; Abraham, W.T.; Beshai, J.F.; Klein, H.; Sculpher, M. 2016: Cost-effectiveness of implantable cardiac devices in patients with systolic heart failure. Heart 102(21): 1742-1749
Broughton, E.I.; Muhire, M.; Karamagi, E.; Kisamba, H. 2016: Cost-effectiveness of implementing the chronic care model for HIV care in Uganda. International Journal for Quality in Health Care: Journal of the International Society for Quality in Health Care 28(6): 802-807
Suen, S.-C.; Bendavid, E.; Goldhaber-Fiebert, J.D. 2015: Cost-effectiveness of improvements in diagnosis and treatment accessibility for tuberculosis control in India. International Journal of Tuberculosis and Lung Disease: the Official Journal of the International Union Against Tuberculosis and Lung Disease 19(9): 1115-1124 I-XV
Wolfson, L.J.; Gibbert, J.; Wirth, D.; Diel, R. 2015: Cost-effectiveness of incorporating bedaquiline into a treatment regimen for MDR/XDR-TB in Germany. European Respiratory Journal 46(6): 1826-1829
Milte, R.; Miller, M.D.; Crotty, M.; Mackintosh, S.; Thomas, S.; Cameron, I.D.; Whitehead, C.; Kurrle, S.; Ratcliffe, J. 2016: Cost-effectiveness of individualized nutrition and exercise therapy for rehabilitation following hip fracture. Journal of Rehabilitation Medicine 48(4): 378-385
Avritscher, E.B.; Cooksley, C.D.; Geraci, J.M.; Bekele, B.N.; Cantor, S.B.; Rolston, K.V.; Elting, L.S. 2016: Cost-effectiveness of influenza vaccination of adult cancer patients. Journal of Clinical Oncology 24(18_Suppl): 6079-6079
Llibre, J.M.; de Lazzari, E.; Molina, J.-M.; Gallien, S.éb.; Gonzalez-García, J.; Imaz, A.; Podzamczer, D.; Clotet, B.; Domingo, P.; Gatell, J.M. 2018: Cost-effectiveness of initial antiretroviral treatment administered as single vs. multiple tablet regimens with the same or different components. Enfermedades Infecciosas y Microbiologia Clinica 36(1): 16-20
Boland, M.R.S.; Kruis, A.L.; Tsiachristas, A.; Assendelft, W.J.J.; Gussekloo, J.; Blom, C.M.G.; Chavannes, N.H.; Rutten-van Mölken, M.P.M.H. 2015: Cost-effectiveness of integrated COPD care: the RECODE cluster randomised trial. Bmj Open 5(10): E007284
Duarte, A.; Walker, J.; Walker, S.; Richardson, G.; Holm Hansen, C.; Martin, P.; Murray, G.; Sculpher, M.; Sharpe, M. 2015: Cost-effectiveness of integrated collaborative care for comorbid major depression in patients with cancer. Journal of Psychosomatic Research 79(6): 465-470
Boege, I.; Corpus, N.; Schepker, R.; Kilian, R.; Fegert, J.M. 2015: Cost-effectiveness of intensive home treatment enhanced by inpatient treatment elements in child and adolescent psychiatry in Germany: a randomised trial. European Psychiatry: the Journal of the Association of European Psychiatrists 30(5): 583-589
Tao, L.; Wilson, E.C.F.; Wareham, N.J.; Sandbaek, A.; Rutten, G.E.H.M.; Lauritzen, T.; Khunti, K.; Davies, M.J.; Borch-Johnsen, K.; Griffin, S.J.; Simmons, R.K. 2015: Cost-effectiveness of intensive multifactorial treatment compared with routine care for individuals with screen-detected Type 2 diabetes: analysis of the ADDITION-UK cluster-randomized controlled trial. Diabetic Medicine: a Journal of the British Diabetic Association 32(7): 907-919
Kowada, A.; Takasaki, J.; Kobayashi, N. 2015: Cost-effectiveness of interferon-gamma release assay for systematic tuberculosis screening of healthcare workers in low-incidence countries. Journal of Hospital Infection 89(2): 99-108
Kowada, A. 2016: Cost-effectiveness of interferon-gamma release assays for tuberculosis screening in nursing homes. Epidemiology and Infection 144(15): 3215-3225
Singh, K.; Chandra Sekaran, A.M.; Bhaumik, S.; Aisola, M.; Chattopadhyay, K.; Gamage, A.U.; de Silva, P.; Selvaraj, S.; Roy, A.; Prabhakaran, D.; Tandon, N. 2015: Cost-effectiveness of interventions to control cardiovascular diseases and type 2 diabetes mellitus in South Asia: protocol for a systematic review. Bmj Open 5(3): E007205
Banstola, A.; Mytton, J. 2017: Cost-effectiveness of interventions to prevent road traffic injuries in low- and middle-income countries: A literature review. Traffic Injury Prevention 18(4): 357-362
Roskott, A.M.; Groen, H.; Rings, E.H.H.M.; Haveman, J.W.; Ploeg, R.J.; Serlie, M.J.; Wanten, G.; Krabbe, P.F.M.; Dijkstra, G. 2015: Cost-effectiveness of intestinal transplantation for adult patients with intestinal failure: a simulation study. American Journal of Clinical Nutrition 101(1): 79-86
Chamuleau, S.A.J.; Dijkgraaf, M.G.W.; van Eck-Smit, B.L.F.; Tijssen, J.G.P.; Piek, J.J. 2005: Cost-effectiveness of intracoronary flow velocity measurements and myocardial perfusion scintigraphy for management of intermediate coronary lesions. Netherlands Heart Journal: Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation 13(6): 214-223
Yanagi, Y.; Fukuda, A.; Barzey, V.; Adachi, K. 2017: Cost-effectiveness of intravitreal aflibercept versus other treatments for wet age-related macular degeneration in Japan. Journal of Medical Economics 20(2): 204-212
Veerman, J.L.; Zapata-Diomedi, B.; Gunn, L.; McCormack, G.R.; Cobiac, L.J.; Mantilla Herrera, A.M.; Giles-Corti, B.; Shiell, A. 2016: Cost-effectiveness of investing in sidewalks as a means of increasing physical activity: a RESIDE modelling study. Bmj Open 6(9): E011617
Shaheen, R.; Persson, L.Åke.; Ahmed, S.; Streatfield, P.Kim.; Lindholm, L. 2015: Cost-effectiveness of invitation to food supplementation early in pregnancy combined with multiple micronutrients on infant survival: analysis of data from MINIMat randomized trial, Bangladesh. Bmc Pregnancy and Childbirth 15: 125
Kapoor, S.; Gupta, A.; Shah, M. 2016: Cost-effectiveness of isoniazid preventive therapy for HIV-infected pregnant women in India. International Journal of Tuberculosis and Lung Disease: the Official Journal of the International Union Against Tuberculosis and Lung Disease 20(1): 85-92
Gold, H.T.; Do, H.T.; Osborne, M.P. 2016: Cost-effectiveness of isosulfan blue vs. methylene blue dye in sentinel node biopsy. Journal of Clinical Oncology 23(16_Suppl): 6103-6103
Rosselli, D.; Rueda, J.-D.; Diaz, C.E. 2015: Cost-effectiveness of kidney transplantation compared with chronic dialysis in end-stage renal disease. Saudi Journal of Kidney Diseases and Transplantation: An Official Publication of the Saudi Center for Organ Transplantation Saudi Arabia 26(4): 733-738
Cavallo, M.C.; Sepe, V.; Conte, F.; Abelli, M.; Ticozzelli, E.; Bottazzi, A.; Geraci, P.M. 2014: Cost-effectiveness of kidney transplantation from DCD in Italy. Transplantation Proceedings 46(10): 3289-3296
Wang, C.; Chen, H.-N.; Zhou, Z.-G. 2015: Cost-effectiveness of laparoscopy in rectal cancer: should China take a second look?. Diseases of the Colon and Rectum 58(2): E17
Maheu-Giroux, M.; Castro, M.C. 2014: Cost-effectiveness of larviciding for urban malaria control in Tanzania. Malaria Journal 13: 477
Goss, T.F.; Szende, A.; Schaefer, C.P.; Totten, P.J.; Wang, M.Y.; List, A.F. 2016: Cost-effectiveness of lenalidomide in treating patients with transfusion-dependent myelodysplastic syndromes (MDS) in the United States. Journal of Clinical Oncology 24(18_Suppl): 6128-6128
Usmani, S.Z.; Cavenagh, J.D.; Belch, A.R.; Hulin, C.; Basu, S.; White, D.; Nooka, A.; Ervin-Haynes, A.; Yiu, W.; Nagarwala, Y.; Berger, A.; Pelligra, C.G.; Guo, S.; Binder, G.; Gibson, C.J.; Facon, T. 2016: Cost-effectiveness of lenalidomide plus dexamethasone vs. bortezomib plus melphalan and prednisone in transplant-ineligible U.S. patients with newly-diagnosed multiple myeloma. Journal of Medical Economics 19(3): 243-258
Delea, T.E.; Karnon, J.; Barghout, V.; Thomas, S.K.; Papo, N.L. 2016: Cost-effectiveness of letrozole and anastrozole as adjuvant therapy for hormone receptor positive early breast cancer in postmenopausal women. Journal of Clinical Oncology 24(18_Suppl): 10577-10577
Korte, J.; Cristina Majo, M.; Bohlmeijer, E.T.; Westerhof, G.J.; Smit, F. 2015: Cost-effectiveness of life-review for older adults with moderate depressive symptomatology: a pragmatic randomized controlled trial. Journal of Aging Studies 34: 146-154
Fisher, M.; Walker, A.; Falqués, M.; Moya, M.; Rance, M.; Taylor, D.; Lindner, L. 2016: Cost-effectiveness of linaclotide compared to antidepressants in the treatment of irritable bowel syndrome with constipation in Scotland. European Journal of Health Economics: Hepac: Health Economics in Prevention and Care 17(9): 1091-1100
Ruhago, G.M.; Ngalesoni, F.N.; Robberstad, B.; Norheim, O.F. 2015: Cost-effectiveness of live oral attenuated human rotavirus vaccine in Tanzania. Cost Effectiveness and Resource Allocation: C/E 13: 7
Li, M.; Dick, A.; Montenovo, M.; Horslen, S.; Hansen, R. 2015: Cost-effectiveness of liver transplantation in methylmalonic and propionic acidemias. Liver Transplantation: Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 21(9): 1208-1218
Antunes, H.él.S.; Schluckebier, L.F.; Herchenhorn, D.; Small, I.A.; Araújo, C.M.M.; Viégas, C.M.P.; Rampini, M.P.; Ferreira, E.M.S.; Dias, F.L.; Teich, V.; Teich, N.; Ferreira, C.G. 2016: Cost-effectiveness of low-level laser therapy (LLLT) in head and neck cancer patients receiving concurrent chemoradiation. Oral Oncology 52: 85-90
Rajagopalan, K.; Meyer, K.; O'Day, K.; Denno, M.; Loebel, A. 2015: Cost-effectiveness of lurasidone vs quetiapine extended-release (XR) in patients with bipolar depression. Journal of Medical Economics 18(10): 821-827
Hansen, K.S.; Grieve, E.; Mikhail, A.; Mayan, I.; Mohammed, N.; Anwar, M.; Baktash, S.H.; Drake, T.L.; Whitty, C.J.M.; Rowland, M.W.; Leslie, T.J. 2015: Cost-effectiveness of malaria diagnosis using rapid diagnostic tests compared to microscopy or clinical symptoms alone in Afghanistan. Malaria Journal 14: 217
Van Dongen, J.M.; Groeneweg, R.; Rubinstein, S.M.; Bosmans, J.E.; Oostendorp, R.A.B.; Ostelo, R.W.J.G.; van Tulder, M.W. 2016: Cost-effectiveness of manual therapy versus physiotherapy in patients with sub-acute and chronic neck pain: a randomised controlled trial. European Spine Journal: Official Publication of the European Spine Society the European Spinal Deformity Society and the European Section of the Cervical Spine Research Society 25(7): 2087-2096
Aronsson, M.; Svennberg, E.; Rosenqvist, M.år.; Engdahl, J.; Al-Khalili, F.; Friberg, L.; Frykman-Kull, V.; Levin, L.-Åk. 2015: Cost-effectiveness of mass screening for untreated atrial fibrillation using intermittent ECG recording. Europace: European Pacing Arrhythmias and Cardiac Electrophysiology: Journal of the Working Groups on Cardiac Pacing Arrhythmias and Cardiac Cellular Electrophysiology of the European Society of Cardiology 17(7): 1023-1029
Ngalesoni, F.N.; Ruhago, G.M.; Mori, A.T.; Robberstad, B.; Norheim, O.F. 2016: Cost-effectiveness of medical primary prevention strategies to reduce absolute risk of cardiovascular disease in Tanzania: a Markov modelling study. Bmc Health Services Research 16: 185
Fanari, Z.; Weintraub, W.S. 2015: Cost-effectiveness of medical, endovascular and surgical management of peripheral vascular disease. Cardiovascular Revascularization Medicine: Including Molecular Interventions 16(7): 421-425
Gao, L.Lin.; Basta, M.; Kanchwala, S.K.; Serletti, J.M.; Low, D.W.; Wu, L.C. 2017: Cost-effectiveness of microsurgical reconstruction for head and neck defects after oncologic resection. Head and Neck 39(3): 541-547
Cher, D.J.; Frasco, M.A.; Arnold, R.ée.J.; Polly, D.W. 2016: Cost-effectiveness of minimally invasive sacroiliac joint fusion. Clinicoeconomics and Outcomes Research: Ceor 8: 1-14
Gauchan, D.; Ramaekers, R.; Copur, S.M. 2015: Cost-effectiveness of molecular profiling for early breast cancer. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 33(14): 1627
Subramaniam, S.; Sharp, D.; Jardim, C.; Batstone, M.D. 2016: Cost-effectiveness of monitoring free flaps. British Journal of Oral and Maxillofacial Surgery 54(5): 579-583
Shepard, D.S.; Lwin, A.K.; Barnett, N.P.; Mastroleo, N.; Colby, S.M.; Gwaltney, C.; Monti, P.M. 2016: Cost-effectiveness of motivational intervention with significant others for patients with alcohol misuse. Addiction 111(5): 832-839
Goorden, M.; van der Schee, E.; Hendriks, V.M.; Hakkaart-van Roijen, L. 2016: Cost-effectiveness of multidimensional family therapy compared to cognitive behavioral therapy for adolescents with a cannabis use disorder: Data from a randomized controlled trial. Drug and Alcohol Dependence 162: 154-161
Cerantola, Y.; Dragomir, A.; Tanguay, S.; Bladou, F.; Aprikian, A.; Kassouf, W. 2016: Cost-effectiveness of multiparametric magnetic resonance imaging and targeted biopsy in diagnosing prostate cancer. Urologic Oncology 34(3): 119.E1-9
Romanus, D.; Cardarella, S.; Cutler, D.; Landrum, M.B.; Lindeman, N.I.; Gazelle, G.S. 2015: Cost-effectiveness of multiplexed predictive biomarker screening in non-small-cell lung cancer. Journal of Thoracic Oncology: Official Publication of the International Association for the Study of Lung Cancer 10(4): 586-594
Vermeulen, K.M.; Jansen, D.ël.E.M.C.; Knorth, E.J.; Buskens, E.; Reijneveld, S.A. 2017: Cost-effectiveness of multisystemic therapy versus usual treatment for young people with antisocial problems. Criminal Behaviour and Mental Health: Cbmh 27(1): 89-102
Bosetti, R. 2015: Cost-effectiveness of nanomedicine: the path to a future successful and dominant market?. Nanomedicine 10(12): 1851-1853
Robotham, J.V.; Deeny, S.R.; Fuller, C.; Hopkins, S.; Cookson, B.; Stone, S. 2016: Cost-effectiveness of national mandatory screening of all admissions to English National Health Service hospitals for meticillin-resistant Staphylococcus aureus: a mathematical modelling study. Lancet. Infectious Diseases 16(3): 348-356
Ledwidge, M.T.; O'Connell, E.; Gallagher, J.; Tilson, L.; James, S.; Voon, V.; Bermingham, M.; Tallon, E.; Watson, C.; O'Hanlon, R.; Barry, M.; McDonald, K. 2015: Cost-effectiveness of natriuretic peptide-based screening and collaborative care: a report from the STOP-HF (St Vincent's Screening TO Prevent Heart Failure) study. European journal of heart failure 17(7): 672-679
Lai, Y.; Li, K.; Li, J.; Liu, S.X. 2014: Cost-effectiveness of navigated radiofrequency ablation for hepatocellular carcinoma in China. International Journal of Technology Assessment in Health Care 30(4): 400-408
Stryja, J.; Staffa, R.; Říha, D.; Stryjová, K.; Nicielniková, K. 2015: Cost-effectiveness of negative pressure wound therapy in outpatient setting. Rozhledy V Chirurgii: Mesicnik Ceskoslovenske Chirurgicke Spolecnosti 94(8): 322-328
Driver, V.R.; Eckert, K.A.; Carter, M.J.; French, M.A. 2016: Cost-effectiveness of negative pressure wound therapy in patients with many comorbidities and severe wounds of various etiology. Wound Repair and Regeneration: Official Publication of the Wound Healing Society and the European Tissue Repair Society 24(6): 1041-1058
Lin, C.-Y.; Fang, H.-Y.; Feng, C.-L.; Li, C.-C.; Chien, C.-R. 2016: Cost-effectiveness of neoadjuvant concurrent chemoradiotherapy versus esophagectomy for locally advanced esophageal squamous cell carcinoma: a population-based matched case-control study. Thoracic Cancer 7(3): 288-295
Dams, J.; Balzer-Geldsetzer, M.; Siebert, U.; Deuschl, G.ün.; Schuepbach, W.M.M.; Krack, P.; Timmermann, L.; Schnitzler, A.; Reese, J.-P.; Dodel, R.; Schuepbach, W.M.M.; Rau, J.; Knudsen, K.; Volkmann, J.; Krack, P.; Timmermann, L.; Hälbig, T.D.; Hesekamp, H.; Navarro, S.M.; Meier, N.; Falk, D.; Mehdorn, M.; Paschen, S.; Maarouf, M.; Barbe, M.T.; Fink, G.R.; Kupsch, A.; Gruber, D.; Schneider, G.-H.; Seigneuret, E.; Kistner, A.; Chaynes, P.; Ory-Magne, F.; Brefel Courbon, C.; Vesper, J.; Schnitzler, A.; Wojtecki, L.; Houeto, J.-L.; Bataille, B.; Maltête, D.; Damier, P.; Raoul, S.; Sixel-Doering, F.; Hellwig, D.; Gharabaghi, A.; Krüger, R.; Pinsker, M.O.; Amtage, F.; Régis, J.-M.; Witjas, T.; Thobois, S.; Mertens, P.; Kloss, M.; Hartmann 2016: Cost-effectiveness of neurostimulation in Parkinson's disease with early motor complications. Movement Disorders: Official Journal of the Movement Disorder Society 31(8): 1183-1191
Chidi, A.P.; Rogal, S.; Bryce, C.L.; Fine, M.J.; Good, C.B.; Myaskovsky, L.; Rustgi, V.K.; Tsung, A.; Smith, K.J. 2016: Cost-effectiveness of new antiviral regimens for treatment-naïve U.S. veterans with hepatitis C. Hepatology 63(2): 428-436
Fitzpatrick, M.C.; Wenzel, N.S.; Scarpino, S.V.; Althouse, B.M.; Atkins, K.E.; Galvani, A.P.; Townsend, J.P. 2016: Cost-effectiveness of next-generation vaccines: the case of pertussis. Vaccine 34(29): 3405-3411
Wood, A.; Blackhurst, M.; Hawkins, T.; Xue, X.; Ashbolt, N.; Garland, J. 2015: Cost-effectiveness of nitrogen mitigation by alternative household wastewater management technologies. Journal of Environmental Management 150: 344-354
Crossan, C.; Tsochatzis, E.A.; Longworth, L.; Gurusamy, K.; Davidson, B.; Rodríguez-Perálvarez, M.; Mantzoukis, K.; O'Brien, J.; Thalassinos, E.; Papastergiou, V.; Burroughs, A. 2015: Cost-effectiveness of non-invasive methods for assessment and monitoring of liver fibrosis and cirrhosis in patients with chronic liver disease: systematic review and economic evaluation. Health Technology Assessment 19(9): 1-409 V-VI
Listl, S.; Frühauf, N.; Dannewitz, B.; Weis, C.; Tu, Y.-K.; Chang, H.-J.; Faggion, C.M. 2015: Cost-effectiveness of non-surgical peri-implantitis treatments. Journal of Clinical Periodontology 42(5): 470-477
Costa, J.ão.; Fiorentino, F.; Caldeira, D.; Inês, M.ón.; Lopes Pereira, C.; Pinheiro, L.ís.; Vaz-Carneiro, A.ón.; Borges, M.; Gouveia, M. 2015: Cost-effectiveness of non-vitamin K antagonist oral anticoagulants for atrial fibrillation in Portugal. Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 34(12): 723-737
Liberato, N.Lucio.; Marchetti, M. 2016: Cost-effectiveness of non-vitamin K antagonist oral anticoagulants for stroke prevention in non-valvular atrial fibrillation: a systematic and qualitative review. Expert Review of Pharmacoeconomics and Outcomes Research 16(2): 221-235
Hernandez, I.; Smith, K.J.; Zhang, Y. 2017: Cost-effectiveness of non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with atrial fibrillation at high risk of bleeding and normal kidney function. Thrombosis Research 150: 123-130
Cheng, H-Min.; Pearson, A.; Sung, S-Hsien.; Yu, W-Chung.; Chen, C-Huan.; Karnon, J. 2015: Cost-effectiveness of noninvasive central blood pressure monitoring in the diagnosis of hypertension. American Journal of Hypertension 28(5): 604-614
Crossan, C.; Tsochatzis, E.A.; Longworth, L.; Gurusamy, K.; Papastergiou, V.; Thalassinos, E.; Mantzoukis, K.; Rodriguez-Peralvarez, M.; O'Brien, J.; Noel-Storr, A.; Papatheodoridis, G.V.; Davidson, B.; Burroughs, A.K. 2016: Cost-effectiveness of noninvasive liver fibrosis tests for treatment decisions in patients with chronic hepatitis B in the UK: systematic review and economic evaluation. Journal of Viral Hepatitis 23(2): 139-149
Patel, S.P.; Pena, M.E.; Babcock, C.I. 2015: Cost-effectiveness of noninvasive ventilation for chronic obstructive pulmonary disease-related respiratory failure in Indian hospitals without ICU facilities. Lung India: Official Organ of Indian Chest Society 32(6): 549-556
Katz, J.N.; Smith, S.R.; Collins, J.E.; Solomon, D.H.; Jordan, J.M.; Hunter, D.J.; Suter, L.G.; Yelin, E.; Paltiel, A.D.; Losina, E. 2016: Cost-effectiveness of nonsteroidal anti-inflammatory drugs and opioids in the treatment of knee osteoarthritis in older patients with multiple comorbidities. Osteoarthritis and Cartilage 24(3): 409-418
Mirelman, A.J.; Ballard, S.B.; Saito, M.; Kosek, M.N.; Gilman, R.H. 2015: Cost-effectiveness of norovirus vaccination in children in Peru. Vaccine 33(27): 3084-3091
Najafzadeh, M.; Andersson, K.; Shrank, W.H.; Krumme, A.A.; Matlin, O.S.; Brennan, T.; Avorn, J.; Choudhry, N.K. 2015: Cost-effectiveness of novel regimens for the treatment of hepatitis C virus. Annals of Internal Medicine 162(6): 407-419
Martin-Misener, R.; Harbman, P.; Donald, F.; Reid, K.; Kilpatrick, K.; Carter, N.; Bryant-Lukosius, D.; Kaasalainen, S.; Marshall, D.A.; Charbonneau-Smith, R.; DiCenso, A. 2015: Cost-effectiveness of nurse practitioners in primary and specialised ambulatory care: systematic review. Bmj Open 5(6): E007167
Blommestein, H.M.; de Groot, S.; Aarts, M.J.; Vemer, P.; de Vries, R.; van Abeelen, A.F.M.; Posthuma, E.F.M.W.; Uyl-de Groot, C.A. 2016: Cost-effectiveness of obinutuzumab for chronic lymphocytic leukaemia in the Netherlands. Leukemia Research 50: 37-45
Okubo, R.; Kondo, M.; Hoshi, S.-l.; Yamagata, K. 2015: Cost-effectiveness of obstructive sleep apnea screening for patients with diabetes or chronic kidney disease. Sleep and Breathing 19(3): 1081-1092
Bennison, C.; Stephens, S.; Lescrauwaet, B.; Van Hout, B.; Jackson, T.L. 2016: Cost-effectiveness of ocriplasmin for the treatment of vitreomacular traction and macular hole. Journal of Market Access and Health Policy 4
Pyne, J.M.; Fortney, J.C.; Mouden, S.; Lu, L.; Hudson, T.J.; Mittal, D. 2015: Cost-effectiveness of on-site versus off-site collaborative care for depression in rural FQHCs. Psychiatric Services 66(5): 491-499
Huetson, P.; Palmer, J.L.; Levorsen, A.ée.; Fournier, M.; Germe, M.; McLeod, E. 2015: Cost-effectiveness of once daily GLP-1 receptor agonist lixisenatide compared to bolus insulin both in combination with basal insulin for the treatment of patients with type 2 diabetes in Norway. Journal of Medical Economics 18(8): 573-585
Ben-Hamadi, R.; Duh, M.S.; Henckler, A.; McKenzie, S.; Fastenau, J.; Tak Piech, C. 2016: Cost-effectiveness of once weekly epoetin alfa and darbepoetin alfa in treating chemotherapy-induced anemia. Journal of Clinical Oncology 23(16_Suppl): 6093-6093
Van Bochove, C.A.; Burgers, L.T.; Vahl, A.C.; Birnie, E.; van Schothorst, M.G.; Redekop, W.K. 2016: Cost-effectiveness of open versus endovascular repair of abdominal aortic aneurysm. Journal of Vascular Surgery 63(3): 827-38.E2
Vokó, Z.án.; Túri, G.ő; Zsólyom, A.án. 2016: Cost-effectiveness of oral cancer screening in Hungary. Orvosi Hetilap 157(29): 1161-1170
Kim, B.J.; Aloia, T.A. 2016: Cost-effectiveness of palliative surgery versus nonsurgical procedures in gastrointestinal cancer patients. Journal of Surgical Oncology 114(3): 316-322
Lee, J.Y.; Kim, Y.; Lee, T.J.; Jeon, Y.W.; Kim, K.; Chung, H.H.; Kim, H.J.; Park, S.M.; Kim, J.W. 2015: Cost-effectiveness of para-aortic lymphadenectomy before chemoradiotherapy in locally advanced cervical cancer. Journal of Gynecologic Oncology 26(3): 171-178
Sher, D.J.; Punglia, R.S. 2016: Cost-effectiveness of partial breast irradiation versus whole breast irradiation for early-stage breast cancer. Journal of Clinical Oncology 26(15_Suppl): 6530-6530
Botteman, M.; Detzel, P. 2015: Cost-effectiveness of partially hydrolyzed whey protein formula in the primary prevention of atopic dermatitis in high-risk urban infants in Southeast Asia. Annals of Nutrition and Metabolism 66 Suppl. 1: 26-32
Ladabaum, U.; Mannalithara, A.; Jandorf, L.; Itzkowitz, S.H. 2015: Cost-effectiveness of patient navigation to increase adherence with screening colonoscopy among minority individuals. Cancer 121(7): 1088-1097
Amdahl, J.; Diaz, J.; Park, J.; Nakhaipour, H.R.; Delea, T.E. 2016: Cost-effectiveness of pazopanib compared with sunitinib in metastatic renal cell carcinoma in Canada. Current Oncology 23(4): E340-E354
Delea, T.E.; Amdahl, J.; Nakhaipour, H.R.; Manson, S.C.; Wang, A.; Fedor, N.; Chit, A. 2014: Cost-effectiveness of pazopanib in advanced soft-tissue sarcoma in Canada. Current Oncology 21(6): E748-E759
Delea, T.E.; Amdahl, J.; Diaz, J.; Nakhaipour, H.R.; Hackshaw, M.D. 2015: Cost-effectiveness of pazopanib versus sunitinib for renal cancer in the United States. Journal of Managed Care and Specialty Pharmacy 21(1): 46-54; 54a-B
Beca, J.; Chan, K.K.W. 2016: Cost-effectiveness of pazopanib: an example of improved transparency and accessibility of industry-sponsored economic evaluations through publication in peer-reviewed journals. Current Oncology 23(4): E327-E329
Feingold, B.; Webber, S.A.; Bryce, C.L.; Park, S.Y.; Tomko, H.E.; West, S.C.; Hart, S.A.; Mahle, W.T.; Smith, K.J. 2015: Cost-effectiveness of pediatric heart transplantation across a positive crossmatch for high waitlist urgency candidates. American Journal of Transplantation: Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons 15(11): 2978-2985
Bosse, H.Martin.; Nickel, M.; Huwendiek, Sören.; Schultz, J.Hendrik.; Nikendei, C. 2015: Cost-effectiveness of peer role play and standardized patients in undergraduate communication training. Bmc Medical Education 15: 183
Koh, C.E.; Badgery-Parker, T.; Salkeld, G.; Young, J.M.; Heriot, A.G.; Solomon, M.J. 2016: Cost-effectiveness of pelvic exenteration for locally advanced malignancy. British Journal of Surgery 103(11): 1548-1556
Huang, M.; Lou, Y.; Pellissier, J.; Burke, T.; Liu, F.Xiaoqing.; Xu, R.; Velcheti, V. 2017: Cost-effectiveness of pembrolizumab versus docetaxel for the treatment of previously treated PD-L1 positive advanced NSCLC patients in the United States. Journal of Medical Economics 20(2): 140-150
Pavlakis, N.; Mitchell, P.L.; Stynes, G.; Aristides, M.; Davey, P.; Rajan, N.; Arora, B.; Liepa, A.M. 2016: Cost-effectiveness of pemetrexed for previously treated advanced non-small cell lung cancer. Journal of Clinical Oncology 23(16_Suppl): 6084-6084
Osnabrugge, R.L.; Magnuson, E.A.; Serruys, P.W.; Campos, C.M.; Wang, K.; van Klaveren, D.; Farooq, V.; Abdallah, M.S.; Li, H.; Vilain, K.A.; Steyerberg, E.W.; Morice, M.-C.; Dawkins, K.D.; Mohr, F.W.; Kappetein, A.P.; Cohen, D.J. 2015: Cost-effectiveness of percutaneous coronary intervention versus bypass surgery from a Dutch perspective. Heart 101(24): 1980-1988
Ferko, N.; Ferrante, G.; Hasegawa, J.T.; Schikorr, T.; Soleas, I.M.; Hernandez, J.B.; Sabaté, M.; Kaiser, C.; Brugaletta, S.; de la Torre Hernandez, J.M.; Galatius, S.; Cequier, A.; Eberli, F.; de Belder, A.; Serruys, P.W.; Valgimigli, M. 2017: Cost-effectiveness of percutaneous coronary intervention with cobalt-chromium everolimus eluting stents versus bare metal stents: Results from a patient level meta-analysis of randomized trials. Catheterization and Cardiovascular Interventions: Official Journal of the Society for Cardiac Angiography and Interventions 89(6): 994-1002
Ethgen, O.; Hiligsmann, M.; Burlet, N.; Reginster, J-Y. 2016: Cost-effectiveness of personalized supplementation with vitamin D-rich dairy products in the prevention of osteoporotic fractures. Osteoporosis International: a Journal Established as Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the Usa 27(1): 301-308
Rizk, R. 2016: Cost-effectiveness of phosphate binders among patients with chronic kidney disease not yet on dialysis: a long way to go. Bmc Nephrology 17(1): 75
Kolu, P.äi.; Raitanen, J.; Nygård, C.-H.åk.; Tomás, E.; Luoto, R. 2015: Cost-effectiveness of physical activity among women with menopause symptoms: findings from a randomised controlled trial. Plos one 10(8): E0135099
Vučina, V.V.še.; Filipović, S.K.či.ć; Kožnjak, N.; Stamenić, V.; Clark, A.D.; Mounaud, B.; Blau, J.; Hoestlandt, C.; Kaić, B. 2015: Cost-effectiveness of pneumococcal conjugate vaccination in Croatia. Vaccine 33(Suppl 1): A209-A218
Komakhidze, T.; Hoestlandt, C.; Dolakidze, T.; Shakhnazarova, M.; Chlikadze, R.; Kopaleishvili, N.; Goginashvili, K.; Kherkheulidze, M.; Clark, A.D.; Blau, J. 2015: Cost-effectiveness of pneumococcal conjugate vaccination in Georgia. Vaccine 33(Suppl 1): A219-A226
Hunter, R. 2015: Cost-effectiveness of point-of-care C-reactive protein tests for respiratory tract infection in primary care in England. Advances in Therapy 32(1): 69-85
Aliyu, G.; El-Kamary, S.S.; Abimiku, A.'l.; Hungerford, L.; Obasanya, J.; Blattner, W. 2014: Cost-effectiveness of point-of-care digital chest-x-ray in HIV patients with pulmonary mycobacterial infections in Nigeria. Bmc Infectious Diseases 14: 675
Whitney, R.E.; Santucci, K.; Hsiao, A.; Chen, L. 2016: Cost-effectiveness of point-of-care testing for dehydration in the pediatric ED. American Journal of Emergency Medicine 34(8): 1573-1575
Manchanda, R.; Legood, R.; Burnell, M.; McGuire, A.; Raikou, M.; Loggenberg, K.; Wardle, J.; Sanderson, S.; Gessler, S.; Side, L.; Balogun, N.; Desai, R.; Kumar, A.; Dorkins, H.; Wallis, Y.; Chapman, C.; Taylor, R.; Jacobs, C.; Tomlinson, I.; Beller, U.; Menon, U.; Jacobs, I. 2015: Cost-effectiveness of population screening for BRCA mutations in Ashkenazi jewish women compared with family history-based testing. Journal of the National Cancer Institute 107(1): 380
Nosyk, B.; Min, J.E.; Lima, V.D.; Hogg, R.S.; Montaner, J.S.G.; Barrios, R.; Daly, P.; Gustafson, R.; Kendall, P.R.W.; McGowan, G.; Day, I.; Heath, K.; Hogg, R.S.; Montaner, J.S.G.; Nosyk, B. 2015: Cost-effectiveness of population-level expansion of highly active antiretroviral treatment for HIV in British Columbia, Canada: a modelling study. LANCET. HIV 2(9): E393-E400
Tió, M.M.; Sánchez-Etayo, G.; Bergé, R.; Salazar, F.; Basora, M.; Sala-Blanch, X. 2016: Cost-effectiveness of post-operative cell salvage in total knee arthroplasty. Should we continue to recommend its use today?. Revista Espanola de Anestesiologia y Reanimacion 63(8): 444-450
Hagberg, L.; Hermansson, L.; Fredriksson, C.; Pettersson, I. 2017: Cost-effectiveness of powered mobility devices for elderly people with disability. Disability and Rehabilitation. Assistive Technology 12(2): 115-120
Andrich, R.; Salatino, C.; Converti, R.M.; Saruggia, M. 2015: Cost-effectiveness of powered wheelchairs: findings of a study. Studies in Health Technology and Informatics 217: 84-91
Ying, R.; Sharma, M.; Heffron, R.; Celum, C.L.; Baeten, J.M.; Katabira, E.; Bulya, N.; Barnabas, R.V. 2015: Cost-effectiveness of pre-exposure prophylaxis targeted to high-risk serodiscordant couples as a bridge to sustained ART use in Kampala, Uganda. Journal of the International Aids Society 18(4 Suppl 3: 20013
Doble, B.; John, T.; Thomas, D.; Fellowes, A.; Fox, S.; Lorgelly, P. 2017: Cost-effectiveness of precision medicine in the fourth-line treatment of metastatic lung adenocarcinoma: An early decision analytic model of multiplex targeted sequencing. Lung Cancer 107: 22-35
Pagani, M.; Lucini, D. 2015: Cost-effectiveness of preparticipation screening of athletes with ECG in Europe and Algeria. Internal and Emergency Medicine 10(2): 125-127
Vitale, A.; Spolverato, G.; Burra, P.; De Feo, T.Maria.; Belli, L.; Donato, F.; Baroni, G.Svegliati.; Marianelli, T.; Picciotto, A.; Toniutto, P.; Bhoori, S.; Passigato, N.; Lucà, M.Grazia.; Russo, F.Paolo.; Cillo, U.; Fagiuoli, S.; De Carlis, L.; Colledan, M.; Rossi, G.; Andorno, E.; Risaliti, A.; Mazzaferro, V.; Vivarelli, M.; Tedeschi, U.; Bitetto, D.; Sangiovanni, A.; Caccamo, L.; Neri, D.; Piccolo, G.; Biti, L.; Angeli, P.; Corno, V. 2015: Cost-effectiveness of pretransplant sofosbuvir for preventing recurrent hepatitis C virus infection after liver transplantation. Transplant International: Official Journal of the European Society for Organ Transplantation 28(9): 1055-1065
Atkins, C.Y.; Thomas, T.K.; Lenaker, D.; Day, G.M.; Hennessy, T.W.; Meltzer, M.I. 2016: Cost-effectiveness of preventing dental caries and full mouth dental reconstructions among Alaska Native children in the Yukon-Kuskokwim delta region of Alaska. Journal of Public Health Dentistry 76(3): 228-240
Wansink, H.J.; Drost, R.M.W.A.; Paulus, A.T.G.; Ruwaard, D.; Hosman, C.M.H.; Janssens, J.M.A.M.; Evers, S.M.A.A. 2016: Cost-effectiveness of preventive case management for parents with a mental illness: a randomized controlled trial from three economic perspectives. Bmc Health Services Research 16: 228
Ademi, Z.; Gloy, V.; Glinz, D.; Raatz, H.; Van Stiphout, J.; Bucher, H.C.; Schwenkglenks, M. 2016: Cost-effectiveness of primarily surgical versus primarily conservative treatment of acute and subacute radiculopathies due to intervertebral disc herniation from the Swiss perspective. Swiss Medical Weekly 146: W14382
Forde, G.K.; Chang, J.; Ziogas, A. 2016: Cost-effectiveness of primary debulking surgery when compared to neoadjuvant chemotherapy in the management of stage IIIC and IV epithelial ovarian cancer. Clinicoeconomics and Outcomes Research: Ceor 8: 397-406
Malet-Larrea, A.; García-Cárdenas, V.; Sáez-Benito, L.; Benrimoj, S.I.; Calvo, B.; Goyenechea, E. 2016: Cost-effectiveness of professional pharmacy services in community pharmacy: a systematic review. Expert Review of Pharmacoeconomics and Outcomes Research 16(6): 747-758
Lee, E.K.; Wong, W.W.L.; Trudeau, M.E.; Chan, K.K.W. 2015: Cost-effectiveness of prophylactic granulocyte colony-stimulating factor for febrile neutropenia in breast cancer patients receiving FEC-D. Breast Cancer Research and Treatment 150(1): 169-180
Heijnsdijk, E.A.M.; de Carvalho, T.M.; Auvinen, A.; Zappa, M.; Nelen, V.; Kwiatkowski, M.; Villers, A.; Páez, A.; Moss, S.M.; Tammela, T.L.J.; Recker, F.; Denis, L.; Carlsson, S.V.; Wever, E.M.; Bangma, C.H.; Schröder, F.H.; Roobol, M.J.; Hugosson, J.; de Koning, H.J. 2015: Cost-effectiveness of prostate cancer screening: a simulation study based on ERSPC data. Journal of the National Cancer Institute 107(1): 366
Moriarty, J.P.; Borah, B.J.; Foote, R.L.; Pulido, J.S.; Shah, N.D. 2015: Cost-effectiveness of proton beam therapy for intraocular melanoma. Plos one 10(5): E0127814
Rantonen, J.; Karppinen, J.; Vehtari, A.; Luoto, S.; Viikari-Juntura, E.; Hupli, M.; Malmivaara, A.; Taimela, S. 2016: Cost-effectiveness of providing patients with information on managing mild low-back symptoms in an occupational health setting. Bmc Public Health 16: 316
Nuijten, M.J.C.; Dubois, D.J.; Joseph, A.; Annemans, L. 2015: Cost-effectiveness of prucalopride in the treatment of chronic constipation in the Netherlands. Frontiers in Pharmacology 6: 67
Wetzelaer, P.; Lokkerbol, J.; Arntz, A.; van Asselt, A.; Evers, S. 2016: Cost-effectiveness of psychotherapy for personality disorders. a systematic review on economic evaluation studies. Tijdschrift Voor Psychiatrie 58(10): 717-727
You, J.H.S.; Ming, W-Kit.; Chan, P.K.S. 2015: Cost-effectiveness of quadrivalent influenza vaccine in Hong Kong - A decision analysis. Human Vaccines and Immunotherapeutics 11(3): 564-571
Pichon-Riviere, A.és.; Alcaraz, A.; Caporale, J.ín.; Bardach, A.; Rey-Ares, L.; Klein, K.; Calderón, M.ía.; Augustovski, F.; Tatti, S. 2015: Cost-effectiveness of quadrivalent vaccine against human papilloma virus in Argentina based on a dynamic transmission model. Salud Publica de Mexico 57(6): 504-513
Samadi Kochaksaraei, G.; Congly, S.E.; Matwiy, T.; Castillo, E.; Martin, S.R.; Charlton, C.L.; Coffin, C.S. 2016: Cost-effectiveness of quantitative hepatitis B virus surface antigen testing in pregnancy in predicting vertical transmission risk. Liver International: Official Journal of the International Association for the Study of the Liver 36(11): 1604-1610
Troyer, J.L.; Jones, A.E.; Shapiro, N.I.; Mitchell, A.M.; Hewer, I.; Kline, J.A. 2015: Cost-effectiveness of quantitative pretest probability intended to reduce unnecessary medical radiation exposure in emergency department patients with chest pain and dyspnea. Academic Emergency Medicine: Official Journal of the Society for Academic Emergency Medicine 22(5): 525-535
Ribadeau Dumas, F.; N'Diaye, D.S.; Paireau, J.; Gautret, P.; Bourhy, H.é; Le Pen, C.; Yazdanpanah, Y. 2015: Cost-effectiveness of rabies post-exposure prophylaxis in the context of very low rabies risk: a decision-tree model based on the experience of France. Vaccine 33(20): 2367-2378
Kołtowski, Łu.; Filipiak, K.J.; Kochman, J.; Pietrasik, A.; Huczek, Z.; Balsam, P.; Lewandowski, A.; Chojnacka, K.; Opolski, G.; Wrona, W. 2016: Cost-effectiveness of radial vs. femoral approach in primary percutaneous coronary intervention in STEMi - Randomized, control trial. Hellenic Journal of Cardiology: Hjc 57(3): 198-202
Chai, Y.; Wang, J.; Wang, T.; Shi, F.; Wang, J.; Su, J.; Yang, Y.; Zhou, X.; Ma, H.; He, B.; Liu, Z. 2016: Cost-effectiveness of radical hysterectomy with adjuvant radiotherapy versus radical radiotherapy for FIGO stage IIB cervical cancer. Oncotargets and Therapy 9: 349-354
Chen, M.; Si, L.; Winzenberg, T.M.; Gu, J.; Jiang, Q.; Palmer, A.J. 2016: Cost-effectiveness of raloxifene in the treatment of osteoporosis in Chinese postmenopausal women: impact of medication persistence and adherence. Patient Preference and Adherence 10: 415-423
Haig, J.; Barbeau, M.; Ferreira, A. 2016: Cost-effectiveness of ranibizumab in the treatment of visual impairment due to diabetic macular edema. Journal of Medical Economics 19(7): 663-671
Régnier, S.A.; Malcolm, W.; Haig, J.; Xue, W. 2015: Cost-effectiveness of ranibizumab versus aflibercept in the treatment of visual impairment due to diabetic macular edema: a UK healthcare perspective. Clinicoeconomics and Outcomes Research: Ceor 7: 235-247
Schwendicke, F.; Stolpe, M.; Plaumann, A.; Graetz, C. 2016: Cost-effectiveness of regular versus irregular supportive periodontal therapy or tooth removal. Journal of Clinical Periodontology 43(11): 940-947
Sloth, A.D.; Schmidt, M.R.; Munk, K.; Schmidt, M.; Pedersen, L.; Sørensen, H.T.; Enemark, U.; Parner, E.T.; Bøtker, H.E.; Bøttcher, M.; Kaltoft, A.; Terkelsen, C.; Andersen, N.; Hansen, T.; Trautner, S.; Lassen, J.; Christiansen, E.; Krusell, L.; Kristensen, S.; Thuesen, L.; Nielsen, S.; Rehling, M.; Nielsen, T. 2016: Cost-effectiveness of remote ischaemic conditioning as an adjunct to primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction. European Heart Journal. Acute Cardiovascular Care 2016
Kanzow, P.; Wiegand, A.; Schwendicke, F. 2016: Cost-effectiveness of repairing versus replacing composite or amalgam restorations. Journal of Dentistry 54: 41-47
Annemans, L.; Marbaix, S.; Nackaerts, K.; Bartsch, P. 2015: Cost-effectiveness of retreatment with varenicline after failure with or relapse after initial treatment for smoking cessation. Preventive Medicine Reports 2: 189-195
Zhang, Z.; Kolm, P.; Grau-Sepulveda, M.V.; Ponirakis, A.; O'Brien, S.M.; Klein, L.W.; Shaw, R.E.; McKay, C.; Shahian, D.M.; Grover, F.L.; Mayer, J.E.; Garratt, K.N.; Hlatky, M.; Edwards, F.H.; Weintraub, W.S. 2015: Cost-effectiveness of revascularization strategies: the ASCERT study. Journal of the American College of Cardiology 65(1): 1-11
Einerson, B.D.; Grobman, W.A.; Miller, E.S. 2016: Cost-effectiveness of risk-based screening for cervical length to prevent preterm birth. American Journal of Obstetrics and Gynecology 215(1): 100.E1-7
Müller, D.; Fischer, K.; Kaiser, P.; Eichhorst, B.; Walshe, R.; Reiser, M.; Kellermann, L.; Borsi, L.; Civello, D.; Mensch, A.; Bahlo, J.; Hallek, M.; Stock, S.; Fingerle-Rowson, G.ün. 2016: Cost-effectiveness of rituximab in addition to fludarabine and cyclophosphamide (R-FC) for the first-line treatment of chronic lymphocytic leukemia. Leukemia and Lymphoma 57(5): 1130-1139
Buse, S.; Hach, C.E.; Klumpen, P.; Alexandrov, A.; Mager, R.; Mottrie, A.; Haferkamp, A. 2016: Cost-effectiveness of robot-assisted partial nephrectomy for the prevention of perioperative complications. World Journal of Urology 34(8): 1131-1137
Kim, C.W.; Baik, S.H.; Roh, Y.H.; Kang, J.; Hur, H.; Min, B.S.; Lee, K.Y.; Kim, N.K. 2015: Cost-effectiveness of robotic surgery for rectal cancer focusing on short-term outcomes: a propensity score-matching analysis. Medicine 94(22): E823
Xie, Y. 2015: Cost-effectiveness of robotic surgery in gynecologic oncology. Current Opinion in Obstetrics and Gynecology 27(1): 73-76
Wijburg, C.J. 2016: Cost-effectiveness of robotic surgery; what do we know?. Bju International 117(6): 852-853
Cosin Sales, J.; Fuentes Jiménez, F.J.é; Mantilla Morató, T.; Ruiz, E.; Becerra, V.; Aceituno, S.; Ferrario, M.G.; Lizán, L.; Gracia, A. 2015: Cost-effectiveness of rosuvastatin versus simvastatin, atorvastatin and pitavastatin in patients with high and very high cardiovascular risk in Spain. Clinica e Investigacion en Arteriosclerosis: Publicacion Oficial de la Sociedad Espanola de Arteriosclerosis 27(5): 228-238
Ahmeti, A.; Preza, I.; Simaku, A.; Nelaj, E.; Clark, A.D.; Felix Garcia, A.G.; Lara, C.; Hoestlandt, C.él.; Blau, J.; Bino, S. 2015: Cost-effectiveness of rotavirus vaccination in Albania. Vaccine 33(Suppl 1): A201-A208
Sigei, C.; Odaga, J.; Mvundura, M.; Madrid, Y.; Clark, A.D.; Mutie, D.; Kamau, P.; Mungai, A.I.; Watiri, T.; Gatheru, Z.; Charo, J.; Osano, B.; Mwinyi, B.; Kamenwa, R.; Nyangoa, J.; Chitala, K.; Muitherero, C.; Koskei, N.; Omurwa, T.; Murunga, P.; Mayanja, R.; Aanyu, H.; Mugisha, D.; Mulindwa, A.; Nalumansi, E.; Kisakye, A.; Henry, L.; Lochoro, P.; Bwogi, J.; Walimbwa, A.; Robinson, E.; Ruhambarama, J. 2015: Cost-effectiveness of rotavirus vaccination in Kenya and Uganda. Vaccine 33(Suppl 1): A109-A118
Koksal, T.; Akelma, A.Z.; Koksal, A.O.; Kutukoglu, I.; Ozdemir, O.; Yuksel, C.N.; Bozkaya, D.; Catal, F.; Sari, S. 2017: Cost-effectiveness of rotavirus vaccination in Turkey. Journal of Microbiology Immunology and Infection 50(5): 693-699
Hojjat, H.; Svider, P.F.; Folbe, A.J.; Raza, S.N.; Carron, M.A.; Shkoukani, M.A.; Merati, A.L.; Mayerhoff, R.M. 2017: Cost-effectiveness of routine computed tomography in the evaluation of idiopathic unilateral vocal fold paralysis. Laryngoscope 127(2): 440-444
Laine, J.; Jokiranta, T.S.; Eklund, K.K.; Väkeväinen, M.; Puolakka, K. 2016: Cost-effectiveness of routine measuring of serum drug concentrations and anti-drug antibodies in treatment of rheumatoid arthritis patients with TNF-α blockers. Biologics: Targets and Therapy 10: 67-73
Goverde, A.; Spaander, M.Cw.; van Doorn, H.C.; Dubbink, H.J.; van den Ouweland, A.Mw.; Tops, C.M.; Kooi, S.G.; de Waard, J.; Hoedemaeker, R.F.; Bruno, M.J.; Hofstra, R.Mw.; de Bekker-Grob, E.W.; Dinjens, W.Nm.; Steyerberg, E.W.; Wagner, A. 2016: Cost-effectiveness of routine screening for Lynch syndrome in endometrial cancer patients up to 70years of age. Gynecologic oncology 143(3): 453-459
Littlewood, K.J.; Ouwens, M.J.N.M.; Sauboin, C.; Tehard, B.; Alain, S.; Denis, F.ço. 2015: Cost-effectiveness of routine varicella vaccination using the measles, mumps, rubella and varicella vaccine in France: an economic analysis based on a dynamic transmission model for varicella and herpes zoster. Clinical Therapeutics 37(4): 830-841.E7
Mol, F.; van Mello, N.M.; Strandell, A.; Jurkovic, D.; Ross, J.A.; Yalcinkaya, T.M.; Barnhart, K.T.; Verhoeve, H.R.; Graziosi, G.C.; Koks, C.A.; Mol, B.W.; Ankum, W.M.; van der Veen, F.; Hajenius, P.J.; van Wely, M.; Janssen, I.C.A.H.; Kragt, H.; Hoek, A.; Trimbos-Kemper, T.C.M.; Broekmans, F.J.M.; Willemsen, W.N.P.; Dijkman, A.B.; Thurkow, A.L.; van Dessel, H.J.H.M.; van der Linden, P.J.Q.; Bouwmeester, F.W.; Oosterhuis, G.J.E.; van Beek, J.J.; Emanuel, M.H.; Visser, H.; Doornbos, J.P.R.; Pernet, P.J.M.; Friederich, J.; Strandell, K.; Hogström, L.; Klinte, I.; Pettersson, F.; Sabetirad, Z.; Nilsson, K.; Tegerstedt, G.; Platz-Christensen, J.J. 2015: Cost-effectiveness of salpingotomy and salpingectomy in women with tubal pregnancy (a randomized controlled trial). Human Reproduction 30(9): 2038-2047
Da Costa, D.W.; Dijksman, L.M.; Bouwense, S.A.; Schepers, N.J.; Besselink, M.G.; van Santvoort, H.C.; Boerma, D.; Gooszen, H.G.; Dijkgraaf, M.G.W. 2016: Cost-effectiveness of same-admission versus interval cholecystectomy after mild gallstone pancreatitis in the PONCHO trial. British Journal of Surgery 103(12): 1695-1703
Gu, S.; Deng, J.; Shi, L.; Mu, Y.; Dong, H. 2015: Cost-effectiveness of saxagliptin vs glimepiride as a second-line therapy added to metformin in Type 2 diabetes in China. Journal of Medical Economics 18(10): 808-820
Turner, H.C.; Truscott, J.E.; Fleming, F.M.; Hollingsworth, T.D.éi.; Brooker, S.J.; Anderson, R.M. 2016: Cost-effectiveness of scaling up mass drug administration for the control of soil-transmitted helminths: a comparison of cost function and constant costs analyses. LANCET. Infectious Diseases 16(7): 838-846
Cortejoso, Lía.; García-González, X.; García, Mía.I.; García-Alfonso, P.; Sanjurjo, Mía.; López-Fernández, L.A. 2016: Cost-effectiveness of screening for DPYD polymorphisms to prevent neutropenia in cancer patients treated with fluoropyrimidines. Pharmacogenomics 17(9): 979-984
Plumpton, C.O.; Yip, V.L.M.; Alfirevic, A.; Marson, A.G.; Pirmohamed, M.; Hughes, D.A. 2015: Cost-effectiveness of screening for HLA-A*31:01 prior to initiation of carbamazepine in epilepsy. Epilepsia 56(4): 556-563
Ong, J.J.; Fairley, C.K.; Carroll, S.; Walker, S.; Chen, M.; Read, T.; Grulich, A.; Bradshaw, C.; Kaldor, J.; Clarke, P. 2016: Cost-effectiveness of screening for anal cancer using regular digital ano-rectal examinations in men who have sex with men living with HIV. Journal of the International Aids Society 19(1): 20514
Jacobs, M.S.; Kaasenbrood, F.; Postma, M.J.; van Hulst, M.; Tieleman, R.G. 2018: Cost-effectiveness of screening for atrial fibrillation in primary care with a handheld, single-lead electrocardiogram device in the Netherlands. Europace: European Pacing Arrhythmias and Cardiac Electrophysiology: Journal of the Working Groups on Cardiac Pacing Arrhythmias and Cardiac Cellular Electrophysiology of the European Society of Cardiology 20(1): 12-18
Bolin, T.D.; Korman, M.G.; Nicholson, F.; Pezzullo, L.; Engelman, J.; Collings, K.; Creelman, D.G. 2016: Cost-effectiveness of screening for bowel cancer. Medical Journal of Australia 204(1): 11-12
Wong, W.W.L.; Tu, H.-A.; Feld, J.J.; Wong, T.; Krahn, M. 2015: Cost-effectiveness of screening for hepatitis C in Canada. Cmaj: Canadian Medical Association Journal 187(3): E110-E121
Coward, S.; Leggett, L.; Kaplan, G.G.; Clement, F. 2016: Cost-effectiveness of screening for hepatitis C virus: a systematic review of economic evaluations. Bmj Open 6(9): E011821
Puggina, A.; Broumas, A.; Ricciardi, W.; Boccia, S. 2016: Cost-effectiveness of screening for lung cancer with low-dose computed tomography: a systematic literature review. European Journal of Public Health 26(1): 168-175
Kearns, B.; Chilcott, J.; Whyte, S.; Preston, L.; Sadler, S. 2016: Cost-effectiveness of screening for ovarian cancer amongst postmenopausal women: a model-based economic evaluation. Bmc Medicine 14(1): 200
Van Giessen, A.; Boonman-de Winter, L.J.M.; Rutten, F.H.; Cramer, M.J.; Landman, M.J.; Liem, A.H.; Hoes, A.W.; Koffijberg, H. 2016: Cost-effectiveness of screening strategies to detect heart failure in patients with type 2 diabetes. Cardiovascular Diabetology 15: 48
Xu, J.; Zhou, F.; Reed, C.; Chaves, S.S.; Messonnier, M.; Kim, I.K. 2016: Cost-effectiveness of seasonal inactivated influenza vaccination among pregnant women. Vaccine 34(27): 3149-3155
Nonvignon, J.; Aryeetey, G.Cecilia.; Issah, S.; Ansah, P.; Malm, K.L.; Ofosu, W.; Tagoe, T.; Agyemang, S.Agyei.; Aikins, M. 2016: Cost-effectiveness of seasonal malaria chemoprevention in upper west region of Ghana. Malaria Journal 15: 367
Brogan, A.J.; Talbird, S.E.; Davis, A.E.; Thommes, E.W.; Meier, G. 2017: Cost-effectiveness of seasonal quadrivalent versus trivalent influenza vaccination in the United States: A dynamic transmission modeling approach. Human Vaccines and Immunotherapeutics 13(3): 533-542
Pennington, B.; Akehurst, R.; Wasan, H.; Sangro, B.; Kennedy, A.S.; Sennfält, K.; Bester, L. 2015: Cost-effectiveness of selective internal radiation therapy using yttrium-90 resin microspheres in treating patients with inoperable colorectal liver metastases in the UK. Journal of Medical Economics 18(10): 797-804
Penaloza-Ramos, M.Cristina.; Jowett, S.; Mant, J.; Schwartz, C.; Bray, E.P.; Sayeed Haque, M.; Richard Hobbs, F.D.; Little, P.; Bryan, S.; Williams, B.; McManus, R.J. 2016: Cost-effectiveness of self-management of blood pressure in hypertensive patients over 70 years with suboptimal control and established cardiovascular disease or additional cardiovascular risk diseases (TASMIN-SR). European Journal of Preventive Cardiology 23(9): 902-912
Dimitropoulos, G.; Leventogiannis, G.; De Bono, J. 2018: Decompensated Heart Failure with Ventricular Arrhythmia: how Useful Is VT Ablation?. Current Heart Failure Reports 15(4): 201-213
Cure, S.; Guerra, I.; Dusheiko, G. 2015: Cost-effectiveness of sofosbuvir for the treatment of chronic hepatitis C-infected patients. Journal of Viral Hepatitis 22(11): 882-889
Cure, S.; Guerra, I.; Cammà, C.; Craxì, A.; Carosi, G. 2015: Cost-effectiveness of sofosbuvir plus ribavirin with or without pegylated interferon for the treatment of chronic hepatitis C in Italy. Journal of Medical Economics 18(9): 678-690
Zhang, S.; Bastian, N.D.; Griffin, P.M. 2015: Cost-effectiveness of sofosbuvir-based treatments for chronic hepatitis C in the US. Bmc Gastroenterology 15: 98
Zhang, P.; Yang, Y.; Wen, F.; He, X.; Tang, R.; Du, Z.; Zhou, J.; Zhang, J.; Li, Q. 2015: Cost-effectiveness of sorafenib as a first-line treatment for advanced hepatocellular carcinoma. European Journal of Gastroenterology and Hepatology 27(7): 853-859
Leung, H.W.C.; Liu, C.-F.; Chan, A.L.F. 2016: Cost-effectiveness of sorafenib versus SBRT for unresectable advanced hepatocellular carcinoma. Radiation Oncology 11: 69
Gao, X.; Reddy, P.; Dhanda, R.; Gondek, K.; Yeh, Y.C.; Stadler, W.M.; Jonasch, E. 2016: Cost-effectiveness of sorafenib versus best supportive care in advanced renal cell carcinoma. Journal of Clinical Oncology 24(18_Suppl): 4604-4604
Leininger, B.; McDonough, C.; Evans, R.; Tosteson, T.; Tosteson, A.N.A.; Bronfort, G. 2016: Cost-effectiveness of spinal manipulative therapy, supervised exercise, and home exercise for older adults with chronic neck pain. Spine Journal: Official Journal of the North American Spine Society 16(11): 1292-1304
Aarnio, E.; Korhonen, M.J.; Huupponen, R.; Martikainen, J. 2015: Cost-effectiveness of statin treatment for primary prevention in conditions of real-world adherence--estimates from the Finnish prescription register. Atherosclerosis 239(1): 240-247
Rich, M.W. 2015: Cost-effectiveness of statins in older adults: further evidence that less is more. Annals of Internal Medicine 162(8): 590-591
Lobotesis, K.; Veltkamp, R.; Carpenter, I.H.; Claxton, L.M.; Saver, J.L.; Hodgson, R. 2016: Cost-effectiveness of stent-retriever thrombectomy in combination with IV t-PA compared with IV t-PA alone for acute ischemic stroke in the UK. Journal of Medical Economics 19(8): 785-794
Smith, B.D.; Jiang, J.; Chang, J.Y.; Welsh, J.; Likhacheva, A.; Buchholz, T.A.; Swisher, S.G.; Shirvani, S.M. 2015: Cost-effectiveness of stereotactic radiation, sublobar resection, and lobectomy for early non-small cell lung cancers in older adults. Journal of Geriatric Oncology 6(4): 324-331
Lester-Coll, N.H.; Dosoretz, A.P.; Magnuson, W.J.; Laurans, M.S.; Chiang, V.L.; Yu, J.B. 2016: Cost-effectiveness of stereotactic radiosurgery versus whole-brain radiation therapy for up to 10 brain metastases. Journal of Neurosurgery 125(Suppl 1): 18-25
Hall, M.D.; McGee, J.L.; McGee, M.C.; Hall, K.A.; Neils, D.M.; Klopfenstein, J.D.; Elwood, P.W. 2014: Cost-effectiveness of stereotactic radiosurgery with and without whole-brain radiotherapy for the treatment of newly diagnosed brain metastases. Journal of Neurosurgery 121 Suppl: 84-90
Edwards, R.T.; Yeo, S.T.; Russell, D.; Thomson, C.E.; Beggs, I.; Gibson, J.N.A.; McMillan, D.; Martin, D.J.; Russell, I.T. 2015: Cost-effectiveness of steroid (methylprednisolone) injections versus anaesthetic alone for the treatment of Morton's neuroma: economic evaluation alongside a randomised controlled trial (MortISE trial). Journal of Foot and Ankle Research 8: 6
Pietzsch, J.B.; Garner, A.; Gaul, C.; May, A. 2015: Cost-effectiveness of stimulation of the sphenopalatine ganglion (SPG) for the treatment of chronic cluster headache: a model-based analysis based on the Pathway CH-1 study. Journal of Headache and Pain 16: 530
Nolan, M.T.; Plana, J.Carlos.; Thavendiranathan, P.; Shaw, L.; Si, L.; Marwick, T.H. 2016: Cost-effectiveness of strain-targeted cardioprotection for prevention of chemotherapy-induced cardiotoxicity. International Journal of Cardiology 212: 336-345
Chapko, M.K.; Dufour, D.R.; Hatia, R.I.; Drobeniuc, J.; Ward, J.W.; Teo, C.-G. 2015: Cost-effectiveness of strategies for testing current hepatitis C virus infection. Hepatology 62(5): 1396-1404
Gidengil, C.A.; Gay, C.; Huang, S.S.; Platt, R.; Yokoe, D.; Lee, G.M. 2015: Cost-effectiveness of strategies to prevent methicillin-resistant Staphylococcus aureus transmission and infection in an intensive care unit. Infection Control and Hospital Epidemiology 36(1): 17-27
Zhao, Y.J.; Khoo, A.L.; Lin, L.; Teng, M.; Koh, C.J.; Lim, S.G.; Lim, B.P.; Dan, Y.Y. 2016: Cost-effectiveness of strategy-based approach to treatment of genotype 1 chronic hepatitis C. Journal of Gastroenterology and Hepatology 31(9): 1628-1637
Van den Houten, M.M.L.; Lauret, G.J.; Fakhry, F.; Fokkenrood, H.J.P.; van Asselt, A.D.I.; Hunink, M.G.M.; Teijink, J.A.W. 2016: Cost-effectiveness of supervised exercise therapy compared with endovascular revascularization for intermittent claudication. British Journal of Surgery 103(12): 1616-1625
Loures, F.B.; Chaoubah, A.; Maciel, V.íc.S.; Paiva, E.P.; Salgado, P.P.; Netto, Ál.C. 2015: Cost-effectiveness of surgical treatment for hip fractures among the elderly in Brazil. Revista Brasileira de Ortopedia 50(1): 38-42
Küster, D.; Nast, A.; Gerdes, S.; Weberschock, T.; Wozel, G.; Gutknecht, M.; Schmitt, J. 2016: Cost-effectiveness of systemic treatments for moderate-to-severe psoriasis in the German health care setting. Archives of Dermatological Research 308(4): 249-261
Warren, E.; Wright, A.; Jones, B. 2014: Cost-effectiveness of telaprevir in patients with genotype 1 hepatitis C in Australia. Value in Health: the Journal of the International Society for Pharmacoeconomics and Outcomes Research 17(8): 792-800
Dixon, P.; Hollinghurst, S.; Edwards, L.; Thomas, C.; Foster, A.; Davies, B.; Gaunt, D.; Montgomery, A.A.; Salisbury, C. 2016: Cost-effectiveness of telehealth for patients with depression: evidence from the Healthlines randomised controlled trial. Bjpsych Open 2(4): 262-269
Dixon, P.; Hollinghurst, S.; Edwards, L.; Thomas, C.; Gaunt, D.; Foster, A.; Large, S.; Montgomery, A.A.; Salisbury, C. 2016: Cost-effectiveness of telehealth for patients with raised cardiovascular disease risk: evidence from the Healthlines randomised controlled trial. Bmj Open 6(8): E012352
Fasterholdt, I.; Gerstrøm, M.; Rasmussen, B.S.B.; Yderstræde, K.B.; Kidholm, K.; Pedersen, K.M.øl. 2018: Cost-effectiveness of telemonitoring of diabetic foot ulcer patients. Health Informatics Journal 24(3): 245-258
Austin, K.; Chambers, G.M.; de Abreu Lourenco, R.; Madan, A.; Susic, D.; Henry, A. 2015: Cost-effectiveness of term induction of labour using inpatient prostaglandin gel versus outpatient Foley catheter. Australian and New Zealand Journal of Obstetrics and Gynaecology 55(5): 440-445
Looman, W.M.; Huijsman, R.; Bouwmans-Frijters, C.A.M.; Stolk, E.A.; Fabbricotti, I.N. 2016: Cost-effectiveness of the 'Walcheren Integrated Care Model' intervention for community-dwelling frail elderly. Family Practice 33(2): 154-160
Bargalló-Rocha, J.E.; Lara-Medina, F.; Pérez-Sánchez, V.; Vázquez-Romo, R.; Villarreal-Garza, C.; Martínez-Said, H.; Shaw-Dulin, R.J.; Mohar-Betancourt, A.; Hunt, B.; Plun-Favreau, J.; Valentine, W.J. 2015: Cost-effectiveness of the 21-gene breast cancer assay in Mexico. Advances in Therapy 32(3): 239-253
Rahilly-Tierney, C.; Walton, S.M. 2015: Cost-effectiveness of the 70-gene signature versus adjuvant! Online and systematic chemotherapy for risk stratification of patients with node-negative breast cancer: does accuracy matter?. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 33(14): 1628-1629
Hall, M.K.; Omer, T.; Moore, C.L.; Taylor, R.A. 2016: Cost-effectiveness of the Cardiac Component of the Focused Assessment of Sonography in Trauma Examination in Blunt Trauma. Academic Emergency Medicine: Official Journal of the Society for Academic Emergency Medicine 23(4): 415-423
Lu, H.; Luo, L.; Chen, L.; Zhang, S.; Liang, Y.; Li, L.; Chen, Z.; Huo, X.; Wu, X. 2015: Cost-effectiveness of the HIV screening program carried out in Guangxi Zhuang Autonomous Region infectious disease special demonstration project areas. Zhonghua Liu Xing Bing Xue Za Zhi 36(6): 580-583
Groessl, E.J.; Kaplan, R.M.; Castro Sweet, C.M.; Church, T.; Espeland, M.A.; Gill, T.M.; Glynn, N.W.; King, A.C.; Kritchevsky, S.; Manini, T.; McDermott, M.M.; Reid, K.F.; Rushing, J.; Pahor, M. 2016: Cost-effectiveness of the LIFE Physical Activity Intervention for Older Adults at Increased Risk for Mobility Disability. Journals of Gerontology. Series a Biological Sciences and Medical Sciences 71(5): 656-662
De Menil, V.; Knapp, M.; McDaid, D.; Raja, S.; Kingori, J.; Waruguru, M.; Wood, S.K.; Mannarath, S.; Lund, C. 2015: Cost-effectiveness of the Mental Health and Development model for schizophrenia-spectrum and bipolar disorders in rural Kenya. Psychological Medicine 45(13): 2747-2756
Coop, C.; Edlin, R.; Brown, J.; Farquhar, C. 2015: Cost-effectiveness of the New Zealand diabetes in pregnancy guideline screening recommendations. Bmj Open 5(6): E006996
van Luijt, P.A.; Heijnsdijk, E.A.M.; de Koning, H.J. 2017: Cost-effectiveness of the Norwegian breast cancer screening program. International Journal of Cancer 140(4): 833-840
Nishijima, D.K.; Yang, Z.; Urbich, M.; Holmes, J.F.; Zwienenberg-Lee, M.; Melnikow, J.; Kuppermann, N. 2015: Cost-effectiveness of the PECARN rules in children with minor head trauma. Annals of Emergency Medicine 65(1): 72-80.E6
Pinto, M.; Steffen, R.E.; Cobelens, F.; van den Hof, S.; Entringer, A.; Trajman, A. 2016: Cost-effectiveness of the Xpert® MTB/RIF assay for tuberculosis diagnosis in Brazil. International Journal of Tuberculosis and Lung Disease: the Official Journal of the International Union Against Tuberculosis and Lung Disease 20(5): 611-618
Tin, S.Sai.; Wiwanitkit, V. 2015: Cost-effectiveness of the baclofen versus chlordiazepoxide in alcohol withdrawal syndrome. Indian Journal of Pharmacology 47(1): 125; Discussion: 125-126
Basu, R.; Ory, M.G.; Towne, S.D.; Smith, M.Lee.; Hochhalter, A.K.; Ahn, S. 2015: Cost-effectiveness of the chronic disease self-management program: implications for community-based organizations. Frontiers in Public Health 3: 27
Fuentes Camps, E.; Luis del Val García, J.é; Bellmunt Montoya, S.; Hmimina Hmimina, S.; Gómez Jabalera, E.; Muñoz Pérez, M.Án. 2016: Cost-effectiveness of the deep vein thrombosis diagnosis process in primary care. Atencion Primaria 48(4): 251-257
Oliver, J.B.; Burnett, A.S.; Ahlawat, S.; Chokshi, R.J. 2015: Cost-effectiveness of the evaluation of a suspicious biliary stricture. Journal of Surgical Research 195(1): 52-60
Tabata, H.; Akita, T.; Matsuura, A.; Kaishima, T.; Matsuoka, T.; Ohisa, M.; Awai, K.; Tanaka, J. 2014: Cost-effectiveness of the introduction of low-dose CT screening in Japanese smokers aged 55 to 74 years old. Hiroshima Journal of Medical Sciences 63(1-3): 13-22
De Kinderen, R.J.A.; Postulart, D.; Aldenkamp, A.P.; Evers, S.M.A.A.; Lambrechts, D.A.J.E.; Louw, A.J.A.d.; Majoie, M.H.J.M.; Grutters, J.P.C. 2015: Cost-effectiveness of the ketogenic diet and vagus nerve stimulation for the treatment of children with intractable epilepsy. Epilepsy Research 110: 119-131
Downing, J.; El Ayadi, A.; Miller, S.; Butrick, E.; Mkumba, G.; Magwali, T.; Kaseba-Sata, C.; Kahn, J.G. 2015: Cost-effectiveness of the non-pneumatic anti-shock garment (NASG): evidence from a cluster randomized controlled trial in Zambia and Zimbabwe. Bmc Health Services Research 15: 37
Johnston, K.M.; McPherson, E.; Osenenko, K.; Vergidis, J.; Levy, A.R.; Peacock, S. 2015: Cost-effectiveness of therapies for melanoma. Expert Review of Pharmacoeconomics and Outcomes Research 15(2): 229-242
Carter, M.J.; Waycaster, C.; Schaum, K.; Gilligan, A.M. 2014: Cost-effectiveness of three adjunct cellular/tissue-derived products used in the management of chronic venous leg ulcers. Value in Health: the Journal of the International Society for Pharmacoeconomics and Outcomes Research 17(8): 801-813
Grau, S.; Pozo, J.C.; Romá, E.; Salavert, M.; Barrueta, J.A.; Peral, C.; Rodriguez, I.; Rubio-Rodríguez, D.; Rubio-Terrés, C. 2015: Cost-effectiveness of three echinocandins and fluconazole in the treatment of candidemia and/or invasive candidiasis in nonneutropenic adult patients. Clinicoeconomics and Outcomes Research: Ceor 7: 527-535
Parker, S.L.; Anderson, L.H.; Nelson, T.; Patel, V.V. 2015: Cost-effectiveness of three treatment strategies for lumbar spinal stenosis: Conservative care, laminectomy, and the Superion interspinous spacer. International Journal of Spine Surgery 9: 28
Han, Y.; Huang, L.; Zhang, W.; Zhang, Y.; Jia, X.; Ni, T.; Sun, H.; Liang, P.; Yu, H.; Guo, Y.; Zhang, A.; Li, J.; Zhang, H. 2015: Cost-effectiveness of three-stage newborns hearing screening in Beijing. Zhonghua Liu Xing Bing Xue Za Zhi 36(5): 455-459
Eklund, O.; Afzal, F.; Borgström, F.; Flavin, J.; Ternouth, A.; Ojanguren, M.E.; Crespo, C.; Baldwin, M. 2016: Cost-effectiveness of tiotropium versus glycopyrronium in moderate to very severe chronic obstructive pulmonary disease in Canada, Spain, Sweden, and the UK. Clinicoeconomics and Outcomes Research: Ceor 8: 243-252
Eklund, O.; Afzal, F.; Borgström, F. 2015: Cost-effectiveness of tiotropium versus usual care and glycopyrronium in the treatment of chronic obstructive pulmonary disease in Sweden. Cost Effectiveness and Resource Allocation: C/E 13: 13
Kowada, A. 2015: Cost-effectiveness of tobacco cessation support combined with tuberculosis screening among contacts who smoke. International Journal of Tuberculosis and Lung Disease: the Official Journal of the International Union Against Tuberculosis and Lung Disease 19(7): 857-863
Tanaka, E.; Inoue, E.; Hoshi, D.; Shimizu, Y.; Kobayashi, A.; Sugimoto, N.; Shidara, K.; Sato, E.; Seto, Y.; Nakajima, A.; Momohara, S.; Taniguchi, A.; Yamanaka, H. 2015: Cost-effectiveness of tocilizumab, a humanized anti-interleukin-6 receptor monoclonal antibody, versus methotrexate in patients with rheumatoid arthritis using real-world data from the IORRA observational cohort study. Modern Rheumatology 25(4): 503-513
Jamookeeah, C.; Robinson, P.; O'Reilly, K.; Lundberg, J.; Gisby, M.; Ländin, M.; Skov, J.; Trueman, D. 2016: Cost-effectiveness of tolvaptan for the treatment of hyponatraemia secondary to syndrome of inappropriate antidiuretic hormone secretion in Sweden. Bmc Endocrine Disorders 16(1): 22
Smith, S.R.; Katz, J.N.; Collins, J.E.; Solomon, D.H.; Jordan, J.M.; Suter, L.G.; Yelin, E.H.; David Paltiel, A.; Losina, E. 2017: Cost-Effectiveness of Tramadol and Oxycodone in the Treatment of Knee Osteoarthritis. Arthritis Care and Research 69(2): 234-242
Fanari, Z.; Weintraub, W.S. 2016: Cost-effectiveness of transcatheter versus surgical management of structural heart disease. Cardiovascular Revascularization Medicine: Including Molecular Interventions 17(1): 44-47
Ong, A.A.; Carroll, W.W.; Nguyen, S.A.; Gillespie, M.B. 2017: Cost-effectiveness of transfacial gland-preserving removal of parotid sialoliths. Laryngoscope 127(5): 1080-1086
Fletcher, J.J.; Kotagal, V.; Mammoser, A.; Peterson, M.; Morgenstern, L.B.; Burke, J.F. 2015: Cost-effectiveness of transfers to centers with neurological intensive care units after intracerebral hemorrhage. Stroke 46(1): 58-64
Jahn, A.F. 2018: Decompensated labyrinthine weakness presenting as de novo peripheral vertigo: a discrete clinical entity?. Journal of Laryngology and Otology 132(2): 117-121
Shrime, M.G. 2014: Cost-effectiveness of transoral robotic surgery in the unknown primary: the problem of extended dominance. Otolaryngology--Head and Neck Surgery: Official Journal of American Academy of Otolaryngology-Head and Neck Surgery 151(6): 1093
De Almeida, J.R.; Moskowitz, A.J.; Miles, B.A.; Goldstein, D.P.; Teng, M.S.; Sikora, A.G.; Gupta, V.; Posner, M.; Genden, E.M. 2016: Cost-effectiveness of transoral robotic surgery versus (chemo)radiotherapy for early T classification oropharyngeal carcinoma: a cost-utility analysis. Head and Neck 38(4): 589-600
Rouprêt, M.; Malavaud, B.; Molinier, L.; Leleu, H.; Blachier, M.; Marteau, F. 2015: Cost-effectiveness of transurethral resection of the bladder with blue light in patients with non muscle invasive bladder cancer in France. Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 25(5): 256-264
Werner, E.F.; Hamel, M.S.; Orzechowski, K.; Berghella, V.; Thung, S.F. 2015: Cost-effectiveness of transvaginal ultrasound cervical length screening in singletons without a prior preterm birth: an update. American Journal of Obstetrics and Gynecology 213(4): 554.E1-6
Garattini, L.; van de Vooren, K.; Curto, A. 2015: Cost-effectiveness of trastuzumab in metastatic breast cancer: mainly a matter of price in the EU?. Health Policy 119(2): 212-216
Scott, N.; Iser, D.M.; Thompson, A.J.; Doyle, J.S.; Hellard, M.E. 2016: Cost-effectiveness of treating chronic hepatitis C virus with direct-acting antivirals in people who inject drugs in Australia. Journal of Gastroenterology and Hepatology 31(4): 872-882
Vottonen, P.; Kankaanpää, E. 2016: Cost-effectiveness of treating wet age-related macular degeneration at the Kuopio University Hospital in Finland based on a two-eye Markov transition model. Acta Ophthalmologica 94(7): 652-656
Megiddo, I.; Chatterjee, S.; Nandi, A.; Laxminarayan, R. 2014: Cost-effectiveness of treatment and secondary prevention of acute myocardial infarction in India: a modeling study. Global Heart 9(4): 391-398.E3
Van Dongen, T.M.A.; Schilder, A.G.M.; Venekamp, R.P.; de Wit, G.A.; van der Heijden, G.J.M.G. 2015: Cost-effectiveness of treatment of acute otorrhea in children with tympanostomy tubes. Pediatrics 135(5): E1182-E1189
Cogle, C.R.; Ortendahl, J.D.; Bentley, T.G.; Anene, A.M.; Megaffin, S.; McKearn, T.J.; Petrone, M.E.; Mukherjee, S. 2016: Cost-effectiveness of treatments for high-risk myelodysplastic syndromes after failure of first-line hypomethylating agent therapy. Expert Review of Pharmacoeconomics and Outcomes Research 16(2): 275-284
Azadi, M.; Bishai, D.M.; Dowdy, D.W.; Moulton, L.H.; Cavalcante, S.; Saraceni, V.; Pacheco, A.G.; Cohn, S.; Chaisson, R.E.; Durovni, B.; Golub, J.E. 2014: Cost-effectiveness of tuberculosis screening and isoniazid treatment in the TB/HIV in Rio (THRio) Study. International Journal of Tuberculosis and Lung Disease: the Official Journal of the International Union Against Tuberculosis and Lung Disease 18(12): 1443-1448
Vlassoff, M.; Diallo, A.; Philbin, J.; Kost, K.; Bankole, A. 2016: Cost-effectiveness of two interventions for the prevention of postpartum hemorrhage in Senegal. International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics 133(3): 307-311
Fernandes, S.; Sicuri, E.; Kayentao, K.; van Eijk, A.Maria.; Hill, J.; Webster, J.; Were, V.; Akazili, J.; Madanitsa, M.; ter Kuile, F.O.; Hanson, K. 2015: Cost-effectiveness of two versus three or more doses of intermittent preventive treatment for malaria during pregnancy in sub-Saharan Africa: a modelling study of meta-analysis and cost data. Lancet. Global Health 3(3): E143-E153
Punekar, Y.S.; Roberts, G.; Ismaila, A.; O'Leary, M. 2015: Cost-effectiveness of umeclidinium/vilanterol combination therapy compared to tiotropium monotherapy among symptomatic patients with chronic obstructive pulmonary disease in the UK. Cost Effectiveness and Resource Allocation: C/E 13: 22
Bishai, D.; Sachathep, K.; LeFevre, A.; Thant, H.N.N.; Zaw, M.; Aung, T.; McFarland, W.; Montagu, D. 2015: Cost-effectiveness of using a social franchise network to increase uptake of oral rehydration salts and zinc for childhood diarrhea in rural Myanmar. Cost Effectiveness and Resource Allocation: C/E 13: 3
Ovcinnikova, O.; Panca, M.; Guest, J.F. 2015: Cost-effectiveness of using an extensively hydrolyzed casein formula plus the probiotic Lactobacillus rhamnosus GG compared to an extensively hydrolyzed formula alone or an amino acid formula as first-line dietary management for cow's milk allergy in the US. Clinicoeconomics and Outcomes Research: Ceor 7: 145-152
Schnippel, K.; Michelow, P.; Chibwesha, C.J.; Makura, C.; Lince-Deroche, N.; Goeieman, B.; Mulongo, M.; Jordaan, S.; Firnhaber, C. 2015: Cost-effectiveness of using the Cervex-Brush (broom) compared to the elongated spatula for collection of conventional cervical cytology samples within a high-burden HIV setting: a model-based analysis. Bmc Health Services Research 15: 499
Chiles, K.A.; Schlegel, P.N. 2016: Cost-effectiveness of varicocele surgery in the era of assisted reproductive technology. Asian Journal of Andrology 18(2): 259-261
Patil, R.; Kolu, P.; Raitanen, J.; Valvanne, J.; Kannus, P.; Karinkanta, S.; Sievänen, H.; Uusi-Rasi, K. 2016: Cost-effectiveness of vitamin D supplementation and exercise in preventing injurious falls among older home-dwelling women: findings from an RCT. Osteoporosis International: a Journal Established as Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the Usa 27(1): 193-201
Karantana, A.; Scammell, B.E.; Davis, T.R.C.; Whynes, D.K. 2015: Cost-effectiveness of volar locking plate versus percutaneous fixation for distal radial fractures: Economic evaluation alongside a randomised clinical trial. Bone and Joint Journal 97-B(9): 1264-1270
Choi, S.-E.; Brignone, M.él.; Cho, S.J.; Jeon, H.J.; Jung, R.; Campbell, R.; Francois, C.ém.; Milea, D. 2016: Cost-effectiveness of vortioxetine versus venlafaxine (extended release) in the treatment of major depressive disorder in South Korea. Expert Review of Pharmacoeconomics and Outcomes Research 16(5): 629-638
Rodríguez, S.; Balbinotto Neto, G.ác.; Kiss, G.; Brandão, A. 2016: Cost-effectiveness of whole-body bone scans in the pre-liver transplant assessment of patients with hepatocellular carcinoma in Southern Brazil. Clinical Transplantation 30(4): 399-406
Patterson, P.Daniel.; Smith, K.J.; Hostler, D. 2016: Cost-effectiveness of workplace wellness to prevent cardiovascular events among U.S. firefighters. Bmc Cardiovascular Disorders 16(1): 229
Carter, J.A.; Snedecor, S.J.; Kaura, S.; Botteman, M. 2016: Cost-effectiveness of zoledronic acid (ZOL) versus denosumab (Dmab) in prevention of skeletal-related events (SREs) in metastatic breast cancer (mBC). Journal of Clinical Oncology 29(27_Suppl): 294-294
Andronis, L.; Goranitis, I.; Pirrie, S.; Pope, A.; Barton, D.; Collins, S.; Daunton, A.; McLaren, D.; O'Sullivan, J.M.; Parker, C.; Porfiri, E.; Staffurth, J.; Stanley, A.; Wylie, J.; Beesley, S.; Birtle, A.; Brown, J.E.; Chakraborti, P.; Hussain, S.A.; Russell, J.M.; Billingham, L.J.; James, N.D. 2017: Cost-effectiveness of zoledronic acid and strontium-89 as bone protecting treatments in addition to chemotherapy in patients with metastatic castrate-refractory prostate cancer: results from the TRAPEZE trial (ISRCTN 12808747). Bju International 119(4): 522-529
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2016: Cost-effectiveness of zoledronic acid vs. pamidronate in the management of hormone refractory prostate cancer (HRPC) patients with bone metastases. Journal of Clinical Oncology 24(18_Suppl): 14660-14660
Hassan, C.; Gralnek, I.M. 2015: Cost-effectiveness of "full spectrum endoscopy" colonoscopy for colorectal cancer screening. Digestive and Liver Disease: Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 47(5): 390-394
Hillner, B.E.; Schrag, D.; Sargent, D.J.; Fuchs, C.S.; Goldberg, R.M. 2016: Cost-effectiveness projections of FOLFOX vs. IFL in first-line therapy of metastatic colorectal cancer in the context of the U.S. health care system. Journal of Clinical Oncology 23(16_Suppl): 3531-3531
Achterberg, W.P.; Gussekloo, J.; van den Hout, W.B. 2015: Cost-effectiveness research in elderly residents in long-term care: prevention is better than cure, but not always cheaper. Nederlands tijdschrift voor geneeskunde 159: A8903
Zygourakis, C.C.; Kahn, J.G. 2015: Cost-effectiveness research in neurosurgery. Neurosurgery Clinics of North America 26(2): 189-196 Viii
Wong, C.K.H.; Lam, C.L.K.; Wan, Y.F.; Fong, D.Y.T. 2015: Cost-effectiveness simulation and analysis of colorectal cancer screening in Hong Kong Chinese population: comparison amongst colonoscopy, guaiac and immunologic fecal occult blood testing. Bmc Cancer 15: 705
Tang, M.B.Y.; Leong, K.F.; Ou, L.-S.; Munasir, Z.; Parekh, P.R.; Azmi, S.; Low, W.H.H.; Goh, A. 2015: Cost-effectiveness study of pediatric atopic dermatitis in Asia: atopiclair vs. regular emollient (AD-ATOP). Journal of Drugs in Dermatology: Jdd 14(2): 169-175
Herráez, Ós.; Asencio-Egea, M.ía.Án.; Huertas-Vaquero, M.ía.; Carranza-González, R.; Castellanos-Monedero, J.ús.; Franco-Huerta, M.ía.; Barberá-Farré, J.é R.ón.; Tenías-Burillo, J.é M.ía. 2017: Cost-effectiveness study of the microbiological diagnosis of tuberculosis using gene Xpert MTB/RIF®. Enfermedades Infecciosas y Microbiologia Clinica 35(7): 403-410
Chen, S.Y.; Wang, J.Y.; Jie-Chen; Zhang, X.D.; Zhang, S.S. 1997: Cost-effectiveness study on treatment of duodenal ulcer. World Journal of Gastroenterology 3(3): 194
Culyer, A.J. 2016: Cost-effectiveness thresholds in health care: a bookshelf guide to their meaning and use. Health Economics Policy and Law 11(4): 415-432
Dubois, R.W. 2016: Cost-effectiveness thresholds in the USA: are they coming? Are they already here?. Journal of Comparative Effectiveness Research 5(1): 9-11
Wu, X.; He, M.; Zhou, Y.; Xiao, J.; Luo, J. 2017: Decomposing a Chunk into its Elements and Reorganizing them as a new Chunk: the two Different Sub-processes Underlying Insightful Chunk Decomposition. Frontiers in Psychology 8: 2001
Daróczi, T.ím.; Bor, R.át.; Fábián, A.; Szabó, E.; Farkas, K.; Bálint, A.; Czakó, L.ás.ó; Rutka, M.; Szűcs, M.ón.; Milassin, Ág.; Molnár, T.ás.; Szepes, Z.án. 2016: Cost-effectiveness trial of self-expandable metal stents and plastic biliary stents in malignant biliary obstruction. Orvosi Hetilap 157(7): 268-274
Goldman, A.S.; Chen, X.; Fan, M.; Frencken, J.E. 2016: Cost-effectiveness, in a randomized trial, of glass-ionomer-based and resin sealant materials after 4 yr. European Journal of Oral Sciences 124(5): 472-479
Zhang, B.; Hunziker, P. 2016: Cost-effectiveness: a challenge for dengue rapid nanodiagnostic tests. Nanomedicine: Nanotechnology Biology and Medicine 12(1): 251-252
Jighly, A.; Joukhadar, R.; Singh, S.; Ogbonnaya, F.C. 2018: Decomposing Additive Genetic Variance Revealed Novel Insights into Trait Evolution in Synthetic Hexaploid Wheat. Frontiers in Genetics 9: 27
Celen, S.; Yildiz, Y.; Kahyaoglu, S.; Kaymak, O.; Ozel, M.; Timur, H.; Danisman, N. 2012: Cost-effectivity analysis of one-step versus two-step screening for gestational diabetes. Eurasian Journal of Medicine 44(2): 84-87
Yang, T.-S.; Chi, C.-C.; Wang, S.-H.; Lin, J.-C.; Lin, K.-M. 2016: Cost-efficacy of biologic therapies for psoriatic arthritis from the perspective of the Taiwanese healthcare system. International Journal of Rheumatic Diseases 19(10): 1002-1009
Lens, S.; Bonacci, M.ín. 2015: Cost-efficacy of new antiviral treatments for chronic hepatitis C. Atencion Primaria 47(8): 479-481
Turner-Stokes, L.; Bavikatte, G.; Williams, H.; Bill, A.; Sephton, K. 2016: Cost-efficiency of specialist hyperacute in-patient rehabilitation services for medically unstable patients with complex rehabilitation needs: a prospective cohort analysis. Bmj Open 6(9): E012112
Turner-Stokes, L.; Williams, H.; Bill, A.; Bassett, P.; Sephton, K. 2016: Cost-efficiency of specialist inpatient rehabilitation for working-aged adults with complex neurological disabilities: a multicentre cohort analysis of a national clinical data set. Bmj Open 6(2): E010238
Gans, D.N. 2015: Cost-efficiency with medical group staffing. Mgma Connexion 15(8): 24-25
Yang, S.; Wang, J.; Li, S.; Deng, B.; Wei, X.; Yu, H.; Li, H. 2015: Cost-efficient FPGA implementation of basal ganglia and their Parkinsonian analysis. Neural Networks: the Official Journal of the International Neural Network Society 71: 62-75
Kandukuri, J.; Liu, Y.; Yuan, B. 2014: Cost-efficient and multi-functional systems for ultrasound measurement and imaging. Austin Journal of Biomedical Engineering 1(1)
Javed, M.R.; Buthe, A.; Rashid, M.H.; Wang, P. 2016: Cost-efficient entrapment of β-glucosidase in nanoscale latex and silicone polymeric thin films for use as stable biocatalysts. Food Chemistry 190: 1078-1085
Henriques, C.és.A.; Pinto, S.M.A.; Pina, J.ão.; Serpa, C.; Fernandes, A.; Rossi, L.M.; Ribeiro, M.F.; Pereira, M.M.; Calvete, M.ár.J.F. 2016: Cost-efficient method for unsymmetrical meso-aryl porphyrins and iron oxide-porphyrin hybrids prepared thereof. Dalton Transactions 45(41): 16211-16220
Ozaki, Y.; Suzuki, S.; Kashiwase, K.; Shigenari, A.; Okudaira, Y.; Ito, S.; Masuya, A.; Azuma, F.; Yabe, T.; Morishima, S.; Mitsunaga, S.; Satake, M.; Ota, M.; Morishima, Y.; Kulski, J.K.; Saito, K.; Inoko, H.; Shiina, T. 2015: Cost-efficient multiplex PCR for routine genotyping of up to nine classical HLA loci in a single analytical run of multiple samples by next generation sequencing. Bmc Genomics 16: 318
Anyiam, F.; Lechenne, M.; Mindekem, R.; Oussigéré, A.; Naissengar, S.; Alfaroukh, I.O.; Mbilo, C.; Moto, D.D.; Coleman, P.G.; Probst-Hensch, N.; Zinsstag, J. 2017: Cost-estimate and proposal for a development impact bond for canine rabies elimination by mass vaccination in Chad. Acta Tropica 175: 112-120
Furlan, J.C.; Barth, D.; Barnett, C.; Bril, V. 2016: Cost-minimization analysis comparing intravenous immunoglobulin with plasma exchange in the management of patients with myasthenia gravis. Muscle and Nerve 53(6): 872-876
Sanclemente-Ansó, C.; Bosch, X.; Salazar, A.; Moreno, R.ón.; Capdevila, C.; Rosón, B.; Corbella, X. 2016: Cost-minimization analysis favors outpatient quick diagnosis unit over hospitalization for the diagnosis of potentially serious diseases. European Journal of Internal Medicine 30: 11-17
Calvet, X.; Gené, E.; ÀngelRuíz, M.; Figuerola, A.; Villoria, A.; Cucala, M.; Mearin, F.ín.; Delgado, S.; Calleja, J.L. 2016: Cost-minimization analysis favours intravenous ferric carboxymaltose over ferric sucrose or oral iron as preoperative treatment in patients with colon cancer and iron deficiency anaemia. Technology and Health Care: Official Journal of the European Society for Engineering and Medicine 24(1): 111-120
Tapias, G.; García-Romero, M.; Crespo, C.; Cuesta, M.; Forné, C.; Pascual-Pascual, S.Ignacio. 2016: Cost-minimization analysis in the treatment of spasticity in children with cerebral palsy with botulinum toxin type A: an observational, longitudinal, retrospective study. Farmacia Hospitalaria: Organo Oficial de Expresion Cientifica de la Sociedad Espanola de Farmacia Hospitalaria 40(5): 412-426
Takata, K.; Fujita, K.-I.; Kubota, Y.; Ishida, H.; Ichikawa, W.; Shimada, K.; Sekikawa, T.; Taki-Takemoto, I.; Kamei, D.; Iwai, S.; Sasaki, Y. 2016: Cost-minimization analysis of adjuvant chemotherapy regimens given to patients with colorectal cancer in Japan. Journal of Pharmaceutical Health Care and Sciences 2: 30
Joosub, I.; Gray, A.; Crisostomo, A.; Salam, A. 2015: Cost-minimization analysis of imipenem/cilastatin versus meropenem in moderate to severe infections at a tertiary care hospital in Saudi Arabia. Saudi Pharmaceutical Journal: Spj: the Official Publication of the Saudi Pharmaceutical Society 23(6): 626-634
Graham, C.N.; Hechmati, G.; Fakih, M.G.; Knox, H.N.; Maglinte, G.A.; Hjelmgren, J.; Barber, B.; Schwartzberg, L.S. 2015: Cost-minimization analysis of panitumumab compared with cetuximab for first-line treatment of patients with wild-type RAS metastatic colorectal cancer. Journal of Medical Economics 18(8): 619-628
Rønborg, S.; Johnsen, C.R.; Theilgaard, S.; Winther, A.; Hahn-Pedersen, J.; Andreasen, J.N.ør.; Olsen, J. 2016: Cost-minimization analysis of sublingual immunotherapy versus subcutaneous immunotherapy for house dust mite respiratory allergic disease in Denmark. Journal of Medical Economics 19(8): 735-741
Vicente, A.B.; Decimoni, T.C.; Quero, A.A. 2015: Cost-minimization analysis of the carboxymaltose ferric (i.v.) Compared with sacarato ferric (i.v.) in the treatment of anemia under suplementary health care perspective. Value in Health 18(7): A843
Moschetti, K.; Petersen, S.E.; Pilz, G.; Kwong, R.Y.; Wasserfallen, J.-B.; Lombardi, M.; Korosoglou, G.; Van Rossum, A.C.; Bruder, O.; Mahrholdt, H.; Schwitter, J. 2016: Cost-minimization analysis of three decision strategies for cardiac revascularization: results of the "suspected CAD" cohort of the european cardiovascular magnetic resonance registry. Journal of Cardiovascular Magnetic Resonance: Official Journal of the Society for Cardiovascular Magnetic Resonance 18: 3
Dik, J.-W.H.; Hendrix, R.; Friedrich, A.W.; Luttjeboer, J.; Panday, P.N.; Wilting, K.R.; Lo-Ten-Foe, J.R.; Postma, M.J.; Sinha, B. 2015: Cost-minimization model of a multidisciplinary antibiotic stewardship team based on a successful implementation on a urology ward of an academic hospital. Plos one 10(5): E0126106
Onukwugha, E.; McRae, J.; Kravetz, A.; Varga, S.; Khairnar, R.; Mullins, C.Daniel. 2016: Cost-of-Illness Studies: An Updated Review of Current Methods. Pharmacoeconomics 34(1): 43-58
Kruntoradova, I. 2014: Cost-of-Illness Study of Senile Cataract in the Czech Republic. Value in Health: the Journal of the International Society for Pharmacoeconomics and Outcomes Research 17(7): A607
Mlčoch, Táš.; Klimeš, Jří.; Fila, L.; Vávrová, Věra.; Skalická, V.; Turnovec, M.; Krulišová, V.; Jirčíková, J.; Zemková, D.; Dědečková, Kára.Vilimovská.; Bílková, A.; Frühaufová, Víra.; Homola, Láš.; Friedmannová, Z.; Drnek, R.; Dřevínek, P.; Doležal, Táš.; Macek, M. 2017: Cost-of-illness analysis and regression modeling in cystic fibrosis: a retrospective prevalence-based study. European Journal of Health Economics: Hepac: Health Economics in Prevention and Care 18(1): 73-82
Abdullah, M.M.H.; Gyles, C.L.; Marinangeli, C.P.F.; Carlberg, J.G.; Jones, P.J.H. 2015: Cost-of-illness analysis reveals potential healthcare savings with reductions in type 2 diabetes and cardiovascular disease following recommended intakes of dietary fiber in Canada. Frontiers in Pharmacology 6: 167
Mangen, M.-J.ée.J.; Bouwknegt, M.; Friesema, I.H.M.; Haagsma, J.A.; Kortbeek, L.M.; Tariq, L.; Wilson, M.; van Pelt, W.; Havelaar, A.H. 2015: Cost-of-illness and disease burden of food-related pathogens in the Netherlands, 2011. International Journal of Food Microbiology 196: 84-93
Mahan, C.E.; Barco, S.; Spyropoulos, A.C. 2016: Cost-of-illness model for venous thromboembolism. Thrombosis Research 145: 130-132
Grosse, S.D. 2016: Cost-of-illness models for venous thromboembolism: one size does not fit all. Thrombosis Research 145: 65-66
Stollenwerk, B.ör.; Welchowski, T.; Vogl, M.; Stock, S. 2016: Cost-of-illness studies based on massive data: a prevalence-based, top-down regression approach. European Journal of Health Economics: Hepac: Health Economics in Prevention and Care 17(3): 235-244
Jin, H.; McCrone, P. 2015: Cost-of-illness studies for bipolar disorder: systematic review of international studies. Pharmacoeconomics 33(4): 341-353
Jo, C. 2014: Cost-of-illness studies: concepts, scopes, and methods. Clinical and Molecular Hepatology 20(4): 327-337
Musa, B.M.; John, D.; Habib, A.G.; Kuznik, A. 2016: Cost-optimization in the treatment of multidrug resistant tuberculosis in Nigeria. Tropical Medicine and International Health: Tm and Ih 21(2): 176-182
Zafar, S.Y.; Ubel, P.A.; Tulsky, J.A.; Pollak, K.I. 2015: Cost-related health literacy: a key component of high-quality cancer care. Journal of Oncology Practice 11(3): 171-173
Ahmad, S.; Huang, H.; Yu, A.J. 2014: Cost-sensitive Bayesian control policy in human active sensing. Frontiers in Human Neuroscience 8: 955
Hoffman, G. 2015: Cost-sharing, physician utilization, and adverse selection among Medicare beneficiaries with chronic health conditions. Medical care research and review: MCRR 72(1): 49-70
Larsen, M.H.; Wahl, A.K.; Krogstad, A-Lene.; Aas, E. 2016: Cost-utility Analysis of Supported Self-management with Motiva-tional Interviewing for Patients with Psoriasis. Acta Dermato-Venereologica 96(5): 664-668
Zhong, Y.; Lin, P.-J.; Cohen, J.T.; Winn, A.N.; Neumann, P.J. 2015: Cost-utility analyses in diabetes: a systematic review and implications from real-world evidence. Value in Health: the Journal of the International Society for Pharmacoeconomics and Outcomes Research 18(2): 308-314
Brettschneider, C.; Djadran, H.; Härter, M.; Löwe, B.; Riedel-Heller, S.; König, H.-H. 2015: Cost-utility analyses of cognitive-behavioural therapy of depression: a systematic review. PsychoTherapy and Psychosomatics 84(1): 6-21
Nerich, V.; Saing, S.; Gamper, E.M.; Kemmler, G.; Daval, F.; Pivot, X.; Holzner, B. 2016: Cost-utility analyses of drug therapies in breast cancer: a systematic review. Breast Cancer Research and Treatment 159(3): 407-424
Donovan, P.J.; McLeod, D.S.A.; Little, R.; Gordon, L. 2016: Cost-utility analysis comparing radioactive iodine, anti-thyroid drugs and total thyroidectomy for primary treatment of Graves' disease. European Journal of Endocrinology 175(6): 595-603
Warren, D.; Andres, T.; Hoelscher, C.; Ricart-Hoffiz, P.; Bendo, J.; Goldstein, J. 2013: Cost-utility analysis modeling at 2-year follow-up for cervical disc arthroplasty versus anterior cervical discectomy and fusion: a single-center contribution to the randomized controlled trial. International Journal of Spine Surgery 7: E58-E66
Stawowczyk, E.; Kawalec, P.ł; Pilc, A. 2016: Cost-utility analysis of 1-year treatment with adalimumab/standard care and standard care alone for ulcerative colitis in Poland. European Journal of Clinical Pharmacology 72(11): 1319-1325
Kelly, V.; Sagili, K.D.; Satyanarayana, S.; Reza, L.W.; Chadha, S.S.; Wilson, N.C. 2015: Cost-utility analysis of LED fluorescence microscopy in the diagnosis of pulmonary tuberculosis in Indian settings. International Journal of Tuberculosis and Lung Disease: the Official Journal of the International Union Against Tuberculosis and Lung Disease 19(6): 696-701
Alfonso-Rosa, R.M.; Del Pozo-Cruz, J.; Del Pozo-Cruz, B.; Sañudo, B.; Abellán-Perpiñán, J.M. 2015: Cost-utility analysis of a 12-week whole-body vibration based treatment for people with type 2 diabetes: reanalysis of a RCT in a primary care context. Public Health 129(7): 993-995
Jódar-Sánchez, F.; Malet-Larrea, A.; Martín, Jé.J.; García-Mochón, L.; López Del Amo, M.Puerto.; Martínez-Martínez, F.; Gastelurrutia-Garralda, M.A.; García-Cárdenas, V.; Sabater-Hernández, D.; Sáez-Benito, L.; Benrimoj, S.I. 2015: Cost-utility analysis of a medication review with follow-up service for older adults with polypharmacy in community pharmacies in Spain: the conSIGUE program. Pharmacoeconomics 33(6): 599-610
Ginsberg, G.M.; Block, C.; Stein-Zamir, C. 2016: Cost-utility analysis of a nationwide vaccination programme against serogroup B meningococcal disease in Israel. International Journal of Public Health 61(6): 683-692
Brettschneider, C.; Luck, T.; Fleischer, S.; Roling, G.; Beutner, K.; Luppa, M.; Behrens, J.; Riedel-Heller, S.G.; König, H-Helmut. 2015: Cost-utility analysis of a preventive home visit program for older adults in Germany. Bmc Health Services Research 15: 141
Naing, C.; Poovorawan, Y.; Mak, J.W.; Aung, K.; Kamolratankul, P. 2015: Cost-utility analysis of an adjunctive recombinant activated factor VIIa for on-demand treatment of bleeding episodes in dengue haemorrhagic fever. Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 26(4): 403-407
Kaitani, T.; Nakagami, G.; Iizaka, S.; Fukuda, T.; Oe, M.; Igarashi, A.; Mori, T.; Takemura, Y.; Mizokami, Y.; Sugama, J.; Sanada, H. 2015: Cost-utility analysis of an advanced pressure ulcer management protocol followed by trained wound, ostomy, and continence nurses. Wound Repair and Regeneration: Official Publication of the Wound Healing Society and the European Tissue Repair Society 23(6): 915-921
Lanzeta, I.; Mar, J.; Arrospide, A. 2016: Cost-utility analysis of an integrated care model for multimorbid patients based on a clinical trial. Gaceta Sanitaria 30(5): 352-358
Mansel, R.E. 2016: Cost-utility analysis of anastrozole vs tamoxifen in postmenopausal women with early breast cancer from a UK national health service perspective: The 5-year completed treatment analysis of the ATAC ('Arimidex', Tamoxifen Alone or in Combination) trial. Journal of Clinical Oncology 23(16_Suppl): 653-653
Scalone, L.; Cortesi, P.A. 2015: Cost-utility analysis of biologic therapies to treat chronic plaque psoriasis in Italy: the importance of using updated and adequate social tariffs to calculate quality-adjusted life-years. Biodrugs: Clinical Immunotherapeutics Biopharmaceuticals and Gene Therapy 29(1): 69
Kazerooni, R.; Broadhead, C. 2015: Cost-utility analysis of botulinum toxin type a products for the treatment of cervical dystonia. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 72(4): 301-307
Sandberg, M.; Jakobsson, U.; Midlöv, P.; Kristensson, J. 2015: Cost-utility analysis of case management for frail older people: effects of a randomised controlled trial. Health Economics Review 5(1): 51
Hidalgo-Vega, Ál.; Villoro, R.; Blasco, J.A.; Talavera, P.; Ferro, B.én.; Purcaru, O. 2015: Cost-utility analysis of certolizumab pegol versus alternative tumour necrosis factor inhibitors available for the treatment of moderate-to-severe active rheumatoid arthritis in Spain. Cost Effectiveness and Resource Allocation: C/E 13: 11
Fallah, A.; Weil, A.G.; Wang, S.; Lewis, E.; Baca, C.B.; Mathern, G.W. 2016: Cost-utility analysis of competing treatment strategies for drug-resistant epilepsy in children with Tuberous Sclerosis Complex. Epilepsy and Behavior: E&b 63: 79-88
McIntosh, E.; Gray, A.; Daniels, J.; Gill, S.; Ives, N.; Jenkinson, C.; Mitchell, R.; Pall, H.; Patel, S.; Quinn, N.; Rick, C.; Wheatley, K.; Williams, A. 2016: Cost-utility analysis of deep brain stimulation surgery plus best medical therapy versus best medical therapy in patients with Parkinson's: Economic evaluation alongside the PD SURG trial. Movement Disorders: Official Journal of the Movement Disorder Society 31(8): 1173-1182
Orellano, P.W.; Reynoso, J.I.; Stahl, H.-C.; Salomon, O.D. 2016: Cost-utility analysis of dengue vaccination in a country with heterogeneous risk of dengue transmission. Vaccine 34(5): 616-621
Siribumrungwong, B.; Noorit, P.; Wilasrusmee, C.; Leelahavarong, P.; Thakkinstian, A.; Teerawattananon, Y. 2016: Cost-utility analysis of great saphenous vein ablation with radiofrequency, foam and surgery in the emerging health-care setting of Thailand. Phlebology 31(8): 573-581
Bamrungsawad, N.; Chaiyakunapruk, N.; Upakdee, N.; Pratoomsoot, C.; Sruamsiri, R.; Dilokthornsakul, P. 2015: Cost-utility analysis of intravenous immunoglobulin for the treatment of steroid-refractory dermatomyositis in Thailand. Pharmacoeconomics 33(5): 521-531
Le, Q.A.; Hay, J. 2016: Cost-utility analysis of lapatinib in treatment of HER2-positive advanced breast cancer. Journal of Clinical Oncology 26(15_Suppl): 6553-6553
Igarashi, A.; Tang, W.; Guerra, I.; Marié, L.; Cure, S.; Lopresti, M. 2017: Cost-utility analysis of ledipasvir/sofosbuvir for the treatment of genotype 1 chronic hepatitis C in Japan. Current Medical Research and Opinion 33(1): 11-21
Berrigan, P.; Bardouille, T.; MacLellan, M.; Mohamed, I.S.; Murthy, M. 2016: Cost-utility analysis of magnetoencephalography used to inform intracranial electrode placement in patients with drug resistant epilepsy: a model based analysis. Journal of Evaluation in Clinical Practice 22(6): 938-945
Borget, I.; Pérol, M.; Pérol, D.; Lavolé, A.; Greillier, L.; Dô, P.; Westeel, V.; Crequit, J.; Léna, H.é; Monnet, I.; Le Caer, H.é; Fournel, P.; Falchero, L.; Poudenx, M.; Vaylet, F.; Chabaud, S.; Vergnenegre, A.; Zalcman, G.ér.; Chouaïd, C. 2014: Cost-utility analysis of maintenance therapy with gemcitabine or erlotinib vs observation with predefined second-line treatment after cisplatin-gemcitabine induction chemotherapy for advanced NSCLC: IFCT-GFPC 0502-Eco phase IIi study. Bmc Cancer 14: 953
Saint-Laurent Thibault, C.; Özer Stillman, I.; Chen, S.; Getsios, D.; Proskorovsky, I.; Hernandez, L.; Dixit, S. 2015: Cost-utility analysis of memantine extended release added to cholinesterase inhibitors compared to cholinesterase inhibitor monotherapy for the treatment of moderate-to-severe dementia of the Alzheimer's type in the US. Journal of Medical Economics 18(11): 930-943
Maia, C.R.; Stella, S.F.; Wagner, F.; Pianca, T.G.; Krieger, F.V.; Cruz, L.N.; Polanczyk, G.V.; Rohde, L.ís.A.; Polanczyk, C.ís.A. 2016: Cost-utility analysis of methylphenidate treatment for children and adolescents with ADHD in Brazil. Revista Brasileira de Psiquiatria 38(1): 30-38
Carrato, A.; García, P.; López, R.; Macarulla, T.; Rivera, F.; Sastre, J.; Gostkorzewicz, J.; Benedit, P.; Pérez-Alcántara, F. 2015: Cost-utility analysis of nanoparticle albumin-bound paclitaxel (nab-paclitaxel) in combination with gemcitabine in metastatic pancreatic cancer in Spain: results of the PANCOSTABRAX study. Expert Review of Pharmacoeconomics and Outcomes Research 15(4): 579-589
Tuffaha, H.W.; Gillespie, B.M.; Chaboyer, W.; Gordon, L.G.; Scuffham, P.A. 2015: Cost-utility analysis of negative pressure wound therapy in high-risk cesarean section wounds. Journal of Surgical Research 195(2): 612-622
Zhang, E.; Wartelle-Bladou, C.; Lepanto, L.; Lachaine, J.; Cloutier, G.; Tang, A. 2015: Cost-utility analysis of nonalcoholic steatohepatitis screening. European Radiology 25(11): 3282-3294
Rodriguez-Martinez, C.E.; Sossa-Briceño, M.P.; Castro-Rodriguez, J.A. 2016: Cost-utility analysis of once-daily versus twice-daily inhaled corticosteroid dosing for maintenance treatment of asthma in pediatric patients. Journal of Asthma: Official Journal of the Association for the Care of Asthma 53(5): 538-545
Roberts, K.J.; Sutton, A.J.; Prasad, K.R.; Toogood, G.J.; Lodge, J.P.A. 2015: Cost-utility analysis of operative versus non-operative treatment for colorectal liver metastases. British Journal of Surgery 102(4): 388-398
Borisenko, O.; Haude, M.; Hoppe, U.C.; Siminiak, T.; Lipiecki, J.; Goldberg, S.L.; Mehta, N.; Bouknight, O.V.; Bjessmo, S.; Reuter, D.G. 2015: Cost-utility analysis of percutaneous mitral valve repair in inoperable patients with functional mitral regurgitation in German settings. Bmc Cardiovascular Disorders 15: 43
Kulchaitanaroaj, P.; Brooks, J.M.; Chaiyakunapruk, N.; Goedken, A.M.; Chrischilles, E.A.; Carter, B.L. 2017: Cost-utility analysis of physician-pharmacist collaborative intervention for treating hypertension compared with usual care. Journal of Hypertension 35(1): 178-187
Rampersaud, Y.Raja.; Gray, R.; Lewis, S.J.; Massicotte, E.M.; Fehlings, M.G. 2011: Cost-utility analysis of posterior minimally invasive fusion compared with conventional open fusion for lumbar spondylolisthesis. Sas Journal 5(2): 29-35
Kawasaki, R.; Akune, Y.; Hiratsuka, Y.; Fukuhara, S.; Yamada, M. 2015: Cost-utility analysis of screening for diabetic retinopathy in Japan: a probabilistic Markov modeling study. Ophthalmic Epidemiology 22(1): 4-12
Igarashi, A.; Tang, W.; Cure, S.; Guerra, I.; Marié, L.; Lopresti, M.; Tsutani, K. 2017: Cost-utility analysis of sofosbuvir for the treatment of genotype 2 chronic hepatitis C in Japan. Current Medical Research and Opinion 33(1): 1-10
Morris, S.; Patel, N.V.; Dobson, J.; Featherstone, R.L.; Richards, T.; Luengo-Fernandez, R.; Rothwell, P.M.; Brown, M.M. 2016: Cost-utility analysis of stenting versus endarterectomy in the International Carotid Stenting Study. International Journal of Stroke: Official Journal of the International Stroke Society 11(4): 446-453
Jenks, M.; Taylor, M.; Shore, J. 2017: Cost-utility analysis of the insufflation of warmed humidified carbon dioxide during open and laparoscopic colorectal surgery. Expert Review of Pharmacoeconomics and Outcomes Research 17(1): 99-107
Fischer, J.P.; Basta, M.N.; Wink, J.D.; Krishnan, N.M.; Kovach, S.J. 2015: Cost-utility analysis of the use of prophylactic mesh augmentation compared with primary fascial suture repair in patients at high risk for incisional hernia. Surgery 158(3): 700-711
Athanasakis, K.; Tarantilis, F.; Tsalapati, K.; Konstantopoulou, T.; Vritzali, E.; Kyriopoulos, J. 2015: Cost-utility analysis of tocilizumab monotherapy in first line versus standard of care for the treatment of rheumatoid arthritis in Greece. Rheumatology International 35(9): 1489-1495
Ginsberg, G.M.; Kark, J.D.; Einav, S. 2015: Cost-utility analysis of treating out of hospital cardiac arrests in Jerusalem. Resuscitation 86: 54-61
Soini, E.; Hallinen, T.; Brignone, Mélanie.; Campbell, R.; Diamand, Fçoise.; Cure, S.; Aalto-Setälä, M.; Danchenko, N.; Koponen, H.; Kolasa, K. 2017: Cost-utility analysis of vortioxetine versus agomelatine, bupropion SR, sertraline and venlafaxine XR after treatment switch in major depressive disorder in Finland. Expert Review of Pharmacoeconomics and Outcomes Research 17(3): 293-302
Feliu-Soler, A.; Borràs, X.; Peñarrubia-María, Mía.T.; Rozadilla-Sacanell, A.; D'Amico, F.; Moss-Morris, R.; Howard, M.A.; Fayed, Nás.; Soriano-Mas, C.; Puebla-Guedea, M.; Serrano-Blanco, A.; Pérez-Aranda, Aán.; Tuccillo, R.; Luciano, J.V. 2016: Cost-utility and biological underpinnings of Mindfulness-Based Stress Reduction (MBSR) versus a psychoeducational programme (FibroQoL) for fibromyalgia: a 12-month randomised controlled trial (EUDAIMON study). Bmc Complementary and Alternative Medicine 16: 81
Thongsri, W.; Bussabawalai, T.; Leelahavarong, P.; Wanitkun, S.; Durongpisitkul, K.; Chaikledkaew, U.; Teerawattananon, Y. 2016: Cost-utility and budget impact analysis of drug treatments in pulmonary arterial hypertension associated with congenital heart diseases in Thailand. Expert Review of Pharmacoeconomics and Outcomes Research 16(4): 525-536
Babigumira, J.B.; Lubinga, S.J.; Castro, E.; Custer, B. 2018: Cost-utility and budget impact of methylene blue-treated plasma compared to quarantine plasma. Blood Transfusion 16(2): 154-162
de la Torre-Díez, I.; López-Coronado, M.; Vaca, C.; Aguado, Jús.Saez.; de Castro, C. 2015: Cost-utility and cost-effectiveness studies of telemedicine, electronic, and mobile health systems in the literature: a systematic review. Telemedicine Journal and E-Health: the Official Journal of the American Telemedicine Association 21(2): 81-85
Rowland, M.R.; Lesnock, J.L.; Farris, C.; Kelley, J.L.; Krivak, T.C. 2015: Cost-utility comparison of neoadjuvant chemotherapy versus primary debulking surgery for treatment of advanced-stage ovarian cancer in patients 65 years old or older. American Journal of Obstetrics and Gynecology 212(6): 763.E1-8
Thomas, K.; Peter, J.V.; Christina, J.; Jagadish, A.R.; Rajan, A.; Lionel, P.; Jeyaseelan, L.; Yadav, B.; John, G.; Pichamuthu, K.; Chacko, B.; Pari, P.; Murugesan, T.; Rajendran, K.; John, A.; Sathyendra, S.; Iyyadurai, R.; Jasmine, S.; Karthik, R.; Mathuram, A.; Hansdak, S.G.; Abhilash, K.P.P.; Kumar, S.; John, K.R.; Sudarsanam, T.D. 2015: Cost-utility in medical intensive care patients. Rationalizing ongoing care and timing of discharge from intensive care. Annals of the American Thoracic Society 12(7): 1058-1065
Zulliger, R.; Maulsby, C.; Solomon, L.; Baytop, C.; Orr, A.; Nasrullah, M.; Shouse, L.; DiNenno, E.; Holtgrave, D. 2017: Cost-utility of HIV Testing Programs Among Men Who Have Sex with Men in the United States. Aids and Behavior 21(3): 619-625
Slaman, J.; van den Berg-Emons, R.; Tan, S.S.; Russchen, H.; van Meeteren, J.; Stam, H.; Roebroeck, M.; van Meeteren, J.; van der Slot, W.; van Markus, F.; Dallmeijer, A.; Wensink, A. 2015: Cost-utility of a lifestyle intervention in adolescents and young adults with spastic cerebral palsy. Journal of Rehabilitation Medicine 47(4): 338-345
Konnopka, A.; König, H.-H.; Kaufmann, C.; Egger, N.; Wild, B.; Szecsenyi, J.; Herzog, W.; Schellberg, D.; Schaefert, R. 2016: Cost-utility of a specific collaborative group intervention for patients with functional somatic syndromes. Journal of Psychosomatic Research 90: 43-50
Lamond, N.W.D.; Skedgel, C.; Rayson, D.; Younis, T. 2015: Cost-utility of adjuvant zoledronic acid in patients with breast cancer and low estrogen levels. Current Oncology 22(4): E246-E253
Bruhn, D.; Martin, A.A.; Tavares, R.; Hunt, B.; Pollock, R.F. 2016: Cost-utility of albiglutide versus insulin lispro, insulin glargine, and sitagliptin for the treatment of type 2 diabetes in the US. Journal of Medical Economics 19(7): 672-683
Aardoom, J.J.; Dingemans, A.E.; van Ginkel, J.R.; Spinhoven, P.; Van Furth, E.F.; Van den Akker-van Marle, M.E. 2016: Cost-utility of an internet-based intervention with or without therapist support in comparison with a waiting list for individuals with eating disorder symptoms: a randomized controlled trial. International Journal of Eating Disorders 49(12): 1068-1076
Chowdhury, E.K.; Ademi, Z.; Moss, J.R.; Wing, L.M.H.; Reid, C.M. 2015: Cost-utility of angiotensin-converting enzyme inhibitor-based treatment compared with thiazide diuretic-based treatment for hypertension in elderly Australians considering diabetes as comorbidity. Medicine 94(9): E590
Norton, G.; McDonough, C.M.; Cabral, H.; Shwartz, M.; Burgess, J.F. 2015: Cost-utility of cognitive behavioral therapy for low back pain from the commercial payer perspective. Spine 40(10): 725-733
Goorden, M.; Huijbregts, K.M.L.; van Marwijk, H.W.J.; Beekman, A.T.F.; van der Feltz-Cornelis, C.M.; Hakkaart-van Roijen, L. 2015: Cost-utility of collaborative care for major depressive disorder in primary care in the Netherlands. Journal of Psychosomatic Research 79(4): 316-323
Darbà, J.; Kaskens, L.; Sorio Vilela, F.; Lothgren, M. 2015: Cost-utility of denosumab for the treatment of postmenopausal osteoporosis in Spain. Clinicoeconomics and Outcomes Research: Ceor 7: 105-117
Tan, S.S.; Teirlinck, C.H.; Dekker, J.; Goossens, L.M.A.; Bohnen, A.M.; Verhaar, J.A.N.; van Es, P.P.; Koes, B.W.; Bierma-Zeinstra, S.M.A.; Luijsterburg, P.A.J.; Koopmanschap, M.A. 2016: Cost-utility of exercise therapy in patients with hip osteoarthritis in primary care. Osteoarthritis and Cartilage 24(4): 581-588
Maruszczak, M.J.; Montgomery, S.M.; Griffiths, M.J.S.; Bergvall, N.; Adlard, N. 2015: Cost-utility of fingolimod compared with dimethyl fumarate in highly active relapsing-remitting multiple sclerosis (RRMS) in England. Journal of Medical Economics 18(11): 874-885
Soini, E.J.; Hallinen, T.; Sokka, A.-L.; Saarinen, K. 2015: Cost-utility of first-line actinic keratosis treatments in Finland. Advances in Therapy 32(5): 455-476
Polinder, S.; Boyé, N.D.A.; Mattace-Raso, F.U.S.; Van der Velde, N.; Hartholt, K.A.; De Vries, O.J.; Lips, P.; Van der Cammen, T.J.M.; Patka, P.; Van Beeck, E.F.; Van Lieshout, E.M.M.; van der Cammen, T.J.M.; Patka, P.; Van Beeck, E.F.; Van der Velde, N.; Van Lieshout, E.M.M.; Polinder, S.; Mattace-Raso, F.U.S.; Hartholt, K.A.; Boyé, N.D.A.; Looman, C.W.N.; Lips, P.; De Vries, O.J.; Kerver, A.J.H.; Bruijninckx, M.M.M.; de Vries, M.R.; Ziere, G. 2016: Cost-utility of medication withdrawal in older fallers: results from the improving medication prescribing to reduce risk of FALLs (IMPROveFALL) trial. Bmc Geriatrics 16(1): 179
Phan, K.; Hogan, J.A.; Mobbs, R.J. 2015: Cost-utility of minimally invasive versus open transforaminal lumbar interbody fusion: systematic review and economic evaluation. European Spine Journal: Official Publication of the European Spine Society the European Spinal Deformity Society and the European Section of the Cervical Spine Research Society 24(11): 2503-2513
Kourlaba, G.; Relakis, J.; Mahon, R.; Kalogeropoulou, M.; Pantelopoulou, G.; Kousidou, O.; Maniadakis, N. 2016: Cost-utility of ranibizumab versus aflibercept for treating Greek patients with visual impairment due to diabetic macular edema. Cost Effectiveness and Resource Allocation: C/E 14: 7
Van der Linden, N.; Flach, G.ék.B.; de Bree, R.; Uyl-de Groot, C.A. 2016: Cost-utility of sentinel lymph node biopsy in cT1-T2N0 oral cancer. Oral Oncology 53: 20-26
Nord, E. 2015: Cost-value analysis of health interventions: introduction and update on methods and preference data. Pharmacoeconomics 33(2): 89-95
Gatell Artigas, J.M.ía.; Arribas López, J.é R.ón.; Lázaro Y de Mercado, P.; Blasco Bravo, A.J. 2016: Cost/efficacy analysis of preferred Spanish AIDS study group regimens and the dual therapy with lopinavir/ritonavir plus lamivudine for initial ART in HIV infected adults. Enfermedades Infecciosas y Microbiologia Clinica 34(7): 427-430
Lenz, H.; Moss, M.E.; Owens, P.; Proctor, S.; Slone, S.; Edwards, S. 2015: Costa Rica Mission Trip. Kentucky Nurse 63(3): 14-15
Wade, L. 2014: Costa Rica. Celebrated biodiversity institute faces financial crisis. Science 346(6216): 1440
Fedok, F.G. 2016: Costal Cartilage Grafts in Rhinoplasty. Clinics in Plastic Surgery 43(1): 201-212
Barham, H.P.; Knisely, A.; Christensen, J.; Sacks, R.; Marcells, G.N.; Harvey, R.J. 2015: Costal Cartilage Lateral Crural Strut Graft vs Cephalic Crural Turn-in for Correction of External Valve Dysfunction. JAMA Facial Plastic Surgery 17(5): 340-345
David, V.-L.; Cerbu, S.; Haragus, H.; Popoiu, M.-C.; Stanciulescu, C.-M.; Cozma, G.; Burlacu, O.; Boia, E.-S. 2016: Costal Cartilages do not Overgrow in Patients with Pectus Excavatum. Medical Principles and Practice: International Journal of the Kuwait University Health Science Centre 25(6): 533-538
Bachelet, J.-T.; Bourlet, J.ôm.; Château, J.; Jacquemart, M.; Dufour, C.ém.; Mojallal, A.; Gleizal, A. 2015: Costal Grafting in Mandibular Reconstruction. Plastic and Reconstructive Surgery. Global Open 3(11): E565
Brooker, J.E.; Gusenoff, J.A. 2014: Costal bone abnormalities: an unusual cause of spontaneous bilateral breast implant deflation†. Journal of Surgical Case Reports 2014(12)
Quesnot, M.; Zorgani, A.; Bermond, F.; Catheline, S.; Mitton, D. 2015: Costal cartilage elasticity can be estimated non-destructively using speed of sound. Computer Methods in Biomechanics and Biomedical Engineering 18 Suppl. 1: 2032-2033
Ma, J.; Cai, L.; Wang, K.; Wang, C.; Li, X.; Zhao, X.; Zhang, T. 2016: Costal cartilage for rhinoplasty. Zhonghua Zheng Xing Wai Ke Za Zhi 32(1): 25-28
Fukuda, N.; Asato, H.; Umekawa, K.; Takada, G.; Kan, T.; Sasaki, S. 2017: Costal cartilage graft with perichondrium, a possible anti-adhesive material. Journal of Plastic Surgery and Hand Surgery 51(4): 247-253
Yoon, J.S.; Kwon, J.B.; Park, C.B.; Suh, J.H. 2015: Costal exostoses as an unusual cause of spontaneous hemothorax. Journal of Cardiothoracic Surgery 10: 135
Jaka, O.; Casas-Fraile, L.; López de Munain, A.; Sáenz, A. 2015: Costamere proteins and their involvement in myopathic processes. Expert Reviews in Molecular Medicine 17: E12
Wang, H.I.; Smith, A.; Roman, E.; Crouch, S.; Jack, A.; Patmore, R. 2014: Costed Treatment Pathways of Diffuse Large B Cell Lymphoma in a UK Population-Based Cohort: a Patient Level Simulation Model. Value in Health: the Journal of the International Society for Pharmacoeconomics and Outcomes Research 17(7): A624-A625
Sriboonnark, L.; Arora, H.; Falto-Aizpurua, L.; Choudhary, S.; Connelly, E.A. 2015: Costello syndrome with severe nodulocystic acne: unexpected significant improvement of acanthosis nigricans after oral isotretinoin treatment. Case Reports in Pediatrics 2015: 934865
Wirtz, M.; Frank, J. 2015: Costello syndrome. a rare RASopathy with cutaneous symptoms. Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 66(4): 225-228
Calandrelli, R.; D'Apolito, G.; Marco, P.; Zampino, G.; Tartaglione, T.; Colosimo, C. 2015: Costello syndrome: Analysis of the posterior cranial fossa in children with posterior fossa crowding. Neuroradiology Journal 28(3): 254-258
Adams, A.B.; Ford, M.L.; Larsen, C.P. 2016: Costimulation Blockade in Autoimmunity and Transplantation: the CD28 Pathway. Journal of Immunology 197(6): 2045-2050
Malvezzi, P.; Jouve, T.; Rostaing, L. 2016: Costimulation Blockade in Kidney Transplantation: An Update. Transplantation 100(11): 2315-2323
Rostaing, L.; Malvezzi, P. 2016: Costimulation Blockade in Kidney Transplantation: Beyond Belatacept. Transplantation 100(12): 2516-2518
Tsurutani, N.; Mittal, P.; St Rose, M.-C.; Ngoi, S.M.; Svedova, J.; Menoret, A.; Treadway, F.B.; Laubenbacher, R.; Suárez-Ramírez, J.E.; Cauley, L.S.; Adler, A.J.; Vella, A.T. 2016: Costimulation Endows Immunotherapeutic CD8 T Cells with IL-36 Responsiveness during Aerobic Glycolysis. Journal of Immunology 196(1): 124-134
Abken, H. 2016: Costimulation Engages the Gear in Driving CARs. Immunity 44(2): 214-216
Kim, H.-H.; Lee, K.-H.; Lee, D.; Han, Y.-E.; Lee, S.-H.; Sohn, J.-W.; Ho, W.-K. 2015: Costimulation of AMPA and metabotropic glutamate receptors underlies phospholipase C activation by glutamate in hippocampus. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 35(16): 6401-6412
Lim, H.-S.; Cordoba, S.-P.; Dushek, O.; Goyette, J.; Taylor, A.; Rudd, C.E.; van der Merwe, P.A. 2015: Costimulation of IL-2 Production through CD28 Is Dependent on the Size of its Ligand. Journal of Immunology 195(11): 5432-5439
Chen, J.; Luo, Y.; Li, J.; Zhou, X.; Cao, J.; Wang, R.-W.; Wang, Y.; Shelton, S.; Jin, Z.; Walker, L.M.; Feng, Z.; Niu, S.; Feng, W.; Jian, S.; Zhou, L. 2017: Costimulation of soil glycosidase activity and soil respiration by nitrogen addition. Global Change Biology 23(3): 1328-1337
Wright, S.E.; Rewers-Felkins, K.A.; Quinlin, I.; Zohra, F.; Ahmed, J. 2016: Costimulation with anti-cluster of differentiation 3 and anti-cluster of differentiation 28 reduces the activity of mucin 1-stimulated human mononuclear cells. Oncology Letters 11(1): 461-465
Augustine, J.; Hricik, D.E. 2016: Costimulatory Blockade and use of Mammalian Target of Rapamycin Inhibitors: Avoiding Injury Part 1. Advances in Chronic Kidney Disease 23(5): 301-305
Wojciechowski, D.; Vincenti, F. 2016: Costimulatory Blockade and use of mTOR Inhibitors: Avoiding Injury Part 2. Advances in Chronic Kidney Disease 23(5): 306-311
Eickhoff, C.S.; Zhang, X.; Vasconcelos, J.R.; Motz, R.Geoffrey.; Sullivan, N.L.; O'Shea, K.; Pozzi, N.; Gohara, D.W.; Blase, J.R.; Di Cera, E.; Hoft, D.F. 2016: Costimulatory Effects of an Immunodominant Parasite Antigen Paradoxically Prevent Induction of Optimal CD8 T Cell Protective Immunity. Plos Pathogens 12(9): E1005896
Attanasio, J.; Wherry, E.J. 2016: Costimulatory and Coinhibitory Receptor Pathways in Infectious Disease. Immunity 44(5): 1052-1068
Esposito, P.; Rampino, T.; Dal Canton, A. 2015: Costimulatory blockade: a novel approach to the treatment of glomerular disease?. World Journal of Methodology 5(2): 20-25
Lewis, M.; Lee, A. 2016: Costing 'healthy' food baskets in Australia - a systematic review of food price and affordability monitoring tools, protocols and methods. Public Health Nutrition 19(16): 2872-2886
Scarf, V.; Catling, C.; Viney, R.; Homer, C. 2016: Costing Alternative Birth Settings for Women at Low Risk of Complications: a Systematic Review. Plos one 11(2): E0149463
Galactionova, K.; Bertram, M.; Lauer, J.; Tediosi, F. 2015: Costing RTS,S introduction in Burkina Faso, Ghana, Kenya, Senegal, Tanzania, and Uganda: a generalizable approach drawing on publicly available data. Vaccine 33(48): 6710-6718
Bacate, M.L.; Silvestre, M.A.; Capili, D.S.; Salaveria-Imperial, M.L.; Tan, M.C.; Reyes, K.A.; Nuevo, C.E.; Santillan, M.; Zeck, W.; Bermejo, R.A.; Co, P.A. 2015: Costing the National Health Insurance Program Prematurity Benefit Package: The Philippine Experience. Value in Health 18(7): A534
Waterlander, W.E.; Mackay, S. 2016: Costing a healthy diet: measurement and policy implications. Public Health Nutrition 19(16): 2867-2871
Frappier, J.; Tremblay, G.; Charny, M.; Cloutier, L.M. 2015: Costing bias in economic evaluations. Journal of Medical Economics 18(8): 596-599
Thakur, J.; Prinja, S.; Jeet, G.; Bhatnagar, N. 2016: Costing of a State-Wide Population Based Cancer Awareness and Early Detection Campaign in a 2.67 Million Population of Punjab State in Northern India. Asian Pacific Journal of Cancer Prevention: Apjcp 17(2): 791-797
Flessa, S.; Zembok, A. 2014: Costing of diabetes mellitus type Ii in Cambodia. Health Economics Review 4(1): 24
Shemilt, I.; Valentine, J.C.; Pössel, P.; Mugford, M.; Wooldridge, D.T. 2012: Costing program implementation using systematic reviews: interventions for the prevention of adolescent depression. Research Synthesis Methods 3(3): 191-201
Jordan, H.; Dunt, D.; Hollingsworth, B.; Firestone, S.M.; Burgman, M. 2016: Costing the Morbidity and Mortality Consequences of Zoonoses Using Health-Adjusted Life Years. Transboundary and Emerging Diseases 63(5): E301-E312
Shretta, R.; Johnson, B.; Smith, L.; Doumbia, S.; de Savigny, D.; Anupindi, R.; Yadav, P. 2015: Costing the supply chain for delivery of ACT and RDTs in the public sector in Benin and Kenya. Malaria Journal 14: 57
Almora-Barrios, N.; Carchini, G.; Błoński, P.; López, N.úr. 2014: Costless Derivation of Dispersion Coefficients for Metal Surfaces. Journal of Chemical Theory and Computation 10(11): 5002-5009
Schechtman, H.; Souza, M.O. 2015: Costly Inheritance and the Persistence of Insecticide Resistance in Aedes aegypti Populations. Plos one 10(5): E0123961
Lee, S.-i. 2015: Costly Lessons from the 2015 Middle East Respiratory Syndrome Coronavirus Outbreak in Korea. Journal of Preventive Medicine and Public Health 48(6): 274-276
Pascacio-Villafán, C.; Williams, T.; Sivinski, J.; Birke, A.; Aluja, M. 2015: Costly Nutritious Diets do not Necessarily Translate into Better Performance of Artificially Reared Fruit Flies (Diptera: Tephritidae). Journal of Economic Entomology 108(1): 53-59
Hall, D.L.; Cohen, A.B.; Meyer, K.K.; Varley, A.H.; Brewer, G.A. 2015: Costly Signaling Increases Trust, even Across Religious Affiliations. Psychological Science 26(9): 1368-1376
Harrington, K. 2016: Costly and Unnecessary?. Texas Medicine 112(12): 41-46
Schilsky, M.L.; Roberts, E.A.; Hahn, S.; Askari, F. 2015: Costly choices for treating Wilson's disease. Hepatology 61(4): 1106-1108
Crocombe, L.A.; Kraatz, J.; Hoang, H.; Qin, D.; Godwin, D. 2015: Costly chronic diseases: a retrospective analysis of Chronic Disease Dental Scheme expenditure. Australian Health Review: a Publication of the Australian Hospital Association 39(4): 448-452
Ashkar, L.K.; Hafiz, R.M. 2016: Costly coagulation profile tests prior to performing breast biopsies. do we really need it?. Saudi Medical Journal 37(6): 638-640
Iacobucci, G. 2015: Costly hospital mergers have not delivered solutions to failing trusts, says report. Bmj 351: H5090
Costa, T.M.; Hebets, E.A.; Melo, D.; Willemart, R.H. 2016: Costly learning: preference for familiar food persists despite negative impact on survival. Biology Letters 12(7)
Tasimi, A.; Wynn, K. 2016: Costly rejection of wrongdoers by infants and children. Cognition 151: 76-79
Geniole, S.N.; Cunningham, C.E.; Keyes, A.E.; Busseri, M.A.; McCormick, C.M. 2015: Costly retaliation is promoted by threats to resources in women and threats to status in men. Aggressive Behavior 41(6): 515-525
McAuliffe, K.; Jordan, J.J.; Warneken, F. 2015: Costly third-party punishment in young children. Cognition 134: 1-10
Sanabria, C.; Cabrejos, J.; Olortegui, A.; Guevara, C.; Garrido Lecca, S. 2015: Costo - Efectividad de Apixaban con Otros Noacs (Dabigatran y Rivaroxaban) en el Tratamiento de la Fibrilacion Auricular no Valvular (Fanv) en Pacientes de la Seguridad Social de Perú. Value in Health 18(7): A829
Karpf, E.; Londoño, D.; Olaya, A. 2015: Costo - efectividad de la combinacion de glicopirronio/indacaterol vs. Salmeterol/ fluticasona (combinacion de dosis fija - cdf) en el manejo de los pacientes con enfermedad pulmonar obstructiva cronica (epoc) en colombia (sur américa). Value in Health 18(7): A840
Gutierrez-Aguado, A.; Escobedo-Palza, S.; Timana-Ruiz, R.; Sobrevilla-Ricci, A.; Mosqueira-Lovón, R. 2015: Costo de Cáncer de Colon Avanzado en los Establecimientos Hospitalarios del Perú. Value in Health 18(7): A805
Sobrevilla-Ricci, A.; Mosqueira-Lovón, R.; Gutierrez-Aguado, A.; Escobedo-Palza, S.; Timana-Ruiz, R. 2015: Costo de Cáncer de Cuello Uterino en los Establecimientos de Salud del Perú. Value in Health 18(7): A820
Mosqueira-Lovón, R.; Gutierrez-Aguado, A.; Escobedo-Palza, S.; Timana-Ruiz, R.; Sobrevilla-Ricci, A. 2015: Costo de Cáncer de Mama en los Establecimientos de Salud del Perú. Value in Health 18(7): A819
Timana-Ruiz, R.; Sobrevilla-Ricci, A.; Mosqueira-Lovón, R.; Gutierrez-Aguado, A.; Escobedo-Palza, S. 2015: Costo de Cáncer de Prostata en los Establecimientos Hospitalarios del Perú. Value in Health 18(7): A819-A820
Escobedo-Palza, S.; Timana-Ruiz, R.; Sobrevilla-Ricci, A.; Mosqueira-Lovón, R.; Gutierrez-Aguado, A. 2015: Costo de Cáncer Gástrico Avanzado en los Establecimientos Hospitalarios del Perú. Value in Health 18(7): A820
Gutierrez-Aguado, A.; Escobedo-Palza, S.; Timana-Ruiz, R.; Sobrevilla-Ricci, A.; Mosqueira-Lovón, R. 2015: Costo de Diabetes Mellitus no Complicada en los Establecimientos de Salud del Perú. Value in Health 18(7): A863
Mosqueira-Lovón, R.; Gutierrez-Aguado, A.; Escobedo-Palza, S.; Timana-Ruiz, R.; Sobrevilla-Ricci, A. 2015: Costo de Enfermedades Mentales Prevalentes en Perú. Value in Health 18(7): A837-A838
Escobedo-Palza, S.; Timana-Ruiz, R.; Sobrevilla-Ricci, A.; Mosqueira-Lovón, R.; Gutierrez-Aguado, A. 2015: Costo de Hipertension Arterial en los Establecimientos de Salud del Perú. Value in Health 18(7): A829
Timana-Ruiz, R.; Sobrevilla-Ricci, A.; Mosqueira-Lovón, R.; Gutierrez-Aguado, A.; Escobedo-Palza, S. 2015: Costo de Tuberculosis en los Establecimientos de Salud del Perú. Value in Health 18(7): A839
Parody, E.; Guevara, C.A.; Aguirre, A.F. 2015: Costo Efectividad De La Adici"N De Bevacizumab Al Esquema De Primera Línea De Quimioterapia Carboplatino + Paclitaxel En Pacientes Con Cáncer De Pulm"N De Celula No Pequeña No Escamosa Con Ecog Entre 0 Y 1. Value in Health 18(7): A822
Acuña, L.; Soler, L.; Sanchez, P.; Bryon, A. 2015: Costo Efectividad de la Hemodiálisis en los Prestadores de Servicios de dos Aseguradoras a Través de la Evaluación de Indicadores Mínimos para el Análisis de Resultados Clínicos de la Terapia Dialítica en Colombia. Value in Health 18(7): A845-A846
Guevara, C.A.; Parody, E.; Aguirre, A.F. 2015: Costo Efectividad De Múltiples Alternativas Diagn"Sticas En Pacientes Con Sospecha De Cáncer De Pulm"N En Colombia. Value in Health 18(7): A859-A860
Romero, M.; Alfonso Quiñones, P.A.; Benavides, M. 2015: Costo Efectividad y Costo Utilidad del uso de Undecanoato de Testosterona Inyectable en Pacientes con Hipogonadismo y Diabetes Mellitus Tipo 2 en Colombia. Value in Health 18(7): A865
Sánchez, E. 2015: Costo Efectividad de la Terapia Inmunomoduladora en Esclerosis Multiple Tipo Recaída Remision: Busqueda Sistemática de la Literatura. Value in Health 18(7): A879-A880
Corilloclla, R.; Yarma, E.; Quispe, A.; Flores, E. 2015: Costo En Salud De La Intervenci"N En La Atenci"N Del Parto Normal En El Peru 2009 Y 2014. Value in Health 18(7): A833
Carbajal, L. 2015: Costo en Salud del Programa Presupuestal de Salud Materno Neonatal para Reducir la Tasa de Mortalidad Materna y Neonatal en el Perú, 2009 - 2014. Value in Health 18(7): A834
Yarma, E.; Velazco, C.; Gutierrez-Aguado, A. 2015: Costo En Salud En La Intervenci"N De Suplemento De Hierro En Niños De 6 A Menos De 36 Meses De Edad Para Reducir La Anemia En El Perú, 2009-2014. Value in Health 18(7): A844
Figueroa Collado, J.R.; Reynoso Gutierrez, G.F.; Gutierrez-Aguado, A. 2015: Costo en Salud en la Intervencion de Prevencion y Control de Cáncer en el Instituto Nacional de Enfermedades Neoplásicas, 2010-2014. Value in Health 18(7): A821
Sobrevilla-Ricci, A.; Mosqueira-Lovón, R.; Gutierrez-Aguado, A.; Escobedo-Palza, S.; Timana-Ruiz, R. 2015: Costo de Enfermedades Metaxenicas en Los Establecimientos de Salud del Perú. Value in Health 18(7): A869
Ninapaytan, C.; Quispe, A.; Gutierrez, A. 2015: Costo en Salud en la Intervencion de Atencion Integral de Personas Diagnosticadas Con Vih/Sida Para Reducir La Morbimortalidad Por Vih/Sida En El Perú, 2011-2014. Value in Health 18(7): A874
Parody, E.; Guevara, C.A.; Aguirre, A.F.; Tello, P. 2015: Costo-Efectividad De La Cuantificaci"N De La Actividad Enzimática En Leucocitos En Comparaci"N A Su No Realizaci"N Para La Confirmaci"N Diagn"Stica De La Mucopolisacaridosis Tipo Iva En Colombia. Value in Health 18(7): A860
Castro Rodriguez, R.; Rueda-Gallardo, J.A.; Avella Niño, M.F.; Lopez, J.G.; Caicedo Navas, A.G. 2015: Costo-Efectividad de la Vacuna Contra el Dengue 2014. Value in Health 18(7): A871-A872
Garcia Peña, A.A. 2015: Costo-Efectividad de los Nuevos Anticoagulantes Orales en Pacientes con Fibrilacion Auricular no Valvular en Colombia. Value in Health 18(7): A829-A830
Pérez Sosa, M.; Garcia Nuncira, C.Y. 2015: Costo-Efectividad de Octreotide Lar Comparado con Terapia de Soporte Usual para el Tratamiento de Tumores Neuroendocrinos de Intestino Medio en Colombia. Value in Health 18(7): A821
Guevara, C.A.; Parody, E.; Aguirre, A.F. 2015: Costo-Efectividad de Toracotomía versus Videotoracoscopia en Pacientes con Cáncer de Pulmón de Célula no Pequeña en Estadio I. Value in Health 18(7): A821
Guarin, N.E.; Arevalo, H.O.; Moreno, J.A.; Diaz, J.A.; Muñoz-Galindo, I.M. 2015: Costo-Efectividad de un Programa de Nefroproteccion en una Cohorte de 17.000 Pacientes con Enfermedad Renal Cronica Afiliados a una Aseguradora en Salud en Colombia. Value in Health 18(7): A827
Osorio, D.; Avellaneda, P.; Mejía, A. 2015: Costo-Efectividad del Desfibrilador Externo Automático (Dea) Comparado con Reanimación Cardiopulmonar Básica (Rcp) en Colombia. Value in Health 18(7): A860
Rosselli, D.; Rueda, J.D.; Andrade, A.J.; Prieto, V.A. 2015: Costo-Utilidad de Un Esquema Inicial de Tratamiento Con Tofacitinib Comparado Con Terapia Biologica Anti-Tnf en Pacientes Adultos Con Artritis Reumatoide Que Han Presentado Respuesta Inadecuada a Metotrexato en Venezuela. Value in Health 18(7): A875
Sharma, H.; Chowdhury, S.; Navaneetham, A.; Upadhyay, S.; Alam, S. 2015: Costochondral Graft as Interpositional material for TMJ Ankylosis in Children: a Clinical Study. Journal of Maxillofacial and Oral Surgery 14(3): 565-572
Wu, B.-Z.; Ma, L.; Li, Y.; Chen, S.; Yi, B. 2017: Costochondral Graft in Young Children with Hemifacial Microsomia. Journal of Craniofacial Surgery 28(1): 129-133
Tahiri, Y.; Chang, C.S.; Tuin, J.; Paliga, J.T.; Lowe, K.M.; Taylor, J.A.; Bartlett, S.P. 2015: Costochondral grafting in craniofacial microsomia. Plastic and Reconstructive Surgery 135(2): 530-541
Gaete, R. 2015: Costos Unitarios de Servicios Brindados Por Una Unidad de Salud de la Familia: Evidencia en el Caso Paraguayo. Value in Health 18(7): A851-A852
Alvis-Guzman, N.; Castañeda-Orjuela, C.; Carrasquilla-Sotomayor, M.; Sanchez-Ruiz, C.; Mena, R.; Marin-Correa, C. 2015: Costos de Hospitalización Por Infección Respiratoria Aguda Grave (Irag) en Guatemala. Value in Health 18(7): A870
Alvis-Guzman, N.; Carrasquilla-Sotomayor, M.; Salcedo Mejía, F.; Pinzón-Redondo, H.; Coronell-Rodriguez, W.; Dueñas Castell, C.; Marin-Correa, C. 2015: Costos de Infección Respiratoria Aguda Grave Asociada Al Virus de La Influenza en Colombia. Value in Health 18(7): A870
Jumpa, D.; GalvÁn, S. 2015: Costos de Medicamentos en el Marco de un Programa Presupuestal Para el Vih/Sida en Perú, 2012-2014. Value in Health 18(7): A873
Carrasquilla-Sotomayor, M.; Alvis-Guzman, N.; Alvis-Zakzuk, N.; Coronel-Rodriguez, W. 2015: Costos económicos de la otitis media aguda. Una revisión de la literatura. Value in Health 18(7): A869-A870
De Iure, F.; Amendola, L.; Corghi, A.; Cappuccio, M. 2015: Costotransverse screw fixation in a severe cervicothoracic deformity because of a type 1 neurofibromatosis: case report. Spine Journal: Official Journal of the North American Spine Society 15(8): E5-10
Torres, C.; Oyagüez, I.; Prieto, L.; Rodriguez, G.; Esteban, J. 2015: Costs Analysis of Pcr Unyverotm I60-Iti Technique for Detecting Microorganisms in Patients with Suspected Chronic Infection at Musculoskeletal Implants. Value in Health 18(7): A351
Davidson, T.; Iwarsson, E.; Jacobsson, B.; Dagerhamn, J.; Heibert Arnlind, M. 2015: Costs and Cost-Effectiveness of Non-Invasive Prenatal Diagnosis (Nipt) for Detection of Trisomy 21 in Sweden. Value in Health 18(7): A352